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Abstract 
 
Reviewing the current literature for the phytochemical importance of the plants 
belonging to genus Jatropha revealed broad range of secondary metabolites isolated 
such as, diterpenoids, triterpenoids, non-conventional coumarino-lignoids, alkaloids, 
coumarins, flavonoids, cyclic peptides and steroids. This is indeed a reflection on the 
versatility of the enzymatic system present in the plants belonging to the family 
Euphorbiaceae but nothing was reported regarding pelargoniifolia species. Thus, it was 
of interest to explore the active constituents and biological importance for the titled 
plant which is used traditionally to cure ulcers and wounds in Ethiopia and Saudi 
Arabia.  
               In vivo and in vitro studies were carried out to evaluate the potential 
hepatoprotective, antinociceptive, anti-inflammatory and antidiabetic/hypoglycemic 
effects of the total alcoholic extracts of aerial parts and roots of J. pelargoniifolia and 
J. glauca species in comparison to those of standard clinical drugs. As the result, the 
roots of J. glauca showed higher hepatoprotective and antinociceptive (63.85%) 
activities in comparison to indomethacin (69.87%). In addition, the root extracts from 
J. pelargoniifolia exhibited greater anti-inflammatory (50.63%) and hypoglycemic 
(37.98%) activities when compared with phenylbutazone (64.63%) and glibenclamide 
(51.57%), respectively. Finally, extracts from the aerial parts of J. glauca showed 
significantly higher anti-diabetic activity in mice with alloxan-induced diabetes 
(39.93%) when compared with glibenclamide (47.13%). 
             Moreover, the chemical composition of the essential oil separated from J. 
pelargoniifolia roots was determined via GC-FID, resulting in isolation of 80 
compounds representing 99.99% of the total oil constituents. Among these, 77.31% 
were sesquiterpenes, 14.62% were fatty acids, 7.21% were other components (i.e., 
phenolics, hydrocarbons, etc.), and 0.85% were monoterpenes. Then, the essential oil 
was evaluated for its potency as an anti-inflammatory, antioxidant, antipyretic, and 
antinociceptive agent by in vivo and in vitro models. The obtained results demonstrated 
that the investigated essential oil of J. pelargoniifolia roots could be used as a natural 
remedy for their anti-inflammatory, antinociceptive, antipyretic, and antioxidant 
effects.  
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Additionally, the chemical composition of the essential oil isolated from roots 
of J. pelargoniifolia was compared with the essential oils isolated from aerial parts of 
the same plant as well with different Jatropha species, J. glauca aerial parts and roots. 
Oxygenated sesquiterpenes and fatty acids were predominant chemical classes in oil 
isolated from roots of both species. On the other hand, oils from aerial parts were high 
in oxygenated diterpenes (35.30% in J. glauca and 32.23% in J. pelargoniifolia). Oils 
from J. pelargoniifolia aerial parts were high in oxygenated sesquiterpenes followed by 
fatty acids, while those from J. glauca were rich in fatty acids and other phenolics 
(hydrocarbons/cyclic). J. glauca and J. pelargoniifolia have similar morphology, 
except for leaf surface (hairy in J. pelargoniifolia and smooth in J. glauca) and fruit 
color (darker in J. pelargoniifolia), and these species are therefore often confused by 
native people in southern Saudi Arabia. This study clarified chemotaxonomic 
characters of J. glauca and J. pelargoniifolia via chemical composition analysis of 
essential oils of roots and aerial parts. 
             Finally, extensive phytochemical study for different fractions of J. 
pelargoniifolia, resulted in the isolation and identification of a total twenty-two 
compounds belonging to different chemical classes of secondary metabolites by using 
different chromatographic techniques. Two new compounds belong to coumarin 
glucoside and alkaloid; 6-hydroxy-8-methoxycoumarin-7-O-β-D-glycopyranoside and 
2-hydroxymethyl-N-methyltryptamine, respectively were isolated and identified for the 
first time from a natural source. The anti-inflammatory, antinociceptive, antipyretic and 
antioxidant activities were evaluated for some isolated compounds which are available 
in good yields.  Compound 2-hydroxymethyl-N-methyltryptamine can be used as 
starting material for semi synthesis of related analogous aiming to produce new drug 
leads used for treatment of contemporary disease such as; depression, anxiety, pain, 
obesity and many more. The roots of J. pelargoniifolia showed also significant 
antinociceptive, anti-inflammatory, antipyretic and free radical scavenging activities 
may be due to its content of many bioactive constituents belong to various chemical 
classes and those results were support the efficient use of this plant in Saudi Traditional 
Medicine as remedy for pain relieve and curing many inflammatory conditions.          
1Chapter  
3 
 
 
 
 
 
 
Introduction and scope of thesis 
 
 
Hanan Yahya Aati (H.A), Ali A. El-Gamal (A.A.G) and Oliver Kayser (O.K) jointly planned 
and designed the chapter; H.A performed the literature review; H.A wrote the manuscript with 
inputs from all coauthors; A.A.G and O.K oversaw the entire project as supervisors of H.A. 
 
 
 
 
 
 
 
The data for this chapter are unpuplished   
 
 
4 
 
1.1. Background 
Since ancient times, nature has been an important source of medicinal agents. This fact 
is illustrated by the large number of natural products currently used medically. The 
value of natural products in this regard can be assessed using three criteria: first, the 
rate of introduction of new chemical entities of wide structural diversity including 
natural products serving as templates for semi-synthetic and total synthetic analogues. 
Secondly, the large number of diseases treated or prevented by these natural substances. 
Thirdly, their frequent use in treatment of diseases. In recent years, there has been 
growing interest in alternative therapies and the therapeutic use of natural products, 
especially those derived from plants. This interest in drugs of plant origin is due to 
several reasons, namely, the frequent inefficiency of conventional medicine, possible 
development of side effects of synthetic drugs, and that a large percentage of the 
world’s poor population doesn’t have access to conventional medical treatment. In 
addition, the long history of use of folk medicine suggests that “natural” products are 
usually harmless. The plant kingdom offers a unique and renewable resource for the 
discovery of potential new drugs and important leads against various medical targets 
including pain, cancer, HIV/AIDS, SARS, Alzheimer’s and malaria [1]. 
The Arabian Peninsula is recognized as an arid area dominated by deserts and 
poor biodiversity. However, the Kingdom of Saudi Arabia (henceforth abbreviated into 
KSA) has a wide range of flora, consisting of different species of trees, herbs, and 
shrubs and containing numerous edible and medicinal plants. The KSA is characterized 
by its vast area of diverse geographical landscapes and climates. Consequently, there is 
enormous variation in the distribution of plants across the Kingdom. The traditional use 
of ethnomedical plants in the KSA represents a strong interconnection among familiar 
remedies, health, diet, and traditional healing practices characterized by specific 
cultures [2]. 
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1.2. Scope and objective of thesis 
Reviewing the current literature for the importance of genus Jatropha growing 
worldwide and comprising about 200 species, revealed many biological interests such 
as, treatments of skin inflammation, eye infection, chest pain, stomach pain, itching and 
as a vermifuge or as ornamental plants and energy crops [3]. J. glauca, J. curcas, J. 
spinose and J. pelargoniifolia are the only four Jatropha species distributed in Saudi 
Arabia and employed as traditional herbal medicines due to their anti-inflammatory, 
antioxidant, antiseptic and analgesic activities [4, 5].  
Interestingly, nothing was reported concerning the study of Jatropha 
pelargoniifolia growing in Saudi Arabia. Thus, it was of interest to explore the active 
constituents and the biological activities for this plant. Jatropha pelargoniifolia used in 
traditional medicine such as, sap of the petiole is applied to ulcers and wound healing 
as well treatment for various type of skin inflammation. It is widely distributed in East 
tropical Africa (Sudan, Eritrea, Ethiopia, Somalia and Kenya) and Arabian Peninsula 
(Yemen, Oman and Saudi Arabia) [6]. 
The aim of this thesis is to give an overview of the values of J. pelargoniifolia 
root which could be serve as one of the most promising candidate groups of natural 
compounds for the development of safer therapeutic agents used for treatment of many 
contemporary diseases.  
The objectives of this cumulative thesis are worked out as individual chapters 
including the following contents:  
-  Chapter 1: Included scope of presented thesis which inclusive the main aim for 
conducting this work. As well a brief discussion of the taxonomy of the family 
Euphorbiaceae and the genus Jatropha and biological activities of Jatropha extracts 
and their constituents. In addition, the biologically-active compounds isolated from 
genus Jatropha were discussed with emphasis on diterpenes, flavonoids, coumarins and 
alkaloids. 
- Chapter 2: Covered the biological activity of the ethanolic extracts of J. 
pelargoniifolia (root and aerial parts) and compared with other Jatroph species growing 
in Saudi Arabia (J. glauca). The folkloric use of J. pelargoniifolia and J. glauca in the 
management of pain and inflammatory conditions were guide us to select some 
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biological activities to be tested. The selected biological activities were an analgesic, 
anti-inflammatory and hepatoprotective activities as well hypoglycemic activity.  
- Chapter 3: It was revealed to the chemical compositions and the biological 
potentialities of the essential oil of Saudi plant, J. pelargoniifolia roots. The promising 
biological activities to be test were anti-inflammatory, antinociceptive, antipyretic and 
antioxidant.  
- Chapter 4: It was indicated the chemical compositions of essential oils of two Saudi 
plants, J. pelargoniifolia and J. glauca roots and aerial parts. This study has a 
significant value from taxonimical point of view. Whereas, the discernibly different 
chemical composition of the essential oils of the two Jatropha species might be useful 
as an aid in solving problems of scientific plant classification of Jatropha species.  
- Chapter 5: This is representing the first report on phytochemical investigation of 
Jatropha pelargoniifolia roots led to isolate many biologically-active compounds some 
of them were new and isolated here for the first time from a natural source also some 
of them have been isolated and identified for the first time in family Euphorbiaceae. 
The anti-inflammatory, antinociceptive, antipyretic and antioxidant activities were 
evaluated for some isolated compounds which are available in good yields. This work 
has enhanced understanding about the phytoconstituents of the selected plant and gave 
evidence about the efficient use of this plant traditionally and this is referred to the 
presence of these active compounds in high yield.  
- Chapter 6: A review of ethnomedicinal native plants used traditionally in Saudi 
Arabia. 
- Chapter 7: Summary and outlook. 
- Chapter 8: Appendices. 
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1.3. Family Euphorbiaceae 
It is considered as one of the sixth largest plant families in the the plant kingdom. It 
covers about 300 genera distributed in approximately 7,800 species and five 
subfamilies worldwide. These genera occur in tropical and subtropical reigons [7, 8]. 
In Saudi Arabia, family Euphorbiaceae is represented by 15 genera (Andrachne 
L., Flueggea Willd, Phyllanthus L., Clutia L., Chrozophora Neck. ex Juss., Ricinus L., 
Mercurialis L., Erythrococca L., Micrococca Benth., Acalypha L., Tragia L., 
Dalechampia L., Jatropha L., Croton L. and Euphorbia L.) [9]. 
1.4. Genus Jatropha 
The genus Jatropha belongs to the family Euphorbiaceae and comprises about 200 
species which are distributed mainly in the tropical and subtropical regions of Americas 
and Africa [10]. It is represented in Saudi Arabia by four species glauca, curcas, 
spinosa and pelargoniifolia [11]. 
1.5. Jatropha pelargoniifolia Courb. 
It is a frutescent plant about 30 cm. high. Leaves bluish-green small, petioled, 3-5 
digitately lobed with serrate margin and covered with smooth silky hairs. Female 
flowers larger and with larger perianth than the male. Capsule pale, straw-colored, 
scaly, 1 cm. long with smooth black seeds. The stem and roots are excreted red latex 
[12].  
In Saudi Arabia, J. pelargoniifolia Courb. grows wildly in the Southern region 
(Asir) and is known locally as "Obab" )بـــــــبع(  [12] (Figures. 1, 2 and 3). 
1.6. Taxonomic classification of J. pelargoniifolia 
 The taxonomists classify the plant as follows:  
 Kingdom: Plantae, family: Euphorbiaceae, genus: Jatropha, and species: 
pelargoniifolia. 
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Figure 1: Jatropha pelargoniifolia Courb. 
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Figure 2: Jatropha pelargoniifolia Courb. (leaves and fruits)   
 
 
 
 
 
 
 
 
                                Figure 3: Jatropha pelargoniifolia Courb. red latex 
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1.7. Some reported biological activities of various Jatropha species 
Jatropha species are spread worldwide and there are some remarkable similarities in 
their medicinal uses. This might well indicate the presence of the same or similar 
compounds with a particular pharmacological action. Sufficient knowledge of the 
biological activity of Jatropha extracts and constituents is now known to account for 
the major traditional uses of this genus. 
1.7.1. Anticancer and antileukaemic activity 
Although there are many kinds of compounds found in Jatropha plants, most attention 
was paid to diterpenes because of their antitumor activity. Kupchan et al. isolated 
jatrophone from J. gossypiifolia which exhibited antileukaemia and anti-
nasopharyngeal carcinoma activity [13]. 
1.7.2. Anti-inflammatory activity 
Anti-inflammatory activity of topical application of J. multifida root powder in paste 
form for ear inflammation was confirmed in albino mice. Its anti-inflammatory activity 
might be due to effects on several mediators and arachidonic acid metabolism involving 
cyclo-oxygenase pathway resulting in prostaglandin formation anti-proliferative 
activity leading to reduction in granular tissue formation and leukocyte migration from 
the vessels [14].  
1.7.3. Anticoagulant and coagulant activities 
Jatropha curcas, a medicinal plant, which is commonly grown in the tropics, is 
traditionally used as a haemostatic. Investigation of the coagulant activity of the latex 
of J. curcas showed that the whole latex significantly reduced the clotting time of 
human blood. Diluted latex, however, prolonged the clotting time, at high dilutions; the 
blood did not clot at all. This indicates that J. curcas latex possesses both procoagulant 
and anticoagulant activities, the former being evident at high concentrations of the 
latex, while the latter is exhibited at low concentrations. This designates that the J. 
curcas latex anticoagulant inhibits a factor or factors in the intrinsic pathway of blood 
coagulation. At this stage, there is no indication of how the procoagulant in the latex 
acts since it affected the prothrombin time (PT) and activated partial thromboplastin 
time (APTT) in a similar manner, causing instant coagulation in both cases. The 
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observation that the latex actually changed from being a procoagulant to an 
anticoagulant upon dilution raises a few possibilities. One possibility is that the two 
activities are exhibited by different factors, each of which functions optimally at 
different concentrations. It is also possible that the same factor acts as a procoagulant 
and as an anticoagulant under different conditions. For example, it has been shown that 
thrombin acts as a procoagulant when it cleaves ﬁbrinogen and promotes the formation 
of a ﬁbrin clot but functions as an anticoagulant when it activates protein C in the 
presence of the cofactor thrombomodulin [15].  
1.7.4. Antibacterial Activity 
Extracts of J. multifida roots effectively inhibited the growth of Bacillus subtilis and 
Staphylococcus aureus at a concentration of 200 mg/disk. Japodagrin and 
Jatrogrossidentadione two macrocylic diterpenoids possessing lathyrane and jatrophane 
skeletons, respectively, isolated from the root of J. podagrica displayed antibacterial 
activity against some Gram-positive bacteria [10]. 
1.7.5. Antidiarrheal activity 
The MeOH extract of J. curcas root showed antidiarrheal activity against castor oil-
induced diarrhea and intraluminal accumulation of fluid. It also reduced gastrointestinal 
motility after charcoal meal administration in albino mice. These results indicated that 
action of J. curcas root MeOH extract could be through a combination of inhibition of 
elevated prostaglandin biosynthesis and reduced propulsive movement of the small 
intestine [10]. 
1.7.6. Antiviral properties 
It is reported that the aqueous extract of the branches of J. curcas inhibited strongly 
the HIV-induced cytopathic effects with low cytotoxicity [16].  
1.7.7. Pregnancy-terminating effect 
The fertility regulatory effect of the fruit of J. curcas was investigated by oral 
administration of different extracts to pregnant rats for varying periods of time. Fetal 
resorption was observed with different extracts, indicating the abortifacient properties 
of this fruit [10].  
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1.7.8. Other Activities 
There are also other activities of Jatropha plants. Hypotensive and vasorelaxant effects 
of alcoholic extract from J. gossypiifolia L. in rats were reported in 2003 [17].    
It has been found that a formulation from J. curcas, can eliminate malaria 
parasites (Plasmodium falciparum and P. malarie) from the peripheral blood of patients 
with malaria. Additionally, it did not show any undesired effects in the patients as well 
as in laboratory rats [18].  
Furthermore, Jatropha oil was used as biodiesel preparation by lipase-catalyzed 
transesterification [19]. J. curcas seed oil is regarded as a potential alternative to diesel 
fuel, and vegetable oils have numerous advantages in this respect because they are safe 
to store, handle and of their high flash points. The fact that jatropha oil cannot be used 
for nutritional purposes without detoxification makes its use as an energy source for 
fuel production, very attractive [20]. 
1.8. Phytochemical investigation of different Jatropha species 
Previous phytochemical investigation of Jatropha species revealed the presence of 
variety of constituents. These compounds include diterpenes, triterpenes, lignanes, 
coumarins, flavonoids, alkaloids, phytosterols, and some others Figure 4. Some 
selected structures are shown below, and their names and the corresponding plant 
sources are collected in the Table 1. As shown in the Table, diterpenes are the 
predominant constituents within the genus of Jatropha. 
 
 
 
 
 
 
 
 
Figure 4: Major chemical constituents reported in genus Jatroph 
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Table 1: Representative examples for chemical constituents isolated from genus Jatropha. 
Compound names Class Source Structure Reference 
Integerrimene 
 
Diterpene 
(Rhamnofolane) 
J. integerrima  
 
 
 
 
 
 
 
 
 
 
 
 
[21] 
Citlalitrione Diterpene 
(Lathyrane) 
J. gossypiifolia  
 
 
 
 
[22] 
Spruceanol 
 
Diterpene 
(Pimarane) 
J. divaricata  
 
 
 
 
 
 
Name R4 R3 R2 R1 
Spruceanol H OH H H 
Cleistanthol H OH H OH 
[23] 
Cleistanthol 
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Table 1: Cont. 
Compound name Class Source Structure Reference 
Jatropha factor C2 
(Phorobol ester) 
 
Diterpene 
(Tigliane) 
J. curcas  
 
 
 
 
 
 
 
 
 
 
 
 
 
[24] 
5-Epieudesmene-1,2,6-triol Sesquiterpenoid J. neopauciflora  
 
 
 
 
[25] 
Friedelin 
 
 
 
 
Triterpene J. curcas  
 
 
 
 
[26] 
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Table 1: Cont. 
Compound names Class Source Structure Reference 
Vitexin 
 
 Flavonoids 
 
 
J. gossypiifolia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name R2 R1 
Vitexin H β-D-Glu. 
Isovitexin β-D-Glu. H 
Apigenin H H 
[27] 
Isovitexin 
Apigenin 
Scopoletin 
 
 
 
Coumarin J. gossypiifolia  [10] 
Gossypiline 
 
 
 
 
 
Lignane J. gossypiifolia  
 
 
 
 
 
 
 
 
 
 
[10] 
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Table 1: Cont. 
Compound names Class Source Structure Reference 
Propacin Coumarino-
lignan 
 
 
J. gossypiifolia  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name R 
Propacin CH3 
Cleomiscosin A CH2OH 
[10] 
 
 
 
 
 
 
 
 
 
 
Cleomiscosin A 
Tetramethylpyrazine 
  
 
Alkaloid J. podagrica  
 
 
 
 
[10] 
 
Jatropham 
  
 
 
Alkaloid 
 
 
 
J. macrorhiza 
 
 
 
 
 
 
[10] 
 
Pyrimidine-2,4-dione Alkaloid J. curcas  
 
 [28] 
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  Table 1: Cont. 
Compound names Class Source Structure Reference 
Curacycline A 
 
 
 
Cyclic peptide 
 
J. curcas   
 
 
[29] 
 
 
Curacycline B  
 
Cyclic peptide J. curcas  
 
 
 
[29] 
 
β-Sitosterol  
 
 
Phytosterol 
 
 
J. maheshwarii  
 
 
 
 
 
 
 
 
[10] 
 
Campesterol Phytosterol J. unicostata   
 
 
 
 
[30] 
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Table 1: Cont. 
Compound names Class Source Structure Reference 
Ferulic acid 
 
 
Miscellaneous J. gossypiifolia  
 
 
 
 
 
[10] 
 
 
Multifidol Miscellaneous J. multifida  
 
 
 
 
 
[10] 
 
 
Multifidol glucoside Miscellaneous J. multifida  
 
 
 
 
[10] 
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2.1. Abstract 
Background: Traditionally, in Saudi Arabia as well as Ethiopia, Jatropha glauca, are 
mashed in water and the resultant liquid is ingested to treat constipation and used as ear 
drops to treat ear pain. Furthermore, the sap is used as an astringent to treat chronic skin 
diseases. The sap from the petiole of Jatropha pelargoniifolia has been used to cure 
ulcers and wounds.  
Objective: The present study aimed to evaluate the biological activities of the total 
alcoholic extracts obtained from the roots and aerial parts of J. pelargoniifolia and J. 
glauca, which belong to the Euphorbiaceae family and are native to Saudi Arabia.  
Materials and methods: In vivo and in vitro studies were carried out to evaluate the 
potential hepatoprotective, antinociceptive, anti-inflammatory, and anti-
diabetic/hypoglycemic effects of the extracts in comparison to those of standard clinical 
drugs. Their hepatoprotective effect was assessed by examining the changes in levels 
of serum biochemical markers such as aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyl transpeptidase 
(GGT), and total bilirubin. The presence of tissue markers such as malonaldehyde 
(MDA), non-protein sulfhydryl groups (NP-SH), and total protein (TP) content was 
evaluated. Antinociceptive activity was explored by the hot plate and writhing methods 
and the anti-inflammatory effect was evaluated by carrageenan-induced paw edema. 
Finally, hypoglycemic and anti-diabetic activities of the extracts from both Jatropha 
plants were evaluated in alloxan-induced diabetic mice. 
Results: The roots of J. glauca showed higher hepatoprotective and antinociceptive 
(63.85%) activities in comparison to indomethacin (69.87%). In addition, the root 
extracts from J. pelargoniifolia exhibited greater anti-inflammatory (50.63%) and 
hypoglycemic (37.98%) activities when compared with phenylbutazone (64.63%) and 
glibenclamide (51.57%), respectively. Finally, extracts from the aerial parts of J. glauca 
showed significantly higher anti-diabetic activity in mice with alloxan-induced diabetes 
(39.93%) when compared with glibenclamide (47.13%). 
Conclusion: Ethanolic extracts from J. glauca and J. pelargoniifolia (root and aerial 
parts) induced analgesic and anti-inflammatory effects; these results justify the use of 
these plants in folk medicine as analgesics and for the treatment of inflammatory 
conditions. In addition, the extracts also showed significant hepatoprotective and 
hypoglycemic/anti-diabetic activities. 
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2.2. Introduction 
Medicinal plants have been used by various cultures globally for many generations; 
they are still used as a primary form of treatment in many parts of the world [1]. 
However, among the 220,000 known plant species, only a small percentage are used as 
dietary supplements or herbal medicinal products by people and for animals [2]. Many 
other plants might also have the potential to be employed as medicinal plants. About 
40% of the drugs used today in modern society are derived from natural products, which 
is why major pharmaceutical industries are interested in drug discovery from plant 
sources. In low-income countries, about 80% of the population relies on folk medicine 
for their primary health care needs, and about 85% of these traditional medicines 
include the use of plant extracts [3, 4]. 
Jatropha species belonging to the Euphorbiaceae family are used in folk 
medicine to cure several illnesses in Africa, Asia, and Latin America [5, 6]. Important 
medicinal species, including J. gossypifolia, J. curcas, J. glandulifera, J. grossidentata, 
J. macrorhiza, J. podagrica, J. multifida, and J. ciliata, have sparked interest in recent 
years because they exhibit significant pharmacological activities, including cytotoxic, 
anti-inflammatory, molluscicidal, insecticidal, fungicidal, antioxidant, antiplatelet-
aggregative, and diuretic activities [7]. 
The only medicinal species growing in Saudi Arabia are J. glauca, J. curcas, J. 
spinose and J. pelargoniifolia, which are known locally as Obeeb, Shareb, Atheb, and 
Obab, respectively. They are used as traditional herbal medicines due to their anti-
inflammatory, antioxidant, and antinociceptive activities [8].  
Traditionally, in Saudi Arabia as well as Ethiopia, all parts of the J. glauca plant, 
including the roots, are mashed in water and the resultant liquid is ingested to treat 
constipation, and used as ear drops to treat ear pain. Furthermore, the sap is used as an 
astringent to treat chronic skin diseases [9]. The sap from the petiole of J. 
pelargoniifolia has been used to cure ulcers and wounds in Ethiopia and Saudi Arabia 
[10]. 
According to Al Zanbagi et al. (2000), only alcoholic and chloroform extracts 
of J. glauca leaves exhibited molluscicidal activity. However, to our knowledge, J. 
glauca and J. pelargoniifolia species have not been studied [11]. The main purpose of 
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our study was to explore the biological activities of both these species in detail in order 
to gain a broader perspective regarding their ethnomedicinal use. Further, we aimed to 
prove the ethnopharmacological claims regarding these species by rational studies. For 
these purposes, ethanolic extracts of the root and aerial parts were obtained and tested 
for their ability to counter pain, inflammation, hepatic problems, and diabetes. 
2.3. Materials and methods 
2.3.1. Chemicals 
Analytical grade solvents (Sigma-Aldrich, St Louis, MO, USA) were used for the 
extraction process. Silymarin was procured from Sigma Aldrich Chemical Company, 
St Louis, MO, USA. Carbon tetrachloride (CCl4) was purchased from E. Merck, 
Germany. The kits for in vitro enzymatic diagnosis were obtained from Roche 
Diagnostics Corporation, UK. Alloxan was purchased from Sigma (USA), while 
Daonil® (glibenclamide), indomethacin, and phenylbutazone were purchased from 
Spimaco (Saudi Arabia).  
2.3.2. Plant material 
J. glauca and J. pelargoniifolia were collected in September 2015 from Wadi Shogare 
and Wadi Mojasas, respectively, in Jazan City, located in the southern region of the 
Kingdom of Saudi Arabia. The identity of the plants was verified by Dr. Jacob Thomas, 
a taxonomist from the Botany and Microbiology Department, College of Science, King 
Saud University, Riyadh, Saudi Arabia. Voucher specimens (#23063 and 23064, 
respectively) for J. glauca and J. pelargoniifolia were kept at the herbarium of the 
College of Science, King Saud University. 
2.3.3. Preparation of organic extracts  
J. glauca and J. pelargoniifolia plants (500 g each) were collected locally and shade-
dried; their roots and aerial parts were separated from each other and ground. Powdered 
roots and aerial parts were subjected to ethanol extraction by cold maceration and 
treatment with 80% EtOH (3 × 700 mL each). The ethanolic extracts were concentrated 
using a rotary evaporator at 40°C, to obtain a dark green residue from the aerial parts 
(75 g and 69 g for J. glauca and J. pelargoniifolia, respectively). The root parts yielded 
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a dark brown residue (36 g and 45 g of residue were obtained for J. glauca and J. 
pelargoniifolia, respectively).  
2.3.4. Animals 
Male Wistar rats and white male Swiss albino mice with approximate body weights of 
200 g and 20–25 g, respectively, were divided into groups of six. The animals were 
obtained from the Experimental Animal Care Center, College of Pharmacy, King Saud 
University. After a 7-day period in animal accommodation, they were divided into 
groups and maintained at 12 h:12 h light-dark conditions at 55% humidity. Purina chow 
rat diet (UAR-Panlab, Barcelona, Spain) and drinking water were supplied to the animal 
ad libitum. The protocols for the present study were based on the recommendations of 
the Ethical Committee of King Saud University’s Experimental Animal Care Center 
(approval number CPR-7569). 
2.3.5. Acute toxicity assay  
The acute toxicity of the alcoholic extracts was examined in rats by adapting the 
procedures of the Organization for Economic Co-operation and Development (OECD) 
(guideline No. 423) [12]. The animals fasted overnight, after which they were 
administered J. glauca and J. pelargoniifolia (from root and aerial parts) extracts 
suspended in 3% gum acacia in distilled water at fixed oral doses of 50–2000 mg/kg. 
The animals were then assessed every 30 min for 3 h to understand their general 
behavioral, neurological, and autonomic profiles, and every 24 h for a 2-week period to 
determine survival. The extracts did not cause any significant behavioral changes and 
no mortality was observed. 
2.3.6. Study of Biological activities 
2.3.6.1. Anti-inflammatory activity 
2.3.6.1.1. Carrageenan-induced paw edema in rats 
Male Wistar rats weighing around 200 g each were divided into 10 groups (six rats in 
each group). The first group (Group I) received only carrageenan as a control. Groups 
II to IX also received total alcoholic extracts from J. glauca and J. pelargoniifolia (from 
root and aerial parts) at concentrations of 200 and 400 mg/kg, respectively. Group X 
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was administered phenylbutazone (100 mg/kg) as a positive control. Rat paw-edema 
was induced using carrageenan to obtain a model for acute inflammation. A dose of 0.2 
mL of 1% carrageenan was injected into the paw of each rat in the 10 groups. The 
animals were administered suspensions of different extracts an hour before carrageenan 
was injected via the intraperitoneal route.  
The volume of rat paws was measured before receiving carrageenan injection 
and then 3 h after the injection using a Hydro-Plethysmograph (Model 7150, Basile, 
USA). The rats were held firmly, and the right paw was immersed in a pool of mercury 
up to the tibiotarsal joints. The increase in pressure resulting from the slight rise in the 
mercury level was transmitted to the pressure transducer. After amplification, the level 
of transduced signals registered as a deflection in the pen on the chart. These results are 
represented as the percentage (%) inhibition of edema (protection against 
inflammation) in the drug-treated groups 3 h after carrageenan injection as compared 
to the % inhibition observed in the control group [13]. The % inhibition was calculated 
using the following equation: 
% I = 1– (dt/dc) × 100 
Here, “dt” is the change in paw volumes recorded for drug-treated groups, “dc” 
is the change in paw volumes recorded for reference groups, and “I” denotes inhibition. 
2.3.6.2. Antinociceptive (analgesic) activity 
Pain is frequently associated with inflammation; it is the final product of a complex 
information-processing network involving the central and peripheral neuronal 
pathways. Drugs with an anti-inflammatory effect very often possess analgesic 
properties. The analgesic activities of total alcoholic extracts from the root and aerial 
parts of J. glauca and J. pelargoniifolia were evaluated against the acetic acid-induced 
writhing response, which is a standard method for measuring peripheral analgesic 
activity. The central analgesic effect was measured using the hot plate method. 
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2.3.6.2.1. Acetic acid-induced writhing response (chemical stimuli)  
The test was carried out using a method adapted from the procedure put forward by 
Amresha et al. (2007) [14]. Mice were divided into 10 groups of six animals each. 
Group I was intraperitoneally injected solely with 0.6% acetic acid solution. Group II 
to IX orally received 200 and 400 mg/kg doses each of extracts from the root and aerial 
parts of J. glauca and J. pelargoniifolia. Group X received indomethacin [4 mg/kg, per 
os (p.o.)] as a positive control after an overnight fast. One hour after treatment, the mice 
from groups II to X were injected intraperitoneally with a 0.6% acetic acid solution to 
induce the characteristic writhing response. The number of writhings observed in the 5 
to 20 min period following acetic acid administration was counted, recorded, and 
compared to the number recorded for the indomethacin group. 
2.3.6.2.2. Hot plate test method (thermal stimuli) 
The test was performed using a slightly modified version of the protocol described 
previously by Asongalem et al. (2004) [15]. The mice were placed in a 24-cm diameter 
glass cylinder on the heated surface of a hot plate at a constant temperature of 56 ± 1°C. 
Animals were divided into nine groups of six animals each. Group I to VIII orally 
received 200 and 400 mg/kg doses each of extracts from J. glauca and J. pelargoniifolia 
(root and aerial parts), respectively. Group IX was treated with indomethacin (4 mg/kg, 
p.o.) as a positive control. Mice were chosen 24 h before the experiment based on their 
reactivity to the test. The animals were tested at 0, 60, 90, and 120 min after treatments 
were administered. The time interval from the moment that the animal reached the hot 
plate until it licked its forefeet or jumped off was considered as the reaction time. The 
stop time of 20 seconds was set to avoid heat damage to the paws of animals. 
2.3.6.3. Hypoglycemic and anti-diabetic activities 
Male Swiss albino mice with body weights ranging between 20–25 g were divided into 
10 groups (each group consisted of four mice). Extracts from J. glauca and J. 
Pelargoniifolia (root and aerial parts) at doses of 200 and 400 mg/kg of body weight, 
respectively, were administered to each animal. Tween 80 solvent (1 mL) was added to 
each extract. The experiment was carried out using the procedure described by El Tahir 
(2007) [16]. The first group (control) was given a normal saline solution with tween 80; 
the second group was administered a reference oral anti-diabetic drug, Daonil® 
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(glibenclamide) at a dose of 1 mg/kg of body weight, while the remaining animal groups 
were given plant extracts. The extracts and reference drugs were orally administered to 
animals after 24 h of fasting. Blood samples were taken before administering the drugs, 
at time 0 and 2 h after administration. Blood glucose levels were measured using the 
Reflotron® instrument (ROCH). 
For anti-diabetic screening, alloxan (125 mg/kg) was intraperitoneally injected 
for the induction of diabetes in the overnight fasted animals; 72 h after administering 
the injection, the animals became diabetic and the experiment was performed using the 
protocol described for the hypoglycemia-testing experiment. The significance of the 
differences between the treatments and control values were determined using ANOVA. 
2.3.6.4. Hepatoprotective activity 
Male Wistar rats were divided into 11 groups of six animals each. Group I received 
normal saline solution and was used as the control group. Group II received only CCl4 
(1.25 mL/kg of body weight) treatment, while group III was administered silymarin 
(Sil) at a dose of 10 mg/kg p.o. (20.7 μmol/kg). Groups IV–XI were treated with 200 
and 400 mg/kg of the total alcoholic extracts of both plants. Treatment started 6 days 
prior to CCl4 administration and continued until day 7. On day 7, 24 h after CCl4 
administration, ether was used as a general anesthetic to immobilize the animals. The 
heart puncture method was used to collect blood samples, after which the serum was 
separated from plasma for the assessment of biochemical parameters.  
2.3.6.4.1. Determination of biochemical parameters  
The levels of biochemical parameters such as aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), alkaline 
phosphatase (ALP), and total bilirubin were determined according to the method 
described by Edwards and Bouchier (1991) [17]. The enzymatic activities were 
evaluated using Reflotron® (ROCH) analytical strips and visualized on a Reflotron® 
Plus instrument (ROCH). 
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2.3.6.4.2. Determination of malonaldehyde and non-protein sulfhydryl groups, and 
total protein content 
A beaker containing isolated liver samples was cooled by immersion in an ice bath. The 
tissues were homogenized in 0.02 M ethylenediaminetetraacetic acid (EDTA) in a 
Potter–Elvehjem type C homogenizer. Homogenate equivalents of 100 mg of tissues 
were used for the measurements.  
For quantifying the level of MDA, aliquots of the homogenate (1 mL) were 
incubated at 37°C for 3 h in a metabolic shaker. One milliliter of 10% aqueous 
trichloroacetic acid (TCA) was added. The mixture thus obtained was centrifuged at 
800 rpm for 10 min. One milliliter of the supernatant was separated and mixed with 1 
mL of 0.67% w-thiobarbituric acid in water and placed in a water bath containing hot 
water for 10 min. The mixture was cooled and diluted with 1 mL of distilled water. The 
absorbance of the solution was measured at 535 nm. The MDA content (nmol/g wet 
tissue) (index of the magnitude of lipid peroxidation) was then calculated with reference 
to a standard curve for MDA solution [18]. 
Non-protein sulfhydryl groups (NP-SH) were quantified by mixing the 
homogenate with 4 mL of distilled water and 1 mL of 50% TCA in 15 mL test tubes. 
The tubes were shaken intermittently for 10–15 min and then centrifuged for 15 min at 
approximately 3000 rpm to precipitate the protein. Two milliliters of the supernatant 
were mixed with 4 mL of 0.4 M Tris buffer (pH 8.9) and 0.1 mL of 0.01 M DTNB 
[5,50-dithio-bis-(2-nitrobenzoic acid)]; the tube was shaken to mix the contents. 
Absorbance was measured spectrophotometrically within 5 min after the addition of 
DTNB at 412 nm against a reagent blank with no homogenate [19].  
For TP evaluation, parts of the homogenate (1mL) were treated with 0.7 mL of 
Lowry’s solution, mixed, and incubated for 20 min in dark at room temperature. Diluted 
Folin’s reagent (1 mL) was then added, and samples were incubated at room 
temperature in dark for 30 min. The absorbances of the resultant solutions were then 
measured at 750 nm [20]. 
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2.4. Statistical analysis 
Data are expressed as mean ± standard error (SE). The results were first checked for 
normality by Kolmogorov and Smirnov test and homogeneity by Bartlett's test, and 
then analyzed using the Student’s t test and analysis of variance (ANOVA) test. Dunnett 
posttest was used to determine which groups significantly differed from the control 
group. The statistical analysis was performed using GraphPad Prism version 3. Results 
were considered significantly different if the p < 0.05 [21].  
2.5. Results 
The total alcoholic extracts from the root and aerial parts of J. glauca and J. 
pelargoniifolia were tested for anti-inflammatory activities; the corresponding results 
are presented in Table 1. Furthermore, all extracts were evaluated for analgesic activity 
using chemical (writhing method) and thermal stimuli (hot plate method). All results 
are presented in Tables 2 and 3. The results obtained after the assessment of 
hypoglycemic and anti-diabetic activities are summarized in Table 4. Finally, the 
hepatoprotective activity of the different alcoholic extracts was tested against CCl4-
induced toxicity. All results are presented in Tables 5 and 6. 
The effect of crude alcoholic extracts from the roots and aerial parts of J. glauca 
and J. pelargoniifolia on the carrageenan-induced acute inflammation model was 
evaluated at concentrations of 200 mg/kg and 400 mg/kg. The tested extracts reduced 
edema in a dose and time-dependent manner (Table 1). In carrageenan-administered 
animals (Group I), severe swelling was observed within 3 h (paw volume was 1.617 ± 
0.030 mL), and the swelling reduced to 0.655 ± 0.015 mL in the next 180 min. The 
groups treated with extracts exhibited decreased paw edema and showed improvement 
throughout the period of study. Swelling was significantly reduced during 3 h in J. 
pelargoniifolia root extract-treated rats and was decreased by 50.63% and 39.94% at 
doses of 400 mg/kg and 200 mg/kg, respectively, as compared to the 64.63% reduction 
observed in phenylbutazone-treated rats. J. glauca root extracts also caused a reduction 
in edema at a dose of 400 mg/kg (44.52%). Extracts from the aerial parts of J. glauca 
and J. pelargoniifolia showed better anti-inflammatory activities at the higher dose of 
400 mg/kg, while at the lower dose of 200 mg/kg, they showed moderate to low activity 
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(0.522 ± 0.022 mL and 0.547 ± 0.037 mL, respectively) as compared to the activity in 
the control group (0.232 ± 0.018 mL).  
Table 1. Effects of Jatropha pelargoniifolia (J.P.) and J. glauca (J.G.) extracts (root and aerial 
parts) on carrageenan-induced hind paw edema in rats 
All values represent mean ± SE. *p < 0.05; **p < 0.01 vesus carrageenan group (one-way ANOVA, followed by Dunnett's test), 
###p < 0.001 versus carrageenan group (unpaired t-test), •••p < 0.001 versus the corresponding pre-carrageenan treatment group 
(paired t-test). 
 
Table 2 shows the analgesic effect of indomethacin and the extracts tested by 
using the writhing method in mice. The average number of writhings over a period of 
20 min after acetic acid was injected in the control group mice was 27.667 ± 0.955. The 
standard drug indomethacin (at a dose of 4 mg/kg) resulted in a 69.87% reduction in 
the number of writhings (8.333 ± 0.558). The total alcoholic extracts (200 and 400 
mg/kg) from the J. glauca root resulted in a significant reduction in the number of 
writhings in mice (51.20% and 63.85%, respectively) as compared to that caused by the 
analgesic drug. Meanwhile, the total alcoholic extracts (400 mg/kg) from the J. 
pelargoniifolia (root) and J. glauca (aerial parts) resulted in a moderate reduction in the 
writhing response, i.e. 14.166 ± 0.477 (48.76%) and 17.000±0.577 (38.55%), 
respectively, as opposed to the reduction in writhings in control animals. The aerial 
parts of J. pelargoniifolia showed the least effect on writhing in mice at 200 mg/kg. 
However, all results revealed that significant analgesic effects (p < 0.01) resulted from 
the administration of all the treated doses. 
 
Group (n=6) Dose 
(mg/kg) 
 Paw volume before 
carrageenan 
treatment (mL) 
(Mean ± SE) 
Paw volume 3 h after 
treatment (mL) 
(Mean ± SE) 
Increase observed 3 h 
after treatment (mL) 
(Mean ± SE) 
% 
Inhibition 
Carrageenan 0.2 mL 0.962±0.028 •••30±0.071.61 0.655±0.015 ـــــ 
J.P. aerial part 200 0.908±0.038 •••55±0.0251.4 0.547±0.037* 16.53 
J.P. aerial part 400 0.953±0.029 •••22±0.021.36 0.408±0.037** 37.65 
J.P. root 200 0.930±0.027 •••4±0.0231.32 0.393±0.034** 39.94 
J.P. root 400 0.947±0.033 •••2±0.0101.27 0.323±0.032** 50.63 
J.G. aerial part 200 0.943±0.033 •••0±0.0271.46 0.522±0.022** 20.35 
J.G. aerial part 400 0.915±0.031 •••8±0.0131.32 0.408±0.023** 37.65 
J.G. root 200 0.978±0.026 •••6±0.0181.49 0.520±0.015** 20.61 
J.G. root 400 0.958±0.031 •••8±0.0221.32 0.363±0.015** 44.52 
Phenylbutazone 100 0.943±0.032 •••9±0.0151.17 ###8±0.0120.23 64.63 
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Table 2. Determination of the analgesic effects of Jatropha pelargoniifolia (J.P.) and J. glauca 
(J.G.) extracts (root and aerial parts) using the acetic acid-induced writhing method in mice 
 
Group (n=6) Dose mg/kg Number of writhings in 20 min % Inhibition 
Acetic acid 0.2 mL 27.667±0.955 ـــــــ 
J.P. aerial part 200 25.833±0.946 6.62 
J.P. aerial part 400 22.500±0.428** 18.67 
J.P. root 200 18.333±0.422** 33.73 
J.P. root 400 14.166±0.477** 48.79 
J.G. aerial part 200 20.500±1.310** 25.90 
J.G. aerial part 400 17.000±0.577** 38.55 
J.G. root 200 13.500±0.428** 51.20 
J.G. root 400 10.000±0.577** 63.85 
 Indomethacin 4 ###83±0.5538.3 69.87 
All values represent mean ± SE.; **p < 0.01 versus acetic acid group (one-way ANOVA, followed by Dunnett's test), ###p < 0.001 
versus acetic acid group (unpaired t-test). 
In addition, indomethacin showed 116.66% analgesia after 120 min of 
treatment, the extracts from the root and aerial parts of J. glauca resulted in the highest 
percentage inhibition of pain (73.77% and 72.13%, respectively) as compared to 
inhibition with the control drug. Furthermore, J. pelargoniifolia root extracts showed 
moderate activity (50.79%), and the activity was lower in extracts obtained from the 
aerial parts (42.42%), as documented in Table 3. 
Table 3. Determination of the analgesic effects of Jatropha pelargoniifolia (J.P.) and J. glauca 
(J.G.) (root and aerial parts) extracts using the hot plate latency method in mice 
All values represent mean ± SE. **p < 0.01 versus the corresponding group before treatment (Repeted measures ANOVA, followed 
by Dunnett's test). 
 
After treatment Before 
treatment 
Dose 
mg/kg 
Group (n=6) 
 
 
120 min 90 min 60 min 0 min 
% 
Change 
Mean ± SE % 
Change 
Mean ± SE % 
Change 
Mean ± SE Mean ± SEM 
36.66 13.667±0.422** 26.66 12.666±0.494** 13.33 11.333±0.333  10.000±0.258 200 J.P. aerial part 
42.42 15.667±0.422** 33.33 14.667±0.333** 10.60 12.167±0.307 11.000±0.365 400 J.P. aerial part 
15.38 12.500±0.428** 12.30 12.167±0.307** 3.07 11.167±0.307 10.833±0.307 200 J.P. root 
50.79 15.833±0.477** 41.26 14.833±0.307** 22.22 12.833±0.477** 10.500±0.342 400 J.P. root 
19.40 13.333±0.333** 16.41 13.000±0.365** 16.41 13.000±0.365** 11.167±0.307 200 J.G. aerial part 
72.13 17.500±0.224** 55.73 15.833±0.477** 36.06 13.833±0.478** 10.167±0.307 400 J.G. aerial part 
37.28 13.500±0.563** 30.50 12.833±0.401** 13.55 11.167±0.307  9.833±0.307 200 J.G. root 
73.77 17.667±0.422** 67.21 17.000±0.258** 37.70 14.000±0.447**  10.167±0.307 400 J.G. root 
116.66 21.667±0.422** 96.66 19.667±0.615** 58.33 15.833±0.601** 10.000±0.258 4 Indomethacin 
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Furthermore, the total alcoholic extracts from J. glauca and J. pelargoniifolia 
(root and aerial parts) were examined for hypoglycemic and anti-diabetic activity. The 
blood glucose level of both normal and diabetic mice were significantly decreased (p < 
0.001) after administration with the extracts a dose of 400 mg/kg of body weight, when 
compared to glibenclamide. Changes in blood glucose levels of diabetic mice after 
treatment with extracts at a dose of 400 mg/kg of body weight are illustrated in Table 
4. The blood glucose levels of the animals treated with extracts from J. glauca aerial 
parts showed a significant decrease of 39.93%. However, the blood glucose level was 
lower after treatment with J. pelargoniifolia (26.68%), and the least percentage 
reduction in the glucose levels were achieved by extracts of J. glauca root (13.77%) 
and J. pelargoniifolia aerial parts (9.53%). 
 
Table 4. Effects of Jatropha pelargoniifolia (J.P.) and J. glauca (J.G.) extracts (root and 
aerial parts) on the glucose levels in normal and diabetic mice  
 
All values represent mean ± SE. ***p < 0.001 (paired t-test), i.p= intraperitoneal.a versus normal group before treatment, b versus 
alloxanized group.  
 
 
Groups (n=6) 
 
 
 
Dose 
mg/kg 
(p.o) 
Glucose levels in normal 
mice (mg/dL) 
Glucose levels in diabetic 
mice (mg/dL) 
Before 
treatments 
After treatments 
 (2 h) 
% 
decrease 
Before 
treatments 
After treatments 
 (2 h) 
% 
decrease 
Normal ـــ 102.517±3.169 102.567±5.543 ـــ ـــ ـــ ـــ 
Alloxanized 125 (i.p) ـــ ـــ ـــ - 309.667±3.084 - 
Glibenclamide 1 110.167±2.535 a ,***18±1.8053.35 51.57 299.167±6.306 b ,***7±3.497158.16 47.13 
J.P. aerial part 200 101.850±3.187 90.567±3.312 11.07 299.833±8.499 285.500±4.617 4.78 
J.P. aerial part 400 100.533±3.706 88.300±3.215 12.16 304.000±5.744 275.000±4.008 9.53 
J.P. root 200 113.000±2.646 a ,***6±1.54079.75 29.42 309.167±8.056 279.167±7.245 9.70 
J.P. root 400 110.667±2.290 a ,***1±1.35368.63 37.98 303.833±5.474 b ,***2±8.767216.66 26.68 
J.G. aerial part 200 104.850±3.352 82.133±2.702 21.66 297.833±5.375 255.000±5.079 14.38 
J.G. aerial part 400 109.750±2.988 a ,***9±2.91771.26 35.06 315.50±6.212 b ,***80±5.070189.5 39.93 
J.G. root 200 112.000±2.898 88.117±2.866 21.32 309.000±5.398 283.000±5.132 8.41 
J.G. root 400 114.833±3.081 81.617±2.777 28.92 304.833±4.799 b ,***23±3.963262.8 13.77 
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Treatment with J. glauca and J. pelargoniifolia (root and aerial part) total 
extracts showed a dose-dependent reduction in the levels of all the measured markers. 
AST, ALT, ALP, GGT, and bilirubin levels decreased significantly (p < 0.01) to 
31.77%, 37.22%, 13.21%, 31.38%, and 30.13% in animals treated with J. glauca root 
extracts at a dose of 200 mg/kg; while the corresponding levels in animals treated with 
a dose of 400 mg/kg were 38.24%, 55.60%, 18.59%, 45.48%, and 47.15%, respectively, 
indicating that J. glauca root extract was more protective against CCl4-induced liver 
damage as compared to silymarin. Moreover, treatment with alcoholic extracts obtained 
from the aerial parts of J. glauca at doses of 200 and 400 mg/kg resulted in a lesser 
improvement in these parameters. However, all results were highly significant (p < 
0.01), except for the reduction in ALT (7.34%) (p < 0.05) at a dose of 200 mg/kg. On 
the other hand, animals treated with J. pelargoniifolia extracts (from root and aerial 
parts) showed the least improvement as compared to animals treated with J. glauca 
(root and aerial parts), especially at a lower dose of 200 mg/kg. However, the results 
were highly significant, p < 0.05 and 0.01 (Table 5).  
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Table 5. Effects of Jatropha pelargoniifolia (J.P.) and J. glauca (J.G.) extracts (root and aerial parts) on serum biochemical parameter 
 All values represent mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA, followed by Dunnett's test), ###p < 0.001 (unpaired t-test), a versus normal control group, b versus CCl4 group.
 
Treatments 
(n=6) 
 
 
Dose 
mg/kg 
AST (U/L) ALT (U/L) ALP (U/L) GGT (U/L) Bilirubin (mg/dL) 
Mean ± SE % 
decrease 
Mean ± SE % decrease Mean ± SE % 
decrease 
Mean ± SE % 
decrease 
Mean ± SE % 
decrease 
Normal ـــ 100.383±4.857 ـــ 26.983±1.732 ـــ 319.500±7.584 ـــ 5.783±0.206 ـــ 0.550±0.011 ـــ 
4CCl 1.25mL/kg 
a ,###6.7073±3320.3 ـــ 
a ,###13±5.993292.8 ـــ a ,###73±7.153587.8 ـــ  a ,###8±0.96719.01 ـــ a ,###9±0.0583.07 ـــ 
4Silymarin + CCl 10 
b ,###60±6.530178.5 44.27 b ,###90±7.03086.1 70.59 b ,###4±11.797377.16 35.83  b ,###20±0.3908.0 57.93 b ,###3±0.0651.16 62.15 
J.P. aerial part+ 
4CCl 
200 b ,**16±5.736284.6 11.13 b ,**900±5.30263.5 10.01 b ,*20±5.880557.0 5.24  b ,443±0.4317.0 10.42 b ,5±0.0532.95 4.06 
J.P. aerial part+ 
4CCl 
400 b ,**500±3.710255. 20.39 b ,**80±4.280224.5 23.33 b ,*73±7.293527.3 10.29 b ,**4±0.22713.61 28.39 b ,**4±0.0632.48 19.32 
4J.P. root+ CCl 200 
b ,73±4.783308.3 3.74 b ,003±4.73276.8 5.46 b ,53±7.853576.8 1.87  b ,*2±0.68716.06 15.51 b ,*8±0.0532.86 6.98 
4J.P. root+ CCl 400 
b ,**93±5.283284.3 11.23  b ,4±3.896281.16 3.98  b ,5±4.417568.16 3.34  b ,**8±0.34713.91 26.81 b ,**6±0.0672.64 14.02 
J.G. aerial part+ 
4CCl 
200 b ,**600±6.20272.5 14.93 b ,*03±6.963271.3 7.34  b ,**4±5.473544.83 7.31  b ,**1±0.357614.8 21.82  b ,1±0.0732.88 6.33 
J.G. aerial part+ 
4CCl 
400 b ,**93±4.963253.8 20.76 b ,**3±5.243248.83 15.00  b ,**333±7.873536. 8.76  b ,**400±0.4013.6 28.48  b ,**9±0.0302.29 25.60 
4J.G. root+ CCl 200 
b ,**4±6.240218.50 31.77 b ,**6±5.573183.83 37.22 b ,**5±6.627510.16 13.21  b ,**3±0.46712.96 31.38  b ,**4±0.0412.15 30.13 
4J.G. root+ CCl 400 
b ,**93±3.443197.8 38.24 b ,**2000±3.10130. 55.60 b ,**450±6.050478. 18.59  b ,**3±0.23710.36 45.48  b ,**9±0.0571.62 47.15 
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Moreover, the normal control group showed MDA levels of 0.465 ± 0.018 
nmol/g in their healthy liver tissues. The levels of MDA increased to 5.270 ± 0.220 
nmol/g in liver tissues following CCl4 treatment. The standard drug silymarin was 
effective in reducing these elevated levels to 1.262 ± 0.038 nmol/g. The total extracts 
induced a dose-dependent reduction in the MDA levels. Treatment of animals with 
extracts from J. glauca root, J. pelargoniifolia root, J. pelargoniifolia aerial parts, and 
J. glauca aerial parts at a dose of 400 mg/kg of body weight decreased the level of 
MDA to 1.970 ± 0.058, 2.203 ± 0.069, 3.273 ± 0.095, and 4.342 ± 0.136 nmol/g, 
respectively (Table 6). All treatments with extracts at a dose of 200 mg/kg resulted in 
a significant (p < 0.05, 0.01) reduction in MDA levels in the liver tissues. 
In addition, treatment of animals with CCl4 reduced the hepatic NP-SH level 
from 8.083 ± 0.198 to 4.028 ± 0.214 nmol/g of wet weight tissue (Table 6). Pretreatment 
of animals with silymarin at a dose of 10 mg/kg significantly suppressed the reduction 
in NP-SH content by increasing it to 7.492 ± 0.353 nmol/g (p < 0.001) of wet weight in 
hepatic tissues. Animals that received the total extracts derived from the J. 
pelargoniifolia root showed a significant recovery of the NP-SH content (p < 0.001) 
with doses of 200 and 400 mg/kg as well. However, the NP-SH level after 
administration of 400 mg/kg of extracts was 7.892 ± 0.263 nmol/g, which was better 
than the levels observed with silymarin. Pretreatment with total alcoholic extracts from 
aerial parts of J. glauca at doses of 200 and 400 mg/kg resulted in a significant 
improvement in NP-SH levels to 5.407 ± 0.164 and 6.431 ± 0.163 nmol/g wet weight 
tissues, respectively (p < 0.01). Treatments with extracts from the J. glauca root and 
aerial parts of J. pelargoniifolia (200 and 400 mg/kg) were less effective, but the results 
were statistically significant (p < 0.01) for the results obtained after J. glauca root 
extracts administration. 
It is well-known that carbon tetrachloride (CCl4)-induced acute liver injury 
model shares a similar molecular mechanism with acute chemical liver injury in 
humans [22]. Especially, oxidative stress, inflammation response, and apoptosis have 
been recognized as the most important pathomechanisms during the progress of CCl4-
induced acute liver injury. Within the liver, CCl4 as a hepatotoxicant is metabolized by 
the cytochrome P450 enzyme to a highly reactive trichloromethyl free radical and/or 
trichloromethyl peroxyl radical, which sequentially attacks hepatic tissue, leading to 
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liver lipid peroxidation and oxidative damage. In addition, CCl4 exposure could trigger 
the production of inflammatory cytokines and chemokines, stimulating the recruitment 
of inflammatory cells. Moreover, as another crucial event involved in the acute liver 
injury induced by CCl4, apoptosis is a programmed cell death leading to morphological 
changes and death in the hepatocytes [22].   
The treatment of rats with CCl4 resulted in a reduction of more than 50% in liver 
tissue protein content, which eventually reached a value of 54.291 ± 1.336 g/L (Table 
6). Treatment with silymarin increased the levels of TP in liver tissues to 94.211 ± 2.811 
g/L in control mice. The treatment of rats with total extracts from the root of J. glauca 
and J. pelargoniifolia roots and aerial parts (400 mg/kg) increased the TP levels in liver 
tissues to 85.828 ± 1.439, 75.050 ± 1.712, and 68.263 ± 1.829 g/L, respectively. 
Treatment with a dose of 200 mg/kg body weight of total extracts from roots of J. 
glauca and J. pelargoniifolia increased the protein level significantly to 70.658 ± 1.931 
and 65.070 ± 2.265 g/L (p < 0.01) in liver tissues, respectively. When 200 mg/kg doses 
of extracts from aerial parts of both J. glauca and J. pelargoniifolia were administered, 
they caused lesser increase in the TP levels to 59.880 ± 2.051 and 59.880 ± 3.330 g/L, 
respectively, in liver tissues. 
Table 6. Effects of Jatropha pelargoniifolia (J.P.) and J. glauca (J.G.) (root and aerial parts) 
extracts on MDA, NP-SH, and TP in rat liver 
 All values represent mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA, followed by Dunnett's test), ###p < 0.001 
(unpaired t-test), a versus normal control group, b versus CCl4 group. 
Treatments  
(n=6) 
Dose mg/kg MDA 
(nmol/g) 
NP-SH 
(nmol/g) 
Total protein 
(g/l) 
Mean ± SM Mean ± SE Mean ± SE 
Normal ـــ 0.465±0.018 8.083±0.198 110.578±1.143 
4CCl 1.25 mL/kg 
a ,###20±0.2705.2 a ,###4±0.2184.02 a ,###6±1.33154.29 
4Silymarin + CCl 10 
b ,###8±0.0321.26 b ,###3±0.3527.49 b ,###11±2.8194.21 
4J.P. aerial part+ CCl 200 
b ,1±0.4014.54 b ,4±0.5335.07 b ,0±3.33059.88 
 4J.P. aerial part+ CCl 400 
b ,**5±0.0933.27  b ,9±0.3795.59 b ,*9±1.82368.26 
4J.P. root+ CCl 200 
b ,**7±0.1493.31  b ,**4±0.3076.75 b ,**5±2.267065.0 
  4J.P. root+ CCl  400 
b ,**9±0.0632.20  b ,***3±0.2627.89 b ,**2±1.715075.0 
4J.G. aerial part+ CCl 200 
b ,*6±0.1234.67  b ,**4±0.1675.40  b ,1±1.18358.28 
4J.G. aerial part+ CCl 400 
b ,**6±0.1324.34  b ,**3±0.1616.43 b ,*1±2.05059.88 
4J.G. root+ CCl 200 
b ,**6±0.10703.0  b ,**6±0.2755.75 b ,**1±1.93870.65 
4J.G. root+ CCl 400 
b ,**8±0.05701.9  b ,**0±0.2386.37 b ,**9±1.43885.82 
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2.6. Discussion 
Our results revealed that all tested extracts protected the rats from carrageenan-induced 
inflammation and showed significant anti-inflammatory activity (decrease in paw 
swelling) against the control group (p < 0.05 and p < 0.01) at both doses (Table 1). 
Generally, carrageenan is used in experimental pharmacology to induce acute arthritis 
[23]. The intraperitoneal administration of the total extracts of J. glauca and J. 
pelargoniifolia caused a pronounced (p < 0.05 and p < 0.01) inhibition of late phase 
edema, induced by the sub-plantar injection of carrageenan; it caused no inhibitory 
effect in the initial phase of the experiment. The second phase (late phase) of 
carrageenan-induced edema was susceptible to anti-inflammatory drugs that have been 
commonly used clinically to evaluate the antiphlogistic effects of natural products [24]. 
Jatropha species might exhibit anti-inflammatory activity due to its flavonoid content, 
which might lead to a reduction in the total leukocyte and monocyte percentage and/or 
number of circulating phagocytes [25].  
The antinociceptive activity of the alcoholic extracts from J. glauca and J. 
pelargoniifolia (root and aerial parts) were evaluated by using the acetic acid writhing 
and the hot plate methods. The results obtained for the writhing test were very similar 
to those obtained for the induction of edema using carrageenan.  
The analgesic effect of J. glauca and J. pelargoniifolia has not been previously 
reported; thus, the mechanism by which it occurs is not fully understood. The 
administration of acetic acid causes increased membrane phospholipase activity and 
greater synthesis of pain and inflammation mediators, such as cytokines, eicosanoids, 
leukotrienes, and prostaglandins; therefore, protection against acetic acid-induced 
writhing is indicative of the inhibition of prostaglandin-like mediators [26]. 
Hot plate paw licking is used to study the neuronal mechanisms of opioids and 
stimulation-induced antinociceptive effects. Thermal stimuli were used in the test; 
however, the hot plate paw latency response is a supraspinally-integrated response 
[27]. In conclusion, all extract-treated groups showed a significant analgesic response 
(p < 0.05 and p < 0.01) as compared to the control group. Further studies are needed to 
understand if a significant level of analgesic activity occurs via the effect on the central 
nervous system due to the presence of significant amounts of cyclopeptides and 
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alkaloids in the studied Jatropha species [28]. The docking study confirmed that an 
interaction occurs between the cyclopeptide alkaloids and μ-opioid receptor [29]. 
The current study demonstrates the efficacy of the extracts from J. glauca and 
J. pelargoniifolia as analgesic and anti-inflammatory agents, and scientifically justifies 
the use of these plants as non-specific therapeutic agents in Arabian traditional 
medicine [10, 11]. Therefore, these two species can serve as unique natural sources of 
secondary metabolites for use as antinociceptive agents. 
Alloxan and streptozotocin are the most popular diabetogenic agents used for 
assessing the antidiabetic or hypoglycemic capacity of test compounds/extracts. The 
diabetogenicity of alloxan is under lined by its selective cellular up take by beta cells 
of the pancreas and consequent accumulation in these cells. Notably, alloxan is far less 
expensive and more readily available than streptozotocin. On this ground, one will 
logically expect a preference for use of alloxan in experimental diabetes studies [30]. 
Although, streptozotocin is actually preferred chemical agent to stimulate experimental 
diabetes because it has longe half-life (15 min), sustained hyperglycemia with regard 
to longer duration and also the development associated with well characterized diabetic 
problems with less incidences associated with ketosis in addition to mortality [31]. 
Alloxan not just has poisonous effects upon islets associated with Langerhans, but 
additionally affect additional body internal organs. It generally produces serious 
diabetes. Streptozotocin is actually more particular to beta cells instead of alloxan. 
Streptozotocin is much better especially whenever inducing DM type-2. Alloxan 
altered the standard pathways associated with cellular metabolic process, including the 
actual inactivation associated with certain nutrients, which resulted in liver harm and 
passing away [31].  
The decrease in glucose level caused by the extracts from roots of J. 
pelargoniifolia at 400 mg/kg was found to be 37.98%, which was a significant reduction 
in glucose level, as compared to glibenclamide. On the other hand, aerial parts and roots 
of J. glauca resulted in moderate reductions of 35.06% and 28.92% in glucose levels, 
respectively. The aerial parts of J. pelargoniifolia caused the least reduction in the 
glucose level as compared to the control group (Table 4).  
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The significant lowering of blood glucose level in both normal and diabetic 
experimental animals, particularly because of the alcoholic extracts of J. glauca aerial 
parts and the roots of J. pelargoniifolia, ranged from 39.93% to 37.98%, which 
highlighted the hypoglycemic activity of the plant constituents. A number of 
mechanisms of action for these extracts have been suggested. Some hypotheses state 
that the possible effects on the activity of pancreatic β-cells are attributable to the fact 
that the extracts might increase the inhibitory action against insulinase enzyme and 
increase insulin sensitivity or insulin-like activity. Other mechanisms have also been 
suggested, such as an increase in the peripheral utilization of glucose, increase in the 
synthesis of hepatic glycogen, or decrease in glycogenolysis, inhibition of intestinal 
glucose absorption, reduction in glycemic index of carbohydrate, and a reduction in the 
action of glutathione [32]. All are equally important because they could potentially be 
used for the treatment of different aspects of diabetes mellitus. Therefore, plant extracts 
are a rich source of new hypoglycemic agents [33]. 
A previous phytochemical study on Jatropha species revealed that they contain 
numerous classes of secondary metabolites, such as terpenoids, steroids, flavonoids, 
alkaloids, and coumarinolignans [7]. The hypoglycemic and anti-diabetic activity of J. 
glauca and J. pelargoniifolia may be attributable to the presence of different classes of 
active ingredients that can act synergistically or independently under the conditions of 
type II diabetes as shown in our experiments. 
Furthermore, the CCl4-induced hepatic toxicity is commonly used as an 
experimental model for screening the hepatoprotective activity for convenient drugs or 
natural products [34]. Increasing the level of the liver enzymes indicating liver injury 
beside histopathological imaging [17]. Induction of liver injury by CCI4 lead to 
significant elevation of liver enzymes and total bilirubin levels beside increase the 
levels of MDA and reduction of both total protein and NP-SH levels, (Tables 5 & 6) 
and indicates also injury caused to the hepatocytes. Here, ALT and AST were observed 
to be the most sensitive markers of hepatocellular injury [35]. Release of enzymes into 
the circulation is mainly due to a disturbance effect in the transport function of liver 
cells due to change in permeability of hepatocytes membrane which lead to elevation 
the level of biomarker enzymes, particularly AST and ALT [36]. The elevated levels of 
AST, ALT, ALP, GGT, and bilirubin caused by the CCl4 injury (44.27, 70.59, 20.56, 
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57.93, and 62.15%, respectively), were effectively suppressed after the pretreatment of 
rats with silymarin. The oral administration of J. glauca and J. pelargoniifolia extracts 
after CCl4 treatment also significantly protected against the elevation of transaminase 
levels, indicating an improvement in cellular integrity and status of hepatic cells. 
Increased levels of GGT and ALP are a significant sign of liver damage [37]. 
Improvement in the GGT and ALP levels after treatment with plant extracts is 
indicative of their membrane-stabilizing effect. Perhaps, the increase in total serum 
bilirubin concentration following CCl4 treatment is attributable to the failure in normal 
uptake, conjugation, and excretion by the damaged hepatic parenchyma. The increased 
total bilirubin content due to CCl4 intoxication was reduced after treatment with total 
extracts from J. glauca and J. pelargoniifolia, which is also indicative of their ability 
to enable normal uptake, conjugation, and excretion [38]. 
Attack of polyunsaturated fatty acid peroxidation by free radical lead to the 
production of malonaldehyde as end product. It is a reactive aldehyde and is one of the 
many reactive electrophilic species that cause toxic stress in cells and form covalent 
protein complex [39]. The level of oxidative stress is measured by this biomarker 
aldehyde in an organism [40]. The treatment of the animals with roots and aerial parts 
of J. glauca and J. pelargoniifolia decreased the level of MDA, reflecting the 
significant level of protection that the extracts could provide (Table 6).  
Pretreatment of the animals with silymarin significantly increased the NP-SH 
content that had been reduced in hepatic tissues. Animals that received the total J. 
pelargoniifolia root extract showed a significant recovery of the NP-SH content at 
doses of 200 and 400 mg/kg. However, the NP-SH levels in such animals were better 
than the levels in animals given silymarin at a dose of 10 mg/kg. Pretreatment with total 
alcoholic extracts from aerial parts of J. glauca at doses of 200 and 400 mg/kg also 
resulted in a significant improvement in NP-SH levels, while treatment with the root of 
J. glauca and aerial parts of J. pelargoniifolia were less effective but statistically 
significant (Table 6). The NP-SHs are known to be involved in several defense 
processes against oxidative damage; they protect cells against free radical peroxides 
and poisonous substances [41]. 
Protein synthesis by the liver is considered a vital function necessary for having 
a healthy liver. Liver injury leads to the interruption and disassociation of 
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polyribosomes on the endoplasmic reticulum, because of which the total protein 
biosynthesis is reduced. The total protein level in the recovered and healthy liver would 
return to normal [42]. Treatment with the total extracts from the J. glauca root and J. 
pelargoniifolia root caused a significant increase in the TP levels in liver tissues. These 
results indicated that the extracts had a protective effect that was almost similar to the 
effect of silymarin (p < 0.01) at dose 400 mg/kg, while treatment with the extracts from 
aerial parts of J. glauca and J. pelargoniifolia resulted in a lesser, but significant 
improvement in the liver TP levels (p < 0.05). Treatment with total extracts from the 
roots of J. glauca and J. pelargoniifolia even at low dose were significantly increased 
the level of proteins in liver tissues (p < 0.01).  
Finally, a chemical investigation of the Jatropha genus revealed the presence of 
terpenes, alkaloids, coumarinolignans, flavonoids, and steroids. Hence, the prominent 
hepatoprotective activity observed could be attributable to the high percentages of 
phenolics and flavonoids in J. glauca and J. pelargoniifolia [43].  
2.7. Conclusions 
In conclusion, the ethanolic extracts from J. glauca and J. pelargoniifolia (root and 
aerial parts) induced analgesic and anti-inflammatory effects; these results justify the 
traditional use of J. pelargoniifolia and J. glauca as analgesics for the treatment of 
inflammatory conditions. The changes in liver parameters induced by CCl4 intoxication 
were reversed by the alcoholic extracts of J. pelargoniifolia and J. glauca. The NP-SH 
assay indicated that the antioxidant nature of the extracts could be responsible for the 
hepatoprotective activity of both the Jatropha species. Finally, hypoglycemic and anti-
diabetic effects of the extracts were significant, especially for extracts obtained from J. 
glauca aerial parts and J. pelargoniifolia roots. All results presented in this study need 
to be supported with further experiments to clarify the exact mechanism of action before 
the plants and their extracts can be clinically recommended. 
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3.1. Abstract 
The chemical composition of the essential oil from Jatropha pelargoniifolia roots was 
determined via GC-FID. There were 80 compounds, representing 99.99% of the total 
oil constituents. Among these, 77.31% were sesquiterpenes, 14.62% were fatty acids, 
7.21% were other components (i.e., phenolics, hydrocarbons, etc.), and 0.85% were 
monoterpenes. The major compounds in the oil were γ-eudesmol (35.31%), 5-guaien-
11-ol (14.43%), epi-cedrol (8.19%), oleic acid (5.23%), bulnesol (4.45%), α-linoleic 
acid (4.20%), 3,4-dimethoxycinnamic acid (3.83%), palmitic acid (2.69%), 
isolongifolanone (2.68%), eicosane (1.41%), and cedrol (1.14%). Oxygenated 
sesquiterpenes were found to represent more than 50% percent of the total oil content. 
Moreover, the essential oil was evaluated for anti-inflammatory, antioxidant, 
antipyretic, and antinociceptive activities using in vivo and in vitro models. 
Additionally, the antioxidant potential of the oil was evaluated using various in vitro 
antioxidant tests, including DPPH•, ABTS•+ and FRAP. At a dose of 240 µl/kg, the oil 
showed anti-inflammatory (55.64%), antipyretic (37.033±0.120), and antinociceptive 
(47.58%) activities and showed significant (p < 0.01) effect as compared to a standard 
drug (phenylbutazone and indomethacin). These findings demonstrated that the 
essential oil of J. pelargoniifolia root could be used as a natural source for their anti-
inflammatory, antinociceptive, antipyretic, and antioxidant effects.        
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3.2. Introduction  
Jatropha pelargoniifolia is a member of the Euphorbiaceae family. It is a frutescent 
plant of about 30 cm in height with bluish-green small petioles; there are usually 3–5 
digitately-lobed ones with serrate margins covered with smooth silky hairs. Female 
flowers are larger in size with a larger perianth than the male flowers. Capsule is pale, 
straw-colored, scaly, and about 1 cm long with smooth black seeds. This plant is known 
locally in Saudi Arabia as "Obab" [1].  
Species of Jatropha became popular over the years to treat various diseases. 
The roots of some species of Jatropha (J. glandulifera, J. gossypiifolia, J. multifida) 
were used to cure individuals suffering from leprosy and gonorrhea [2]. Traditionally, 
the sap of J. pelargoniifolia petiole is applied to cure ulcers and wounds in Ethiopia 
and Saudi Arabia [3].  
Essential oils are complex mixtures of various chemical classes derived from 
secondary plant metabolism. Mostly, essential oils contain terpenes, including 
monoterpenes and sesquiterpenes, as well phenolics and some lipophilic constituents. 
These oils are extracted from specific plant organs (e.g., leaves, seeds, and peels) and 
also from the roots and rhizome. Generally, the synergistic biological activity of 
essential oils attributed to the presence of active constituents [4]. In fact, the essential 
oils were used in human being and animals and exhibited many promising biological 
activities such as; antimicrobial, antioxidant, anti-inflammatory, antispasmodic, and 
muscle relaxing properties [5]. Biologically active essential oils represent a potential 
source for alternative medicine [4]. As a consequence, essential oils are one of the 
promising candidates amongst natural compounds for the development of safe 
therapeutic agents. 
Much phytochemical and biological work has been carried out on essential oils 
isolated from the genus Jatropha, such as J. curcas, J. ribifolia, J. gossypifolia, and J. 
mutabilis [6, 7, 8, 9]. It is worthy to note that this is the first study describing the 
chemical constituents and biological activities of the essential oil isolated from J. 
pelargoniifolia roots. The motivation of this study was to shed light on the composition 
of J. pelargoniifolia essential oil and to prove if some of the ethnomedical claims about 
the species are linked to the essential oil and its related constituents. 
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3.3. Materials and methods 
3.3.1. Chemicals  
ABTS [2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)], trichloroacetic acid 
(TCA), and DPPH (1,1-diphenyl-2-picrylhydrazyl) were procured from Sigma (Sigma-
Aldrich GmbH, Sternheim, Germany). Potassium Ferricyanide from Loba Chemie Pvt. 
Ltd. (Mumbai, India) and ascorbic acid was obtained from SD Fine Chem. Ltd. (Biosar, 
India) while indomethacin and phenylbutazone were purchased from Spimaco (Saudi 
Arabia). The rest of chemicals and solvents used were of analytical grade and purchased 
from Sigma-Aldrich (St Louis, MO, USA).  
3.3.2. Plant material 
The roots of J. pelargoniifolia were collected (1 kg) in September 2015 from Wadi 
Mojasas, in Jazan area in the south of Kingdom of Saudi. It was identified by Jacob 
Thomas, taxonomist of the Botany and Microbiology Department, King Saud 
University, College of Science. A voucher sample (number- 23064) has been placed at 
the Herbarium Center College of Science, King Saud University.   
3.3.3. Essential oil prepared 
The freshly cut roots (1 kg) were exposed to hydrodistillation for 6 hr. Clevenger type 
apparatus was used following the technique prescribed in the European Pharmacopoeia 
[10]. Anhydrous sodium sulfate powder was used for drying the obtained oil. The dried 
oil was kept on and stored in air-tight, amber colored glass vials at 4°C for further study.  
3.3.4. GC-MS analysis 
Sample components analysis was carried out by using Gas Chromatograph System 
Series (Agilent 5975MS /6890) combined with a flame ionization type of detector (FID) 
with fused silica capillary column HP-5 5% phenylmethylsiloxane capillary column (30 
m × 0.25 mm inner diameter, 0.25 μm film thickness). Oven temperature was gradually 
increased from 40 to 280°C at a rate of 3 °C min-1. The temperature of the injection port 
was kept at 230°C while the detector temperature kept constantly at 280°C. The split 
ratio was (1:20). The injection volume was 1.0 µL. A C7-C21 n-alkanes mixture was 
mixed with n-hexane and used for determination of the temperature programmed 
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retention indices. The sample was analyzed in n-hexane solution. An internal standard 
(n-alkanes) was then mixed with the sample to help in the standardization of retention 
times, and the sample was reanalyzed. Retention indices (RI) for all components were 
verified. The identity of essential oil components was achieved by comparing their 
retention indices (RI) and mass spectra with those reported from authentic samples and/ 
or the Wiley and NBS/NIST libraries and those published by Adams, 2001 [11]. The 
quantitative data regarding the essential constituents were obtained by peak-area 
normalization using the chromatographic technique with flame ionization detection 
(GC-FID) operated under similar conditions to the GC-MS. Compounds with 
concentrations equal or greater than 0.001% were considered for quantiﬁcation. The 
false-positive results were prevented via avoiding coelution phenomena through the 
identification and deconvolution of coeluting peaks are done with Agilent Chemstation 
in combination with AMDIS as deconvolution software. For the identification we are 
using comprehensive internal MS-libraries as well as commercial libraries like NIST. 
Additionally, a retention index calibration is done to have RI as second factor for a 
correct identification. 
3.3.5. Animal testing 
The experiments were performed on male Wistar rats (with six in each group (I-IV) at 
180-200 g b.w., 8/10 weeks old) and Swiss albino mice (with six in each group at 25±5 
g b.w., 8/9 weeks old) of either sex. The required animals were provided from the 
Experimental Animal Care Center, College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia. Those animals were housed in large polypropylene cages in 
22±2°C and gave standard pelleted nourishment and drinking water ad libitum. The 
current study was accepted by the Institutional Animal Ethical Committee of the 
College of Pharmacy, King Saud University, Riyadh, Saudi Arabia (approval number 
CPR-7569). 
3.3.6. Determination of median lethal dose (LD50)  
The LD50 value was evaluated adapting the procedure described by Karber, 1931 [12]. 
The minimal dose that completely killed 100% of the animal (LD100) was carried out 
while the highest dose that failed to kill any animal was also calculated. Many doses at 
equal logarithmic intervals were selected in between these two doses; each dose was 
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administrated orally in a group of six rats. The rats were then evaluated for 24 h and 
recorded any behavioral, neurological symptoms as well as any sign of toxicity and 
mortality in each group.  
3.3.7. Determination of anti-inflammatory activity  
3.3.7.1. Carrageenan-induced paw edema in rats 
The inflammation in rat's paw was induced following the procedure described by 
Winter et al., 1962 [13]. Animals were divided into four groups of six animals each as 
follows: Group I was given an injection of 0.05 ml of 1% carrageenan solution in the 
right hind paw of each rat under the plantar aponeurosis. Group II and III rats were 
treated orally with 120 and 240 µl/kg b.w. of the oil suspended in distilled water 1 h 
before the carrageenan injection. Group IV (control rats) was administered standard 
anti-inflammatory drug (phenylbutazone, 100 mg/kg b.w., orally) 1 h before the 
carrageenan administration. The measurements of foot volume were carried by the 
displacement technique using a plethysmometer (Apelex, France) immediately 3 h after 
the injection of carrageenan. The inhibitory effect percentage was measured following 
the equation shown below:  
% Inhibition = (1- a-x/b-y) X 100 
Where ‘b’ is the mean paw volume of control rats after carrageenan injection and ‘y’ 
before the injection; whereas ‘x’ is the mean paw volume of treated rats before injection 
and ‘a’ is the mean paw volume after carrageenan injection.  
3.3.7.2. Cotton pellet granuloma test in rats 
Goldstein et al. 1967 method was applied with minor modification [14]. 30 mg of 
sterilized cotton pellet was entered subcutaneous in the groin region of rats. Animals 
were divided into four groups of six animals each. Animals in the control group 
administered normal saline. Group I and II were administered the oil orally, in a dose 
of 120 and 240 µl/kg b.w. once daily for four consecutive days. Phenylbutazone 100 
mg/kg b.w. was given to positive control group. On the fifth day, the animals were 
sacrificed using ether. The removed dried cotton pellets from extraneous tissue were 
weight after 24 h.  
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3.3.8. Determination of antipyretic activity in mice (Brewer’s yeast-induced pyrexia 
method) 
Fever was induced in mice by s.c. injection of 20% aqueous suspension of Brewer’s 
yeast in the back, below the nape of the neck (20 ml/kg b.w.) [15]. Animals were 
divided into three groups of six animals each. The animals were then fasted for the 
duration of the experiment (approximately 1 day), with   free water supply. Regular 
temperature measurements were performed 24 h after the yeast administration to 
determine the pyretic response. The oil suspension (120 and 240 µl/kg b.w.) was given 
24 h after the yeast injection and the temperatures were recorded at 30, 60, and 120 
minutes after its administration. Indomethacin (4 mg/kg b.w., administered orally) was 
gave to positive control group. 
3.3.9. Antinociceptive activity  
The analgesic activity was measured against chemical and thermal stimuli.  
3.3.9.1. Chemical method 
3.3.9.1.1. Inhibition of acetic acid-induced writhing in mice 
The experiment was done according to the method approved by Siegmund et al., 1957 
with minor changes by Koster et al., 1959 [16, 17]. Animals were divided into four 
groups of six Swiss albino mice each. Group I was injected i.p with 0.2 ml of 3% acetic 
acid solution only. Group II and III were treated with the suspension of the oil mixture 
in doses of 120 and 240 µl/kg b.w. orally, and group IV was administered indomethacin 
(4 mg/kg b.w., p.o.), as a positive control, after an overnight fast. One hour after the 
treatment, the mice from groups II, III, and IV were injected i.p. with acetic acid 
solution to stimulate the distinctive writhings. The writhing numbers that occurred 
between 5 and 15 minutes after the acetic acid injection was calculated.  
3.3.9.2. Thermal methods 
3.3.9.2.1. Hot-plate test 
The experiment was carried out in order to assess the potential of the response as 
designated by Eddy and Leimback, 1953 with a few modifications [18]. Hot plate 
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temperature was kept at 56±1°C. The mice were placed in a 24-cm diameter glass 
cylinder on the heated surface. The time between placement and licking of the paws or 
jumping was recorded as response latency. Animals were divided into three groups of 
six animals each. Distilled water was administered orally for the control group, and 
indomethacin was used as positive control (4 mg/kg b.w., administered orally). The 
choice of mice was achieved one day before the test based on their reactivity to the 
experiment. The animals were evaluated at 30, 60, and 120 minutes after oral 
administration of the oil suspension (120 and 240 µl/kg b.w.) and indomethacin 
administration. The cut off time was 30 seconds. 
3.3.9.2.2. Tail-flick test 
Acute nociception was induced using tail flick apparatus using (Tail flick Apparatus 
Harvard), according to the method described by D’amour and Smith, 1941 [19]. Briefly, 
each mouse was placed in a restrainer (three groups of six animals each) for 2 minutes 
before treatment; baseline reaction time was determined by focusing on an intensity-
controlled beam of light on the distal one-third portion of the animal tail. The essential 
oil doses of 120 µl/kg and 240 µl/kg were administered intraperitonially. The post-drug 
reaction time was measured after 30, 60, and 120 minutes. Indomethacin was used as 
positive control (4 mg/kg b.w., administered orally). 
3.3.10. Estimating antioxidant activity 
3.3.10.1. DPPH(2,2-diphenyl-1-picrylhydrazyl) radical scavenging activity 
The antioxidant effect of the oil, based on the scavenging potency of the stable 1, 1-
diphenyl-2- picrylhydrazyl (DPPH) free radical, was measured using the technique 
designed by Braca et al., 2001 [20]. Different concentrations of oil were mixed with 3 
mL of a 0.004% ethanol solution of DPPH. One ml methanol instead of oil was used to 
prepare control. The absorbance of color intensity was measured at 520 nm after 30 
minutes and the percentage inhibition of antioxidant effect was calculated using the 
below formula: 
[(A0-A1)/ A0] ×100 
Where A0 is the absorbance of the control (DPPH solution) and A1 is the absorbance 
of the oil/standard.   
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3.3.10.2. ABTS (2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) assay 
The radical scavenging potency of the oil against ABTS radical cation was evaluated 
using the technique described by Re et al., 1999 [21]. The ABTS solution was prepared 
in water with a concentration of 7 mmol/L; an aqueous solution of potassium 
persulphate was also prepared with a concentration of 2.45 mmol/L. The two solutions 
were added in equal volume (1: 1) and stored in dark for 6 hr. at room temperature. 
During that period, ABTS radical was produced. The ABTS stock solution was diluted 
with ethanol to an absorbance of 0.70±0.02 at 734 nm and equilibrated at 30°C. An 
aliquot of oil was mixed with 2.9 ml of diluted ABTS radical cation solution. After the 
reaction was incubated at 30°C for 20 minutes, absorbance was measured at 734 nm. 
The ability of the oil to quench ABTS free radical was calculated according to the 
formula: 
Scavenging (%) = [ (Ac- Aa/ Ac)] ×100 
Where Ac= absorbance of control and Aa= absorbance of the oil. 
3.3.10.3. Ferric reducing antioxidant power (FRAP) assay 
The ferric free radical scavenging power was measured based on the technique 
recommended by Oyaizu, 1986 [22]. The reduction of ferric ion to ferrous ion is 
confirmed by formation of Perl’s Prussian blue color where its intensity is related to the 
antioxidant activity. Serial dilution of the oil (20-100 µg/ml) in 1 mL of distilled water 
were added to 0.2 M phosphate buffer (2.5 mL, pH 6.6) and 1 % potassium ferricyanide 
(2.5 mL). The mixture was incubated at 50°C for 20 minutes. 2.5 ml of 10 % 
trichloroacetic acid was added to the mixture, followed by centrifugation at 3000 rpm 
for 10 minutes. 2.5 ml of distilled water was added to equal amount of the supernatant 
followed by addition of 0.5 ml of 0.1 % FeCl3, the absorbance was recorded at 700 nm.  
2.11. Statistical analysis   
Data are expressed as mean ± standard error (SE). The results were first checked for 
normality by Kolmogorov and Smirnov test and homogeneity by Bartlett's test, and 
then analyzed using the Student’s t test and analysis of variance (ANOVA) test. Dunnett 
posttest was used to determine which groups significantly differed from the control 
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group. The statistical analysis was performed using GraphPad Prism version 3. Results 
were considered significantly different if the p < 0.05 [23].  
3.4. Results and discussion  
Hydrodistillation of J. pelargoniifolia roots provided a yellowish essential oil with a 
yield of 0.52% (v/w), depend on fresh weight of the plant. Analysis and identiﬁcation 
by mass fragmentation and retention index revealed the presence of 80 compounds, 
representing 99.99% of the total oil with 77.31% of these compounds being 
sesquiterpenes, 14.62% fatty acids, 7.21% other components (i.e., phenolics, 
hydrocarbons, cyclic compounds, etc.), and 0.85% were monoterpenes. The chemical 
composition of the essential oil and the percentage of each component determined from 
GC-MS analysis is shown (Table 1). The compounds are arranged in order of their 
elution from column together with their retention indices. 
The major compounds in the essential oil were γ-eudesmol (35.31), 5-guaien-
11-ol (14.43%), epi-cedrol (8.19%), oleic acid (5.23%), bulnesol (4.45%), linoleic acid 
(4.20%), 3,4-dimethoxycinnamic acid (3.83%), palmitic acid (2.69%), 
isolongifolanone (2.68%), eicosane (1.41%), and cedrol (1.40%). Oxygenated 
sesquiterpenes were found to be the major group of compounds that represented more 
than half of the oil content. It consisted almost entirely of γ-eudesmol (35.31%), 5-
guaien-11-ol (14.43%), and epi-cedrol (8.19%). While oxygenated monoterpenes, fatty 
acids, and sesquiterpenes hydrocarbons covered a small percentage of the oil content. 
A review of recent literature confirmed that γ-eudesmol is identified here for 
the first time in the genus Jatropha. Previously, secondary metabolites have been 
reported for many Jatropha essential oils, especially in the species: J. ribifolia, J. 
gossypifolia, and J. mutabilis [7, 8, 24, 9]. Major constituents in J. ribifolia aerial part 
essential oil were β-pinene, isoeugenol methyl ether, α-gurjunene, endo-8-hydroxy-
cycloisolongifolene, α-pinene, and p-menth-1-en-8-ol, while phytol, spathulenol, epi-
α-cadinol, caryophyllene oxide, germacerene D, and α-cadinol were the main 
components derived from J. mutabilis leaves essential oil. Essential oil from the leaves 
of J. gossypifolia was composed mainly of phytol, octadecanal, and viridiflorol, while 
major components of its stem oil were phytol, α-copaene, and limonene.  
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Table 1: Chemical constituents of J. pelargoniifolia root essential oil 
RI Conc. (%) Rt (min.) Constituents # 
834 0.006 6.79 Isovaleric acid 1 
939 0.016 11.92 8-α-Pinenol 2 
965 0.013 12.15 Phenol 3 
987 0.005 13.99 Capronic acid 4 
1033 0.010 16.03 Eucalyptol 5 
1074 0.013 16.46 cis-Linalool oxide 6 
1083 0.010 17.03 Heptanoic acid 7 
1086 0.998 17.10 Guaiacol 8 
1088 0.012 17.66 trans-Linalool oxide 9 
1098 0.005 19.14 Linalool 10 
1110 0.004 19.54 2-Phenylethyl alcohol 11 
1112 0.018 20.00 Fenchol 12 
1148 0.065 20.52 Camphene hydrate 13 
1158 0.004 20.53 1,8-Epoxy-2-p-Exo-Menthanol 14 
1165 0.003 20.92 Borneol 15 
1177 0.527 21.06 4-Terpinenol 16 
1183 0.008 21.40 8-p-Cymenol 17 
1187 0.024 21.87 Caprylic acid 18 
1188 0.006 22.35 Butyl-n-hexanoate 19 
1189 0.128 22.45 α-Terpinol 20 
1194 0.030 23.24 Myrtenol 21 
1229 0.108 23.53 4-Vinyl-phenol 22 
1285 0.014 25.34 Bornyl acetate 23 
1351 0.511 26.15 α-Cubebene 24 
1356 0.004 28.05 Eugenol 25 
1357 0.157 28.65 Octadecanal 26 
1368 0.006 29.13 Cyclosativene 27 
1376 0.589 29.39 α-Copaene 28 
1382 0.061 29.77 β-Elemene 29 
1391 0.042 30.18 Vanillin 30 
1398 0.109 30.30 α-Cyperone 31 
1399 0.039 30.54 Capric acid 32 
1402 0.104 30.77 cis-Isoeugenol 33 
1404 0.074 31.45 Caryophylladiene 34 
1409 0.030 31.88 α-Gurjunene 35 
1418 0.555 31.89 Caryophyllene 36 
1439 0.125 32.43 α-Guaiene 37 
1458 0.049 32.86 E-β-Farnesene 38 
1461  0.091 33.26 Alloaromadendrene 39 
1478 0.011 33.73 2,6-di(t-Butyl)-4-hydroxy-4-methyl-2,5-
cyclohexadien-1-one 
40 
1485 0.071 33.74 β-Selinene 41 
1490 0.809 33.75 Epi-Bicyclosesquiphellandrene 42 
1491 0.168 34.01 Valencene 43 
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*Rt: retention time, *RI: retention indices, GC-MS, gas chromatography-mass spectroscopy; component concentrations were 
calculated from GC-FID peak areas in the order of column elution. 
 
Table 1: Cont. 
RI Conc. (%) Rt (min.) Constituents # 
1492 0.067 34.10 cis-Methyl isoeugenyl  44 
1494 0.095 34.18 α-Selinene 45  
1496 0.157 34.71 β-Dihydroagarofuran 46 
1497 0.028 34.72 δ-Selinene 47 
1499 1.317 34.73 α-Muurolene 48 
1505 1.336 34.73 δ-Guajene 49 
1512 0.032 35.50 Butylated hydroxytoluene 50 
1524 0.379 35.93 δ-Cadinene 51 
1542 0.647 36.30 α-Calacorene 52 
1549 0.628 36.78 Elemol 53 
1595 0.315 37.06 Guajoxid 54 
1596 1.140 37.48 Cedrol 55 
1611 8.191 38.18 Epi-Cedrol 56 
1618 2.679 38.29 trans-Isolongifolanone 57 
1619 1.447 39.07 10-Epi- γ-Eudesmol 58 
1625 14.429 39.91 5-Guaien-11-ol 59 
1630 35.309 41.10 γ-Eudesmol 60 
1645 0.383 41.19 δ-Cadinol 61 
1648 0.388 41.20 4-α-Hydroxy dihydro agarofuran 62 
1666 4.454 41.94 Bulnesol 63 
1777 0.065 45.40 Ethyl myristate 64 
1808 0.510 47.71 Cryptomeridiol 65 
1842 0.760 47.89 Myristic acid  66 
1855 0.262 48.87 8,11-Heptadecadienal 67 
1902 0.350 49.40 Pentadecanoic acid 68 
1927 0.023 50.46 Methyl hexadecanoate 69 
1949 3.828 51.55 3,4-Dimethoxycinnamic acid 70 
1972 2.689 54.95 Palmitic acid 71 
1993 0.118 55.42 Ethyl palmitate 72 
2000 1.411 56.26 Eicosane 73 
2020 0.227 56.63 Geranyl linalool 74 
2156 0.076 57.07 4-Vinylguaiacol 75 
2173 4.196 57.86 α-Linoleic acid 76 
2175 5.232 58.17 Oleic acid 77 
2192 0.732 59.43 Stearic acid 78 
2377 0.417 59.76 5,9-Farnesyl propanone 79 
2723 0.041 60.06 Dehydrodiisoeugenol 80 
- 0.849 - Oxygenated monoterpenes  
- 70.366 - Oxygenated sesquiterpenes  
- 6.941 - Sesquiterpene hydrocarbones 
- 4.939 - Fatty acids (saturated) 
- 9.690 - Fatty acids (unsaturated) 
- 7.205 -  Other 
- 99.99 - Total percentages 
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The 24-hours LD50 was approximately more than 1.2 ml/kg b.w. for the essential 
oil. These results showed that the essential oil of J. pelargoniifolia roots is safe and 
non-toxic because no mice died or showed any severe side effects or intoxication. 
Table 2 shows the effects of oil and phenylbutazone on carrageenan-induced rat 
paw edema. Injection of carrageenan into the sub-plantar tissue of the right hind paw 
of rats in the control group led to rapid growth of edema, which peaked (1.795±0.029 
in paw volume) at 180 min post-phlogistic agent injection. The percent reduction in 
edema after oil administration was 31.68 and 55.64% inhibition observed at 120 µl/kg 
and 240 µl/kg, respectively. This effect was significantly different (P < 0.01) as 
compared to that produced by 100 mg/kg phenylbutazone (77.42% inhibition). 
Carrageenan-induced paw edema is widely used experiment for screening the 
anti-inflammatory drugs including natural products [25]. We found that the 
administration of oil significantly decreased edema volume induced in animal's paw by 
carrageenan. 
The inflammatory response by carrageenan hind paw in the rodent is including 
many stages. Firstly, after carrageenan injection, the paw volume increased due to 
release of internal chemical mediators such as, histamine and serotonin [26]. Then, the 
increase in vascular permeability was sustained by the release of prostaglandins and 
nitric oxide lead to stimulate migration of leukocytes into the inflamed site [27]. The 
last stage of edema is susceptible for commonly used anti-inflammatory drug. So, that 
oil might prevent increased in vascular permeability (edema) and leukocyte 
aggregation. The exact mechanism of action of J. pelargoniifolia root essential oil need 
further investigation. 
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Table 2: Effect of J. pelargoniifolia essential oil on carrageenan-induced paw edema in Wistar 
rats 
 
All values represent mean ± SE. **p < 0.01 versus carrageenan group (one-way ANOVA, followed by Dunnett's test), ###p < 0.001 
versus carrageenan group (unpaired t-test), ••• p < 0.001 versus the corresponding group before treatment (paired t-test). 
Cotton pellet-induced granuloma test was done to assess the efficacy of oil and 
standard anti-inflammatory drug against the proliferative phase of inflammation in 
which tissue degeneration and fibrosis occur . 
According to these results, the anti-proliferative potency of the oil (120 µl/kg 
and 240 µl/kg) was calculated to be 69.667±1.787 and 51.217±1.463 (P < 0.001), 
respectively, while for phenylbutazone (100 mg/kg), was 41.700±1.065. After cotton 
pellet drying, the anti-proliferative effects were calculated based on the dry weights. 
The inhibition of inflammation by the oil and was 39.667±1.787 (23.57%) and 
21.217±1.463 (59.12%) (P< 0.01), respectively, while for phenylbutazone was 
11.700±1.065 (77.45%). 
The cotton pellet-induced granuloma model is popular experimental technique 
used to evaluate the transudative, exudative, and proliferative events during chronic 
inflammation [28]. Perhaps, the reduction in granuloma size revealed the ability of oil 
to decrease the total number of fibroblasts and extending the time need for the synthesis 
of mucopolysaccharide and collagen which are involved in granuloma formation [29]. 
It is better to point out that sesquiterpenes and unsaturated fatty acids, which are 
the major constituents of the currently investigated oil and which play a significant role 
as anti-inflammatory compounds, are all derived from natural sources [30]. The 
essential oil of J. pelargoniifolia roots have been reported to have more than half of its 
constitutes made up of oxygenated sesquiterpenes (70.36%). It consists almost entirely 
of γ-eudesmol, 5-guaien-11-ol, epi-cedrol and bulnesol; these compounds have shown 
significant anti-inflammatory properties due to their various pharmacological activities 
Group (n=6) Dose 
(µl/kg) 
Before 
Carrageenan 
3 hours after Net % 
Inhibition 
Only carrageenan 0.05 ml 0.953±0.034 1.795±0.029••• 0.842±0.017 - 
Essential Oil 120 0.993±0.036 1.568±0.033••• 0.575±0.022** 31.68 
Essential Oil 240 0.982±0.034 1.355±0.028••• 0.373±0.015** 55.64 
Phenylbutazone 100 mg/kg 1.007±0.028 1.197±0.028••• 0.190±0.005### 77.42 
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[31]. In addition, review of literature confirmed that both oleic acid (5.23%) and α-
linoleic acid (4.19%) possess strong anti-inflammatory activities [32]. On the basis of 
this result, it could be proposed that the anti-inflammatory potential exerted by the 
essential root oil may be attributable to the synergistic action of sesquiterpenes and fatty 
acids since they are present in high yield.  
The action of oil and indomethacin on yeast-induced fever in mice is illustrated 
in Table 3. The s.c. injection of an aqueous suspension of brewer's yeast has 
significantly elevated the rectal temperature by 3.2°C after 24 h of injection. Animals 
treated with the essential oil and indomethacin (positive control) showed significant 
reduction in animal's rectal temperature. J. pelargoniifolia oil showed significant 
suppression in rectal temperature after 30 min; the decrease observed was by 0.217°C 
and 0.53°C, i.e., from 38.350±0.126°C to 37.750±0.106°C and from 38.383±0.108°C 
to 37.850±0.112°C (p < 0.05), with doses of 120 µl/kg and 240 µl/kg, respectively. The 
antipyretic effect of oil began 30 min after its administration especially at dose 240 
µl/kg (p < 0.05) and the decrease in rectal temperature was continued for 2 h (p < 0.01 
and 0.05). Indomethacin also displayed a significant decrease in rectal temperature by 
1.85°C, i.e., from 38.750±0.112°C to 36.900±0.086°C, and the percentage inhibition of 
pyrexia was significant (p < 0.001).  
Additionally, after 120 min, there was no important variance between the 
antipyretic effect of oil in comparison to indomethacin. The current study displays that 
J. pelargoniifolia root oil has antipyretic effect in mice. Various reports have verified 
that yeast-induced temperature elevation is a pathogenic pyrexia [33]. At a higher body 
temperature, the thermoregulatory center in the hypothalamus start to release 
prostaglandins. If a central CNS effect or peripheric inhibition of cyclooxygenase 
which is responsible for the pyretic effect, that aspect remains to be studied but was not 
a part of the present study.   
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Table 3: Effect of J. pelargoniifolia essential oil on yeast-induced hyperthermia in mice 
 
 
All values represent mean ± SE. *p < 0.05; **p < 0.01 versus the corresponding group before drug treatment (Repeted ANOVA, 
followed by Dunnett's test), ••• p < 0.001 (paired t-test), the hyperthermic group were compared with normal group befor the yeast 
administration. 
 
 
As seen in Table 4, the mean writhes of the mouse decreased from 25.500±1.176 
to 18.000±0.816 as the dose of the oil increased from 120 to 240 µl/kg, which compared 
to 4 mg/kg of indomethacin (8.500±0.428; 75.00% inhibition of writhing).  
The mechanism of antinociceptive is not obvious in the current study. It is 
expected that prevention of prostaglandins caused reduction in mice visceral pain. Thus, 
it seems that the oil of J. pelargoniifolia prevents the second stage of inflammation and 
causes the inhibition of prostaglandin peripherally [34]. This comment is supported by 
our finding that oil effectively suppressed yeast-induced pyrexia in animal's model. 
The oil at the two doses showed significant analgesic action peaking at 30, 60, 
and 120 minutes at doses of 120 and 240 µl/kg (i.p.) as compared with indomethacin.  
The tail flick method indicated the central analgesic effect of J. pelargoniifolia 
roots oil. The response of the tail flick is assumed to be a spinally mediated reflex, 
which is controlled by a supraspinal inhibitory mechanism [35]. The oil was produced 
significant analgesic activity (p < 0.01) compared to the positive control group. 
Moreover, in the hot plate test, treatment with oil showed significant 
antinociceptive effect (p < 0.01) as compared to that in the positive control group. The 
oil was produced the analgesic effect via increasing the time of response to heat 
sensation, from 6.333±0.211 to 8.667±0.333 at 120 minutes (36.84% analgesia) with a 
dose of 120 µl/kg and 6.667±0.333 to 11.667±0.333 at 120 minutes (75.00% analgesia) 
with a dose of 240 µl/kg. Indomethacin also significantly delayed the reaction time by 
120.00% (p < 0.001). The analgesic effect caused by indomethacin was significantly 
             Rectal temperature °C (Post Drug) 
 
Rectal temperature 
after yeast 
administration 
(20 ml/kg of 20%) 
Normal rector 
temperature 
Dose 
(µl/kg) 
Treatment 
(n=6) 
120 m 60 m 30 m 
37.750±0.106* 37.833±0.109* 38.133±0.123 38.350±0.126••• 35.150±0.076 120 Essential Oil 
37.033±0.120** 37.183±0.128** 37.850±0.112* 38.383±0.108••• 35.183±0.095 240 Essential Oil 
36.033±0.120** 36.583±0.140** 36.900±0.086** 38.750±0.112••• 35.450±0.157 4 mg/kg Indomethacin 
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stronger than that induced by the oil (8.667±0.333 and 11.667±0.333 at doses of 120 
and 240 µl/kg, respectively) versus 14.667±0.333 after 120 minutes (p < 0.001). 
In numerous studies, the pharmacological action of essential oils has been 
referred to the synergistic effect of active components. The oil inactive principles 
pharmacokinetics and bioavailability could be supported by active components. 
Further, it is difficult to establish a relationship between oil constituents and its activity 
[36]. Perhaps, the analgesic activity of the essential oil derived from J. pelargoniifolia 
roots is mainly due to the combined effect of sesquiterpenes as suggested by Lee et al., 
2002 [37], it is maybe responsible for blocking the release of endogenous substances, 
which excite the pain in nociceptive pathway. 
 Table 4: Analgesic effect of J. pelargoniifolia essential oil on Acetic acid –induced writhing 
in mice 
All values represent mean ± SE. **p < 0.01 versus control (one-way ANOVA, followed by Dunnett's test), ###p < 0.001 versus 
control (unpaired t-test). 
The antioxidant activity was measured by using three methods including DPPH, 
ABTS and FRAP. As illustrated in Table 5, the DPPH radical scavenging assay was 
used to assess the antioxidant activity of the essential oil, it was displayed a 
concentration-dependent antioxidant effect by DPPHˉ ion. As expected, ascorbic acid 
showed a higher potency (99.69 %) of free radical scavenging at 100 µg/ml as compared 
to the oil at same concentrations (78.15%).   
The results and mechanism of action obtained from DPPH, ABTS methods were 
similar to each other since their mechanism more or less similar which based on the 
donation of electrons or hydrogen atoms to free radical lead to its inactivation [38]. The 
results obtained from these two methods, regarding scavenging activity of the oil 
increased with the increasing concentration.  
From the investigation of Table 5, we can conclude that the oil showed 
significant ABTS radical-scavenging property (84.10%), which was comparable to that 
of ascorbic acid (90.50%) at 100 μg/ml.  
Treatments (n=6) Dose 
(µl/kg) 
Number of writhing in 20 min. 
 
% Inhibition 
Control (Acetic acid) 0.1 ml of 20% 34.000±1.983 - 
Essential Oil 120 25.500±1.176** 25.00 
Essential Oil 240 18.000±0.816** 47.58 
Indomethacin 4 mg/kg 8.500±0.428### 75.00 
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These results showed that the high antioxidant potential of the oil derived from 
J. pelargoniifolia roots could be attributed to the high percentage of oxygenated 
compounds, such as γ-eudesmol, 5-guaien-11-ol, and epi-cedrol [39]. 
The result obtained from third antioxidant experiment (FRAP) method, is also 
based on the reducing power of the essential oil ingredients which can reduce the ferric 
ions (Fe3+) to ferrous ion (Fe2+) by electron donation. In this experiment the intensity 
of Perl’s Prussian blue color was measured at 700 nm. The higher increase in the 
Prussian blue color intensity revealed strong antioxidant activity [40].  
       As indicated in Table 5, the reducing capabilities of the root oil towards FRAP 
were compared to ascorbic acid as the reference standard. The oil exhibited moderate 
ferric reduction capability (1.06) in comparison to ascorbic acid (1.48) at the same 
concentration (100 µg/ml). As result, the oil showed good reducing activity with 
increasing concentrations as compared to the most famous antioxidant drug; ascorbic 
acid. 
Table 5: Antioxidant effect of J. pelargoniifolia essential oil (DPPH, ABT, and FRAP assays) 
 OD. = Optical density 
 
 
 
 
Treatments DPPH assay ABTS assay FRAP assay 
Concentration 
(µg/ml) 
%Average 
scavenging 
Mean ±S.D %Average 
scavenging 
 
Mean ±S.D Average 
OD. 
 
Mean ±S.D 
Essential Oil 10  
 
13.65 13.650±12.010 13.65 13.650 ±12.090 0.47 0.470±0.090 
Essential Oil 20  
 
32.05 32.050±1.060 43.40 43.400±11.870 0.74 0.745±0.020 
Essential Oil 50  
 
57.30 57.30±2.120 57.05 57.050±13.050 0.89 0.890±0.020 
Essential Oil 100  
 
78.15 78.150±6.570 84.10 84.100±9.330 1.06 1.060±0.020 
Ascorbic acid 100 
 
99.69 99.690±0.030 90.50 90.500±7.770 1.48 1.475±0.007 
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 3.5. Conclusion 
The essential oil constituents obtained from the roots of J. pelargoniifolia are reported 
here for the first time; we have also investigated selected biological activities with 
regard to the ethnomedicinal use of the essential oil of the roots considering that it is a 
native plant to Saudi Arabia [41]. It was found that the essential oil showed promising 
activities as anti-inflammatory, antinociceptive, antipyretic and antioxidant agent. 
Perhaps, these significant biological activities can be referred to the effect of its active 
components. The inactive components could work by influencing pharmacokinetics 
and bioavailability of the active compounds. Furthermore, it is difficult to create a 
relationship between specific oil constituent and certain biological activity due to the 
combined effect between its various constituents. The essential oil isolated from roots 
of J. pelargoniifolia may serve as a promising candidate for the development of safer 
therapeutic agents to be used for treatment of contemporary diseases, such as various 
skin inflammatory condition and acute arthritis. 
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4.1. Abstract 
The roots and aerial parts of Jatropha pelargoniifolia and Jatropha glauca, which 
belong to the family Euphorbiaceae that is native to Saudi Arabia, contain essential oils. 
Here, we studied the essential oil components in these plant parts in a comparative study 
of the two species. The essential oils were obtained by hydrodistillation and were 
analyzed by GC-FID and GC-MS. In total, 80, 42, 45, and 68 compounds, which 
accounted for 99.99%, 86.92%, 92.83%, and 89.84% of the total composition of 
essential oils in J. pelargoniifolia roots, J. pelargoniifolia aerial parts, J. glauca roots, 
and J. glauca aerial parts, respectively, were identified. We conducted a comparative 
study on both species to reveal the chemotaxonomic relationship between J. glauca and 
J. pelargoniifolia based on predominant sesquiterpenoids and diterpenoids. Qualitative 
and quantitative similarities were observed in the oil composition of both species, 
mainly regarding the major components, which for the roots of J. glauca and J. 
pelargoniifolia were γ-eudesmol (28.82% and 35.31%) and 5-guaien-11-ol (22.86% 
and 14.43%), respectively, and for the aerial parts were phytol (33.05 and 24.19 %) and 
palmitic acid (20.43 and 11.53%), respectively. Oxygenated sesquiterpenes and fatty 
acids were predominant chemical classes in oil isolated from roots of both species. On 
the other hand, oils from aerial parts were high in oxygenated diterpenes (35.30% in J. 
glauca and 32.23% in J. pelargoniifolia). Oils from J. pelargoniifolia aerial parts were 
high in oxygenated sesquiterpenes followed by fatty acids, while those from J. glauca 
were rich in fatty acids and other phenolics (hydrocarbons/cyclic). J. glauca and J. 
pelargoniifolia have similar morphology, except for leaf surface (hairy in J. 
pelargoniifolia and smooth in J. glauca) and fruit color (darker in J. pelargoniifolia), 
and these species are therefore often confused by native people in southern Saudi 
Arabia. This study clarified chemotaxonomic characters of J. glauca and J. 
pelargoniifolia via chemical composition analysis of essential oils of roots and aerial 
parts. 
 
 
 
 
 72 
 
4.2. Introduction  
Medicinal plants play a vital role in healthcare provision in numerous countries, and 
they have been used as drugs for the treatment of major human diseases [1, 2]. Herbs 
have been classified by the World Health Organization (WHO) as a superior source for 
drug discovery [3]. Plants belonging to the genus Jatropha are popularly used to treat 
various diseases [4]. Traditionally, J. pelargoniifolia sap of the petiole was applied as 
a healing agent for ulcers and wounds in Ethiopia and Saudi Arabia, while the whole 
plant of J. glauca, including the root, is mashed in water and the liquid is taken to treat 
constipation and as ear drops to treat earache, and the leaf sap is taken as an astringent 
[5].  
The Euphorbiaceae family, which is considered one of the largest families of 
angiosperms worldwide, covers about 7,800 species distributed in approximately 300 
genera and five subfamilies. These species occur preferentially in tropical and 
subtropical environments [6, 7]. Among the main genera belonging to this family, 
Jatropha, which is represented by about 200 species. This genus is widely distributed 
in tropical and subtropical regions of Africa and the Americas [7]. J. pelargoniifolia 
and J. glauca are known locally as “Obab” and “Obeeb,” respectively. They are widely 
distributed in Africa (Sudan, Eritrea, Djibouti, Ethiopia, Somalia) and the Arabian 
Peninsula (Yemen, Saudi Arabia). Native people in the Southern region of Saudi Arabia 
mostly mix both species for ethnomedical use because they have a similar morphology, 
although they differ in leaf structure (hairy versus smooth surface) and fruit color. 
Essential oils are natural products with many applications, e.g., in the food, 
perfume, cosmetics, and pharmaceutical industries. Essential oils are complex mixtures 
and have various pharmacological properties, including anti-inflammatory, 
antibacterial, antifungal, protective of the gastrointestinal tract, anticonvulsant, and 
antioxidant properties [8]. Thus, essential oils are one of the most promising candidate 
groups of natural compounds for the development of safer therapeutic agents. 
Numerous phytochemical and biological studies on essential oils isolated from 
various Jatropha species, such as, J. curcas, J. ribifolia, J. gossypifolia and J. mutabilis 
have been reported [9, 10, 11, 12]. To the best of our knowledge, there are no reports 
on the composition of essential oils isolated from J. pelargoniifolia and J. glauca. 
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Therefore, this study aimed to explore the effects of ecological and geographical factors 
on essential oil characteristics, including chemical constituent classes and 
concentrations, total yield, organoleptics, and physical characters, which can be used 
as chemotaxonomic markers. 
4.3. Materials and methods 
4.3.1. Plant material 
J. glauca (Figure 1Sa) is a frutescent plant of approximately 30 cm in height. Leaves 
are bluish-green, small, petioled, 3–5 digitately lobed with serrate margin, and fruits 
are capsules. Female flowers are larger, with larger perianth, than the male flowers. 
Capsules are pale, straw-colored, scaly, 1 cm long, with smooth black seeds. J. 
pelargoniifolia (Figure 1Sb) is similar in height, and the leaves are slightly smaller and 
are covered with silky hairs [13]. 
J. pelargoniifolia and J. glauca were collected in September 2015 from Wadis 
Mojasas and Shogare (hot and humid areas), respectively, in the Jazan South area of 
the Kingdom of Saudi Arabia. Species were identified by Dr. Jacob Thomas, 
taxonomist at the Botany and Microbiology Department, College of Science, King Saud 
University, Riyadh, Saudi Arabia. Voucher specimens of J. pelargoniifolia and J. 
glauca (numbers 23064 and 23063, respectively) have been deposited at the herbarium 
of College of Science, King Saud University. Aerial parts were separated carefully from 
roots. After removing the dirt, each part was washed with water and then air-dried. The 
fresh roots and aerial parts were weighed: J. pelargoniifolia roots, 0.83 kg; J. 
pelargoniifolia aerial parts, 0.92 kg; J. glauca roots, 0.57 kg; and J. glauca aerial parts, 
0.43 kg.  
4.3.2. Essential oils prepared 
Freshly cut roots and aerial parts were subjected to hydrodistillation for 8 h using a 
Clevenger-type apparatus using an adaption of the procedure described in the European 
Pharmacopoeia (2004) [14]. The oils were dried over anhydrous sodium sulfate and 
stored in air-tight, amber-colored glass vials at 4°C for later analysis.  
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4.3.3. Gas chromatography-flame ionization detector (GC-FID) analysis 
Sample components analysis was carried out by using Gas Chromatograph System 
Series (Agilent 5975MS /6890) combined with a flame ionization type of detector (FID) 
with fused silica capillary column HP-5 5% phenylmethylsiloxane capillary column (30 
m × 0.25 mm inner diameter, 0.25 μm film thickness). Oven temperature was gradually 
increased from 40 to 280°C at a rate of 3°C min-1. The temperature of the injection port 
was kept at 230°C while the detector temperature kept constantly at 280°C. The split 
ratio was (1:20). The injection volume was 1.0 µL. A C7-C21 n-alkanes mixture was 
mixed with n-hexane and used for determination of the temperature programmed 
retention indices. The sample was analyzed in n-hexane solution. An internal standard 
(n-alkanes) was then mixed with the sample to help in the standardization of retention 
times, and the sample was reanalyzed. Retention indices (RI) for all components were 
verified. The identity of essential oil components was achieved by comparing their 
retention indices (RI) and mass spectra with those reported from authentic samples and/ 
or the Wiley and NBS/NIST libraries and those published by Adams, 2001 [15]. The 
quantitative data regarding the essential constituents were obtained by peak-area 
normalization using the chromatographic technique with flame ionization detection 
(GC-FID) operated under similar conditions to the GC-MS. Compounds with 
concentrations equal or greater than 0.001% were considered for quantiﬁcation. The 
false-positive results were prevented via avoiding coelution phenomena through the 
identification and deconvolution of coeluting peaks are done with Agilent Chemstation 
in combination with AMDIS as deconvolution software. For the identification we are 
using comprehensive internal MS-libraries as well as commercial libraries like NIST. 
Additionally, a retention index calibration is done to have RI as second factor for a 
correct identification. 
4.4. Results and discussion 
The data on the essential oil components of different parts of J. pelargoniifolia and J. 
glauca from Saudi Arabia are given in Table 1 and Figure 2S. The essential oil samples 
from aerial parts were observed as yellowish-red liquids and were obtained with yields 
of 0.22% and 0.35% (v/w) from J. pelargoniifolia and J. glauca, respectively. The root 
essential oils were intense yellow liquids with a yield of 0.54% (v/w) for J. 
pelargoniifolia roots and 0.33% (v/w) for J. glauca roots. The essential oil of J. 
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pelargoniifolia roots contained sesquiterpenes (77.31%) and monoterpenes (0.85%). 
Similarly, J. glauca root essential oil consisted of sesquiterpenes (66.74%) and 
monoterpenes (0.96%). The aerial-part essential oils of J. pelargoniifolia and J. glauca 
were abundant in diterpenes (35.61% and 39.74%, respectively), and sesquiterpenes 
(25.57 and 5.65%, respectively), and monoterpenes (0.76% and 0.98%, respectively). 
The oils of aerial parts of J. pelargoniifolia and J. glauca contained diterpenes, which 
were not observed or present in trace amounts in the oils from root samples. The amount 
of sesquiterpenes was higher than that of monoterpenes in roots and aerial parts. The 
majority of compounds of J. pelargoniifolia and J. glauca root essential oils belonged 
to oxygenated sesquiterpenes (70.37% and 66.39%, respectively), while oxygenated 
diterpenes were abundant in aerial-part essential oils (32.23% and 35.30%, 
respectively). In contrast, fatty acids isolated from essential oils of J. pelargoniifolia 
roots, J. pelargoniifolia aerial parts, J. glauca roots and J. glauca aerial parts 
represented 14.63%, 20.95%, 19.71%, and 29.36%, respectively, of the total oil 
content.  
 The abundant compounds of the essential oils of the roots of J. pelargoniifolia 
and J. glauca were γ-eudesmol (35.31% and 28.82%), 5-guaien-11-ol (14.43% and 
22.86%), α-linoleic acid (4.20% and 4.97%), bulnesol (4.45% and 1.60%), oleic acid 
(5.23% and 1.50%,), palmitic acid (2.69% and 8.83%), and 10-epi-γ-eudesmol (1.45% 
and 1.82%). The predominant components of J. pelargoniifolia and J. glauca aerial-
part essential oils were phytol (24.19% and 33.05%), palmitic acid (11.53% and 
20.43%), γ-eudesmol (6.94% and 0.43%), 5-guaien-11-ol (5.21% and 0.78%), 
neophytadiene (3.38% and 4.44%), α-linoleic acid (4.36% and 2.47%), δ-cadinol 
(1.28% and 1.72%), isophytol (1.41% and 1.67%), and myristic acid (2.62% and 
1.28%). Common major volatile components in root and aerial-part essential oils were 
10-epi-γ-eudesmol, γ-eudesmol, 5-guaien-11-ol, and δ-cadinol. Phytol was detected in 
aerial-part essential oils of J. pelargoniifolia and J. glauca and in J. glauca root oil but 
was not detectable in essential oil from the roots of J. pelargoniifolia. 
Volatile oxygenated sesquiterpenes were present in significant amounts in all 
four essential oils, especially in those of J. pelargoniifolia roots, J. pelargoniifolia 
aerial parts, and J. glauca roots. Oxygenated diterpenes were predominant in oils from 
aerial parts of J. pelargoniifolia and J. glauca, and at minor concentrations in root oil 
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from J. glauca, but not J. pelargoniifolia. On the other hand, oxygenated monoterpene 
and sesquiterpene hydrocarbons were detected in all four essential oils at low levels. 
Hydrocarbons derived from monoterpenes and diterpenes were exclusively detected in 
aerial-part essential oils of both species and represented a small fraction of the total oil 
content. While major components of essential oils are very important for their 
biological activity, minor components also play a significant role, as they can 
strengthen the effects of major components, though antagonistic and additive effects 
have also been observed [16] 
The composition of essential oil isolated from the same plant species but from 
different organ sources can differ. We clearly observed similarities in the chemical 
composition of the essential oils, especially, in the major components, isolated from 
different Jatropha species but from the same organ. This indicates the importance of 
the oil-producing organ (i.e., the source of oil production; leaves, roots, bark, or 
flowers) in determining the oil chemical composition and yield [17]. Recently, 
secondary metabolites of essential oils were discussed for various Jatropha species, 
including J. ribifolia, J. mutabilis, J. gossypifolia, and J. curcas. The major components 
in J. ribifolia essential oil were β-pinene, iso-eugenol methyl ether, α-gurjunene, endo-
8-hydroxy-cycloisolongifolene, α-pinene, and p-menth-1-en-8-ol [11], while phytol, 
spathulenol, epi-α-cadinol, caryophyllene oxide, germacrene D, and α-cadinol were the 
major constituents in J. mutabilis leaves essential oils [10]. J. gossypifolia leaves 
essential oil was composed mainly of phytol, octadecanal, and viridiflorol, while stem 
oil mainly contains phytol, α-copaene, and limonene [18]. Finally, the main constituents 
of J. curcas seed oil are unsaturated fatty acids (oleic and linoleic acids) and saturated 
fatty acids (palmitic and steric acids) [12] (Table 2). These findings suggest that 
essential oil chemical constituents and yields depend on many factors, including 
geographical, environmental, and genetic factors. We were able to characterize the 
components of the essential oils of J. pelargoniifolia and J. glauca, and these chemical 
profiles can be considered as chemotaxonomic markers. 
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Table 1: Chemical compositions of roots and aerial parts of Jatropha pelargoniifolia (JP) and 
J. glauca (JG) essential oils  
 
RI 
JGa JGr JPa JPr Constituents 
Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
780 0.018 - - - Butyric acid 
834 - - - 0.006 Isovaleric acid 
844 0.031 - - - Diacetone alcohol 
859 - 0.112 - - Elemyl acetate 
939 - - - 0.016 8-α-Pinenol 
947 0.006 - - - 1-mercapto-3-pentanone 
965 - - - 0.013 Phenol 
987 0.015 - - 0.005 Capronic acid 
1033 - - - 0.010 Eucalyptol 
1043 0.081 - 0.030 - Benzenacetaldehyde 
1065 - - 0.039 - 1,2,4-Trithiolane 
1074 - - - 0.013 cis-Linalool oxide 
1083 -   0.010 Heptanoic acid 
1086 - 0.557 0.310 0.998 Guaiacol 
1088 - - - 0.012 trans-Linalool oxide 
1094 0.073 - - - 3-mercapto-1-hexanol 
1098 - - - 0.005 Linalool 
1099 0.093 - - - 2-Phenyl-1-propanol 
1110 0.107 - - 0.004 2-Phenylethyl alcohol 
1112 - - - 0.018 Fenchol 
1148 - - - 0.065 Camphene hydrate 
1151 0.067 - - - 2,3-Dimethylphenol 
1158 - - - 0.004 1,8-Epoxy-2-p-Exo-
Menthanol 
1162 0.139 - - - 4-Vinylguaiacol 
1165 - - - 0.003 Borneol 
1166 0.009 - - - 1-Phenyl-1,2-
propanedione 
1177 - - - 0.527 4-Terpinenol 
1183 - - - 0.008 8-p-Cymenol 
1185 - 0.012 - - γ-Terpineol 
1187 - 0.073 - 0.024 Caprylic acid 
1188 - - - 0.006 Butyl-n-hexanoate 
1189 - 0.036 - 0.128 α-Terpinol 
1193 0.443 - - - cis-Dihydro carvone 
1194 - - - 0.030 Myrtenol 
1229 0.085 - 0.075 0.108 4-Vinyl-phenol 
1240 0.232 - - - Benzylacetone 
1252 0.133 - 0.299 - p-Anisaldehyde 
1260 0.074 0.035 - - Pelargonic acid 
1285 - - - 0.014 Bornyl acetate 
1288 0.033 - 0.109 - Indole 
1290 - - 0.265 - Thymol 
1323 - 0.016 - - trans-Methylgeraniate 
1337 0.109 - 0.100 - Methylanthranilate 
1342 0.095 - - - Dehydroionene 
1351 - - - 0.511 α-Cubebene 
1356 0.270 - - 0.004 Eugenol 
1357 0.150 0.292 - 0.157 Octadecanal 
1368 - - - 0.006 Cyclosativene 
1376 - - - 0.589 α-Copaene 
1377 0.218 - - - β-Damascenone 
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Table 1: Cont. 
 
RI 
JGa  JGr JPa JPr  
Constituents 
Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
1382 - - - 0.061 β-Elemene 
1391 0.107 0.045 0.085 0.042 Vanillin 
1398 - - - 0.109 α-Cyperone 
1399 - 0.097 0.067 0.039 Capric acid 
1402 0.026 0.080 - 0.104 cis-Isoeugenol 
1404 - - - 0.074 Caryophylladiene 
1409 - 0.023 - 0.030 α-Gurjunene 
1418 - - - 0.555 Caryophyllene 
1426 0.092 - 0.135 - α-Ionone 
1439 - - - 0.125 α-Guaiene 
1458 - - - 0.049 E-β-Farnesene 
1461 - - -  0.091 Alloaromadendrene 
1463 1.254 - - - β-Ionone 
1475 0.101 0.060 - - n-Geranyl propanoate 
1478 0.317 0.039 0.193 0.011 2,6-di(t-Butyl)-4-hydroxy-
4-methyl-2,5-
cyclohexadien-1-one 
1485 - - - 0.071 β-Selinene 
1490 0.713 - - 0.809 Epi-
Bicyclosesquiphellandrene 
1491 - - - 0.168 Valencene 
1492 - - - 0.067 cis-Methyl isoeugenyl  
1494 0.500 0.029 - 0.095 α-Selinene 
1496 - - - 0.157 β-Dihydroagarofuran 
1497 - - - 0.028 δ-Selinene 
1499 - - - 1.317 α-Muurolene 
1505  0.302 - 1.336 δ-Guajene 
1508 0.228 - 0.030 - Dihydro actinidiolide 
1512 2.551 0.768 0.474 0.032 Butylated hydroxytoluene 
1524 - - - 0.379 δ-Cadinene 
1542 - - - 0.647 α-Calacorene 
1549 - 0.688 0.666 0.628 Elemol 
1563 0.176 - 0.134 - Pseudoionone 
1564 0.780 - 1.372 - E-Nerolidol 
1576  0.324 - - Spathulenol 
1581 0.247 0.875 - - Caryophyllenoxide 
1595 - - - 0.315 Guajoxid 
1596 - - - 1.140 Cedrol 
1600 - - 1.610 - Germacrene B 
1611 - 5.592 - 8.191 epi-Cedrol 
1618 - - - 2.679 Isolongifolanone 
1619 0.480 1.821 0.380 1.447 10-Epi- γ-Eudesmol 
1625 0.782 22.863 5.212 14.429 5-Guaien-11-ol 
1630 0.425 28.817 6.941 35.309 γ-Eudesmol 
1645 1.719 0.279 1.279 0.383 δ-Cadinol 
1648 - 3.523 3.221 0.388 4-α-Hydroxy dihydro 
agarofuran 
1666 - 1.603 - 4.454 Bulnesol 
1676 0.336 0.115 - - Tetradecanol 
1693 0.249 0.254 - - Pentadecanal 
1762 0.754 - - - Benzyl benzoate 
1777 0.241 - - 0.065 Ethyl myristate 
1793 0.579 0.202 - - 1-Octadecene 
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Table 1: Cont. 
 
RI 
JGa JGr JPa JPr  
Constituents Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
Concentration 
(%) 
1795 0.352 0.076 - - Hexadecanal 
1808 - - 4.886 0.510 Cryptomeridiol 
1841 4.442 - 3.382 - Neophytadiene 
1842 1.282 1.767 2.615 0.760 Myristic acid  
1855 - 0.286 - 0.262 8,11-Heptadecadienal 
1863 - 1.120 - - Benzylsalicylate 
1902 0.328 0.343 0.988 0.350 Pentadecanoic acid 
1927 0.477 0.650 0.686 0.023 Methyl hexadecanoate 
1944 1.667 - 1.412 - Isophytol 
1949 - - - 3.828 3,4-Dimethoxycinnamic 
acid 
1972 20.431 8.834 11.529 2.689 Palmitic acid 
1993 - - 0.144 0.118 Ethyl palmitate 
1999 33.052 1.771 24.185 - Phytol 
2000 - - 0.365 1.411 Eicosane 
2020 0.359 0.910 - 0.227 Geranyl linalool 
2071 1.005 - - - Methyl linoleate 
2077 0.475 - - - Methyl oleate 
2133 0.537 - - - Methyl stearate 
2156 0.095 0.092 0.075 0.076 4-Vinylguaiacol 
2173 2.470 4.970 4.361 4.196 α-Linoleic acid 
2175 0.338 1.504 - 5.232 Oleic acid 
2179 0.753 - 0.559 - Bovolide 
2192 0.819 0.263 0.518 0.732 Stearic acid 
2221 0.583 - 6.112 - E-Phytol acetate 
2377 0.414 0.074 0.428 0.417 5,9-Farnesyl propanone 
2400 0.122 - - - Tetracosane 
2500 1.857 0.638 - - n-Pentacosane 
2723 - - - 0.041 Dehydrodiisoeugenol 
2808 0.706 - 0.503 - Squalane 
2900 0.608 - 0.659 - Nonacosane 
3000 1.530 - 0.487 - Triacontane 
 68 45 42 80 Number of identified 
components 
 0.802 0.958 0.630 0.849 Oxygenated 
monoterpenes 
 0.176 - 0.134 - Monoterpenes 
hydrocarbons 
 4.433 66.385 23.957 70.366 Oxygenated 
sesquiterpenes 
 1.213 0.354 1.610 6.941 Sesquiterpenes 
hydrocarbons 
 35.302 1.771 32.227 - Oxygenated diterpenes 
 4.442 - 3.382 - Diterpenes 
hydrocarbons 
 29.362 19.706 20.949 14.629 Fatty acids 
 14.110 3.656 4.031 7.205 Others 
 89.84 92.83 86.92 99.99 Total percentages 
*Retention index (RI) relative to n-alkanes on the HP-5 capillary column. 
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Table 2: Conentration (%) of major components of essential oils form different Jatropha 
species 
% Concentration  
Major composition JMl JG JCs JRr JGa JGr JPa JPr 
- - - - 0.40 28.80 6.90 35.30 γ-Eudesmol 
- - - - 0.80 22.90 5.20 14.40 5-Guaien-11-ol 
- - - - - 5.60 - 8.20 epi-Cedrol 
41.40 3.90 - - 33.10 1.80 24.20 - Phytol 
- - - 9.20 - - - - β-pinene 
- - - 8.50 - - - - Isoeugenol methyl ether 
- - - 8.40 - - - - β-vatirenene 
- - - 7.00 - 0.02 - 0.03 α-gurjunene 
- - - 6.40 - - - - α-pinene 
- - - 5.20 - - - - p-menth-1-en-8-ol 
- - - 0.20 - - - - Cedrol 
- - 40.1 - 0.34 1.50 - 5.20 Oleic acid 
- - 37.60 - 2.50 5.0 4.40 4.20 α-linoleic 
- - 15.60 - 20.40 8.80 11.50 2.70 Palmitic acid 
-  8.80 - 0.82 0.26 0.52 0.73 Stearic acid 
1.62 23.30  - - - - - Germacrene-4-ol 
- 15.40 - - - - - - Hexahydrofarnesylacetone 
- 7.70 - - - - - 0.38 δ-cadinene 
- 6.80 - - - - - - tetradecanal 
- 6.10 - - - - - - cubenol 
12.80 - - 0.70 - 0.32 - - Spathulenol 
- 4.1 - - - - - 0.59 α-Copaene 
9.30 - - - - - - - epi-α-cadinol 
4.50 - - - - - - - Germacrene D 
3.90 - - - - - - - α-cadinol 
- 2.00 - - 1.25 - - - β-Ionone 
3.60 - - - - 0.69 0.67 0.63 Elemol 
- 0.90 - - - - - 1.317 α-Muurolene 
4.80 - - - 0.25 0.87 - - Caryophyllene oxide 
20 28 N 49 68 45 42 80 Number of identified 
components 
- 2.80 N 12.70 0.80 0.96 0.63 0.85 Oxygenated monoterpenes 
- 1.40 N 26.80 0.18 - 0.13 - Monoterpenes hydrocarbons 
42.86 56.60 N 22.10 4.43 66.39 23.96 70.37 Oxygenated sesquiterpenes 
12.14 17.70 N 20.90 1.21 0.35 1.61 6.94 Sesquiterpenes hydrocarbons 
41.38 - N - 35.30 1.77 32.23 - Oxygenated diterpenes 
- 3.90 N - 4.44 - 3.38 - Diterpenes hydrocarbons 
- 10.00 N - 29.36 19.71 20.95 14.63 Fatty acids 
3.62 5.5 N 8.90 14.11 3.66 4.03 7.21 Others 
100 97.9 N 91.40 89.84 92.83 86.92 99.99 Total percentages 
(-) = Unidentified, (N) = Not reported, J. pelargoniifolia root (JPr), J. pelargoniifolia aerial (JPa), J. glauca root (JGr), J. glauca aerial 
(JGa), J. ribifolia root (JRr), J. curcas seed (JCs), J. gossypifolia (JG) and J. mutabilis leaves (JMl). 
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4.5. Conclusions 
To our knowledge, this is the first report of chemical profiles of essential oils from roots 
and aerial parts of two plants, J. pelargoniifolia and J. glauca, native to Saudi Arabia. 
The clearly different chemical composition of the essential oils of the two Jatropha 
species indicates that the chemical profile represents a valuable taxonomic character 
that can be useful as a support in solving problems in terms of classification of Jatropha 
species. The distribution of sesquiterpene, diterpene, and monoterpene hydrocarbons 
and their oxygenated derivatives could be used as differentiating parameters for the 
various species. However, the existence of intraspecific chemical differences (chemical 
races) must be kept in mind when making use of chemical characters in plant taxonomy.  
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5.1. Abstract 
Extensive phytochemical analysis of different root fractions of Jatropha pelargoniifolia 
Courb. (Euphorbiaceae) has resulted in the isolation and identification of 22 secondary 
metabolites. 6-hydroxy-8-methoxycoumarin-7-O-β-D-glycopyranoside (15) and 2-
hydroxymethyl N-methyltryptamine (18) were isolated and identified as new 
compounds along with the known diterpenoid (1, 3, 4, and 7), triterpenoid (2 and 6), 
flavonoid (5, 11, 13, 14, and 16), coumarinolignan (8–10), coumarin (15), pyrimidine 
(12), indole (17, 18), and tyramine-derived molecules (19–22). The anti-inflammatory, 
analgesic, antioxidant and antipyretic activities were evaluated for fifteen of the 
adequately available isolated compounds (1–6, 8–11, 13–14, 16, 21, and 22). Seven (4, 
6, 10, 5, 13, 16, and 22) of the tested compounds showed a significant analgesic effect 
ranging from 40% to 80% at 10 mg/kg in two in vivo models. Compound 1 could also 
prove its analgesic property (67.21%) when it was evaluated on a third in vivo model at 
the same dose. The in vitro antioxidant activity was also recorded where all compounds 
showed the ability to scavenge nitric oxide (NO) radical in a dose-dependent manner. 
Moreover, eight compounds (1, 4, 5, 6, 10, 13, 16, and 22) out of the fifteen tested 
compounds exhibited considerable in vivo anti-inflammatory activity which reached 
64.91% for compound 10 at a dose of 10 mg/kg. Moreover, the tested compounds 
exhibited an antipyretic effect in a yeast-induced hyperthermia in mice. The activity 
was found to be highly pronounced with compounds 1, 5, 6, 10, 13, 22 and 16 which 
decreased the rectal temperature to about 37 °C after 2 h of the induced hyperthermia 
(~39 °C) at a dose of 10 mg/kg. This study could provide scientific evidence for the 
traditional use of J. pelargoniifolia as an anti-inflammatory, analgesic, and antipyretic. 
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5.2. Introduction 
Euphorbiaceae is considered as one of the largest families of flowering plants which 
includes approximately 7800 species that are distributed among 300 genera and five 
subfamilies in tropical and subtropical regions [1, 2]. Among the main genera of this 
family, Jatropha L. is represented by approximately 200 species [2]. Jatropha species 
are used in folk medicine to treat various diseases, such as skin inflammation, eye 
infection, chest pain, stomach pain, itching, and as a vermifuge, or as ornamental plants 
and energy crops in Latin America, Africa, and Asia [3]. J. gossypiifolia, J. elliptica, J. 
curcas, and J. mollissima, among other species of Jatropha, have been reported for 
their chemical constituents, biological activities, and medicinal uses [4]. Jatropha 
glauca, J. curcas, J. spinose, and J. pelargoniifolia are the only four species that are 
distributed in Saudi Arabia and are employed as traditional herbal medicines, owing to 
their anti-inflammatory, antioxidant, antiseptic, and analgesic properties [5, 6].  
Jatropha pelargoniifolia Courb. of the current study is grown as a shrub and is 
widely known as “Obab” in Arabic. It is widely distributed in East Tropical Africa 
(Sudan, Eritrea, Ethiopia, Somalia, and Kenya) and the Arabian Peninsula (Yemen, 
Oman, and Saudi Arabia) [7]. The plant is sometimes collected from the wild for local 
medicinal use, especially the petiole sap which is applied to treat ulcers, severe skin 
inflammation, and for wound healing [7]. 
Previous phytochemical studies on the plants belonging to the genus Jatropha 
revealed a broad range of isolated secondary metabolites, such as diterpenoids, 
triterpenoids, non-conventional coumarino-lignans, alkaloids, coumarins, flavonoids, 
cyclic peptides, and steroids [8, 9]. However, accordingly reviewed by Zhang et al. [8], 
the main compounds isolated from Jatropha genus are the terpenoids. Jatropha 
gossypiifolia was subjected to extensive phytochemical studies that resulted in the 
isolation of many secondary metabolites, such as propacin, venkatasin, citlalitrione, 
ricinine, apigenin, jatropholones A & B, and jatrophone [4]. Moreover, curcusones A–
D, taraxerol, nobiletin, curacyclines A & B, as well uracil, have been isolated from J. 
curcas. [5, 6, 8]. Additionally, many reported studies showed the isolation of 
multidione, multifidone, multifolone, and multifidol glucoside from J. multifida, while 
from J. podagrica, there was japodic acid, erythrinasinate, γ-sitosterol, japodagrin, and 
podacyclines A & B [3, 8, 9]. This is indeed a reflection of the versatility of the 
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enzymatic system that is present in Euphorbiaceous plants, however nothing was 
reported regarding J. pelargoniifolia. Thus, it was of interest to explore the active 
constituents and their biological activity to provide evidence to support the old 
traditional use of J. pelargoniifolia. 
5.3. Result and Discussion 
5.3.1. Isolation of compounds 
The alcoholic extract of J. pelargoniifolia roots powder was successively partitioned 
with petroleum ether (60 °C), dichloromethane (CH2Cl2), ethyl acetate (EtOAc), and 
then n-butanol (n-BuOH) to give the correspondent organic fractions. Each fraction was 
subjected to chromatographic separation on normal and reversed phase (RP) silica gel 
to yield compounds 1-16 from petroleum ether, CH2Cl2, and EtOAc fractions. 
Furthermore, the organic extract that was obtained after an acid-base treatment of the 
roots powder was isolated on a normal silica gel column which was followed by 
purification on RP-HPLC and/or crystallization to afford compounds 17-22 (Figure 1). 
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Figure 1. Chemical structures of the compounds isolated from the roots of Jatropha 
pelargoniifolia 
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5.3.2. Structure elucidation 
The new compound 15 was obtained as white crystals. The NMR and ESIMS 
(Electronspray Ionization Mass Spectrometry) data established the molecular formula 
of 15 to be C16H18O10. The IR absorption bands at max 3349, 1719, and 1625 cm
−1 
suggested the presence of hydroxyl, ester carbonyl, and aromatic functionalities, 
respectively. Furthermore, the 13C nuclear magnetic resonance (NMR) spectrum of 15, 
which was measured in deuterated methanol (CD3OD, displayed sixteen signals of nine 
sp2 and seven sp3 carbons (including that of a methoxyl group). Its 1H NMR spectrum 
showed a pair of ortho-coupled protons at δH 6.26 and 7.88 (each, 1H, d, J = 9.5 Hz) as 
was observed by 1H-1H correlated spectroscopy (COSY) that was assignable to H-3 and 
H-4 of an α-pyrone ring system of a coumarin, respectively [10]. This was further 
evidenced from the 13C NMR carbon signals of the pyrone at δC 163.5 (C, C-2), 146.5 
(CH, C-4), 144.4 (C, C-8a), 116.2 (CH, C-3), and 112.7 (C, C-4a) (Table 1). Moreover, 
the single aromatic singlet appearing at δH 7.00 (1H, s) suggested 15 to be a 
trisubstituted coumarin. Six proton signals at δH 3.30–4.99 ppm, a doublet of an 
anomeric proton at δH 4.99 (1H, d, J = 7.8 Hz), and six 13C NMR signals at δC 106.2 
(CH, C-1ˋ), 75.5 (CH, C-2̀), 77.8 (CH, C-3ˋ), 71.0 (CH, C-4̀), 78.5 (CH, C-5ˋ), and 62.2 
(CH2, C-6̀) indicated the presence of a β-D-glucopyranosyl substituent. An aromatic 
methoxy substituent (δH/δC 3.91/57.0) was also revealed. The 3JCH correlations that 
were observed in the heteronuclear multiple bond correlation (HMBC) spectrum linked 
these two substituents to the coumarin carbons at δC 133.2 and 147.5, respectively 
(Figure 2). Thus, a hydroxy group should represent the third substituent on the coumarin 
carbon at δC 145.7. The long-range correlations (HMBC) that were found from H-5 (δH 
7.00, 1H, s) to the carbons at δC 146.5 (C-4), 145.7, C-8a (δC 144.4), and δC 133.2 (C-
7) indicated that C-8 (δC 147.5) is the position of the methoxyl group. To confirm the 
locations of the glucosyl and hydroxyl groups, the NMR data of 15 were further 
compared to those of 5-hydroxy-7-methoxycoumarin-8-O-β-D-glucoside and other 
closely related coumarin derivatives that were previously isolated from Daphne 
pseudo-mezereum [11] and Tetraphis pellucida [12], respectively. The structure of 
compound 15 was thus established as a new natural product and was identified as 6-
hydroxy-8-methoxy coumarin-7-O-β-D-glycopyranoside.  
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Table 1. The 1H (600MHz, δ in ppm, J in Hz) and 13C NMR (125MHz, δ in ppm) spectral data 
for compound 15 in deuterated methanol (CD3OD) 
Position δH δC 
2 - 163.5 
3 6.26 (d, J = 9.5 Hz, 1H) 116.2 
4 7.88 (d, J = 9.5 Hz, 1H) 146.5 
5 7.00 (s, 1H) 106.1 
6 - 145.7 
7 - 133.2 
8 - 147.5 
4a - 112.7 
8a - 144.4 
1' 4.99 (d, J = 7.8 Hz, 1H) 106.2 
2' 3.57 (dd, J = 9.4, 9.4, 1H) 75.5 
3' 3.46 (d, J = 1.9, 1H) 77.8 
*4' 3.47 (brs, 1H) 71.0 
*5' 3.30 (brs, 1H) 78.5 
6' 3.72 (d, J = 4.9, 1H) 
3.80 (d, J = 2.4, 1H) 
62.2 
OCH3-8 3.91 (s, 3H) 57.0 
OH-6 10.53 - 
* Overlapped with solvent signal. 
Compound 18 was isolated from the organic extract of the acid-base treated root 
powder as white needle-shaped crystals. It produced a positive Dragendorff’s test, 
indicating its alkaloid nature. The IR absorption band with a spike at max 3309 cm
−1 
suggested the presence of hydroxyl and/or secondary amine functionality. The UV 
absorptions at max 295, 287, 279, 230 nm in MeOH were characteristic to an indole 
chromophore. The COSY correlations (Figure 2) disclosed the ABCD system of the 
aromatic protons at δH 7.41/7.00 (Table 2), which is consistent with 2,3-disubstituted 
indole alkaloids. A side chain of an ethylene and a N-methyl was linked to C-3 of the 
indole as it was manifested by 2D NMR correlations. However, comparison of 1H NMR 
data of 18 with those of N-methyltryptamine (17) revealed that the 1H proton singlet at 
position 2 in 17 was replaced in 18 by a 2H singlet of a hydroxymethyl proton at δH 
3.91 ppm. The 13C NMR spectroscopic and ESIMS data of 18 was thus consistent with 
a molecular formula C12H16N2O of 30 mass units more than that of 17 (C11H14N2). 
Furthermore, the HMBC correlation that was found from the methylene protons (δH 
3.91, 2H, s) to C-2 and C-3 confirmed its C-2 location of the hydroxymethyl group. 
Finally, a full analysis of th COSY and HMBC spectral correlations (Figure 2) assigned 
the structure of compound 18 to be 3-(2-(methylamino) ethyl)-1H-indol-2-yl) methanol 
or 2-hydroxymethyl N-methyltryptamine, a new indole alkaloid. 
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Table 2. The 1H (700MHz, δ in ppm, J in Hz) and 13C NMR (125MHz, δ in ppm) spectral data 
for compound 18 in deuterated methanol (CD3OD) 
Position δH δC 
2 - 128.0 
3 - 107.2 
3a - 130.6 
4 7.29 (d, J = 7.8 Hz, 1H) 112.0 
5 7.07 (t, J = 7.8 Hz, 1H) 122.4 
6 7.00 (t, J = 7.8 Hz, 1H) 120.0 
7 7.41 (d, J = 7.8 Hz, 1H) 118.6 
7a - 138.1 
αCH2 3.10 (t, J = 5.8 Hz, 2H) 54.1 
βCH2 3.00 (t, J = 5.8 Hz, 2H) 21.5 
CH3 2.69 (s, 3H) 44.9 
CH2OH 3.91 (s, 2H) 52.9 
 
 
Figure 2. Selected heteronuclear multiple bond correlation (HMBC) and correlation 
spectroscopy (COSY) correlations of compounds 15 and 18. 
 
Compounds 1-14, 16-17 and 19-22, which were also isolated from J. 
pelargoniifolia roots, were found to be identical to the previously reported natural 
products by comparison of their spectroscopic (IR, MS, and NMR) data and were 
identified as jatrophadiketone (1) was isolated from the roots of J. curcas [13], β-
sitosterol (2) isolated from J. curcas seed kernels and from the methanolic extract of 
the root bark of Calotropis gigantean (Linn)., [14, 15], curcuson D (3) and curcuson C 
(4) were isolated from J. curcas root extract [16], naringenin (5) was isolated from the 
root extract of J. gossypifolia [17,18], β-sitosterol glucoside (6) was isolated from the 
leave and twig extract of J. curcas, [19], spruceanol (7) was isolated from both the 
aerial extract of J. divaricate and the bark extract of Aleurites moluccana [20, 21], 
propacin (8), cleomiscosin B (9), cleomiscosin A (10) compounds 8 and 10 were 
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isolated from whole plant extracts of J. gossypifolia, while compound 9 was isolated 
from Mallotus apelta [22–26], apigenin (11) was identified in J. gossypifolia [4,27], 
uracil (12) was isolated from the leaves of J. curcas [28–30], cynaroside (13) was 
identified in Scabiosa atropurpurea aerial parts extract [31], linarin (14) was isolated 
from the extracts of aerial parts of both Bupleurum chinense and Valeriana officinalis 
[32,33], hovetricoside C (16) was separated from Artocarpus tonkinensis [34], N-
methyltryptamine (17) was isolated from Zanthoxylum arborescens [35], N-
methyltyramine (19) was isolated from a beer [36], and hordenine (20) was separated 
and identified from Ephedra aphylla that was growing in Egypt [37]. Compounds 21 
(hordenine HCl) and 22 (N-methyltyramine HCl) were identical to the authentic 
samples that were purchased from Sigma-Aldrich (St Louis, MO, USA), and on the 
basis of their 1H NMR and TLC co-chromtographic data, they were isolated previously 
from Ariocarpus kotschoubeyanus [38]. 
5.3.3. Biological activity 
The alcoholic extract of J. pelargoniifolia was found to possess significant anti-
inflammatory, analgesic, and antipyretic activities when it was tested on in vivo models 
in a dose-dependent manner [39]. This prompted us to extend the study of these 
activities on the isolated compounds. The anti-inflammatory, analgesic, antipyretic, and 
antioxidant activities for the compounds which have been isolated in good yields (1–6, 
8–11, 13–14, 16, 21, and 22) were thus evaluated for their analgesic, anti-inflammatory, 
antipyretic, and antioxidant activities using in vivo and in vitro models. The analgesic 
activities were assessed in mice via acetic acid-induced writhing, hot-plate, and tail-
flick methods. 
In the acetic acid-induced writhing method, compounds 1, 5, 4, 6, 10, 13, 14, 
16, and 22 showed a dose-dependent analgesic activity by the reduction in the number 
of writhings. However, the diterpenoids (1 and 4), β-sitosterol glucoside (6), flavonoids 
(5 and 13), and tyramine HCl (22) exhibited the strongest analgesic activity by 
inhibiting writhing in mice (49.07-65.74% inhibition) at a dose of 10 mg/kg compared 
with the standard antinociceptive drug (indomethacin), which showed 72.68% 
reduction in the number of writhings at a concentration of 4 mg/kg (Table 9S). The 
coumarinolignan (8) and hordenine HCl (21) did not show any inhibition either at 5 or 
at 10 mg/kg. 
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In the hot plate method, the thermal responses in the mice that were treated with 
selected compounds after half, one, and two hours were significantly reduced (p < 0.01). 
Especially in the mice that were treated with a dose 10 mg/kg of compounds 22, 10, 6, 
4, 5, 13, 16, and 14, the antinociceptive effects were reduced by 78.57, 76.19, 74.46, 
73.33, 69.56, 59.57, 53.48, and 34.88%, respectively (Table 10S). While in the tail-
flick method, the tested animals that were treated with 10 mg/kg of compounds 22, 1, 
10, 4, 13, 16, 5, 6, 21, 3, and 9 showed a significant (p < 0.01 and 0.05) reduction in 
antinociceptive activity (67.32, 67.21, 60.45, 57.59, 54.04, 53.59, 48.58, 40.30, 21.75, 
20.39, and 10.87%, respectively) compared with indomethacin (95.61%), as depicted 
from Table 11S. The obtained results confirmed that the strong analgesic activity that 
is exhibited by the roots of J. pelargoniifolia could be due to its bioactive compounds 
that may exert their analgesic activities through different CNS (Central Nervous 
System) mechanisms (peripheral and central). Therefore, further studies with purified 
compounds should be conducted in the future for further pharmacological and 
toxicological characterization in order to elucidate the mechanisms that are involved in 
the central analgesic effect of these compounds. 
The anti-inflammatory activities of the major isolated compounds were 
evaluated by using the carrageenan-induced paw edema model in rats. It was found that 
the size of the edema was significantly reduced (p < 0.05, 0.01) in the animals that were 
treated with the low doses of 5 and 10 mg/kg compared with the standard anti-
inflammatory drug (phenylbutazone) at a high dose of 100 mg/kg. The rats that were 
treated with compounds 10, 16, 1, 5, 6, 22, 4, 13, 3, 8, 9, 14, and 21 exhibited a 
significant reduction in their hind paw edema in a dose-dependent manner. Therefore, 
at a dose of 5 mg/kg, the edema size was reduced by 20.44, 47.23, 17.95, 45.85, 33.97, 
44.47, 13.53, 26.51, 7.18, 2.20, 5.52, 6.35, and 6.35, respectively, while at 10 mg/kg, 
the edema size was reduced by 64.91, 55.24, 54.94, 51.38, 51.10, 50.27, 49.17, 48.61, 
13.53, 12.98, 10.22, 10.22, and 8.01%, respectively relative to that reduced by 
phenylbutazone at 100 mg/kg (69.06%) which was almost similar to that produced by 
a dose of 10 mg/kg of compound 10 (64.91%; Table 12S). These anti-inflammatory 
results were almost compatible with those of the above mentioned antinociceptive 
activity for the tested compounds. 
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In addition, the isolated compounds from the J. pelargoniifolia roots were tested 
for their antipyretic activity against yeast-induced hyperthermia in mice. All tested 
compounds, which were administered at doses of 5 and 10 mg/kg, showed a 
considerable reduction in the rectal temperature of the hyper-thermic mice, ranging 
between 36.733 ± 0.136 °C and 38.650 ± 0.111°C as compared with the hypothermic 
effect (36.333 ± 0.112°C) resulting from indomethacin administration (Table 13S). 
Moreover, compounds 5, 6, 10, 13, and 16 displayed about a 1°C reduction in 
temperature less than that of the yeast-induced hyperthermia control (~ 38.8 °C) in the 
first 30 min. of the experiment. 
The percentage inhibition ± SD of the nitric oxide-scavenging activity was 
determined for the selected compounds at concentrations of 20, 40, 60, 80, and 100 
µg/mL, and the obtained results were compared with a standard antioxidant drug 
(ascorbic acid). Compounds 22, 4, 2, 10, 1, 14, 21, 9, 8, 11, 6, 3, 13, 5, and 16 exhibited 
significant free radical-scavenging potency when compared with the free radical-
scavenging activity of a strong known antioxidant drug (ascorbic acid) 87.230 ± 0.980. 
The ability of the tested compounds to produce antioxidant effects was found to be 
concentration-dependent. At a 100 µg/mL dose, the % inhibition ± SD of the tested 
compounds were 77.600 ± 4.220, 77.360 ± 4.220, 76.830 ± 5.010, 75.260 ± 5.540, 
71.660 ± 0.700, 70.360± 14.730, 67.670 ± 5.750, 63.670 ± 12.850, 63.670 ± 12.850, 
57.000 ± 10.210, 56.540 ± 6.030, 38.300 ± 5.630, 33.060 ± 1.860, 27.000 ± 7.850, and 
25.610 ± 5.180, respectively (Table 14S). The significant antioxidant activity that was 
associated with the administration of J. pelargoniifolia roots was perhaps due to its 
content of several phenolic and polyphenolic compounds which play an important role 
in free radical-scavenging activity with less cytotoxicity. 
It is important to mention here that in our previous study, which was carried out 
on the crude alcoholic extract of J. pelargoniifolia roots, we observed a significant anti-
inflammatory activity and analgesic potency [39], likely resulting from the presence of 
cleomiscosin A, hovetricoside C, jatrophadiketone, naringenin, β-sitosterol glucoside, 
N-methyltyramine HCL, curcuson C, cynaroside, curcuson D, propacin, cleomiscosin 
B, linarin, and hordenine HCL in good yield. Undoubtedly, a synergistic effect between 
these bioactive constituents produces significant antinociceptive and anti-inflammatory 
effects. These results justify the use of this plant in folk medicine for the treatment of 
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pain and several inflammatory conditions. Further study will be conducted on the pure 
isolated compounds to investigate the exact mechanisms underlying their promising 
biological activities. 
Our study proved that J. pelargoniifolia roots can be considered as a source of 
several biologically- active compounds such as hordenine, which exhibited various 
biological activities like inhibiting melanogenesis in human melanocytes, increasing 
the respiratory and heart rates [40], the stimulation of gastrin release, inhibition of 
monoamine oxidase B, and antibacterial properties [41]. Furthermore, Chrisitine et al. 
reported that N-methyltyramine increases blood pressure in an anaesthetized rat, relaxes 
guinea pig ileum, and increases both the force and the rate of contraction of guinea-pig 
right atrium by inducing the release of noradrenaline [42]. Additionally, naringenin has 
been reported to have several pharmacological properties, including anti-dyslipidemic, 
anti-obesity and antidiabetic, and antifibrotic [43]. Moreover, cleomiscosin A showed 
strong anti-inflammatory activity and has analgesic and antipyretic potencies [44]. 
Curcuson C has been reported to have antipyretic activity in vivo [45]. 
5.4. Materials and Methods  
5.4.1. Chemicals and Analytical Instruments 
The high-resolution electron spray ionization-mass spectrometry (HRESI-MS) 
analyses were carried out on an Agilent Triple Quadrupole 6410 LC-MS mass 
spectrometer (Central Lab. College of Pharmacy, King Saud University (KSU). The 
infra-red spectra were generally recorded in the potassium bromide pellets, unless 
otherwise specified, using the FTIR spectrophotometer (FT-IR Microscope 
Transmission, company, Waltham, MA, USA). The melting points were recorded by 
using a Mettler FP 80 Central Processor that was supplied with a Mettler FP 81 MBC 
Cell Apparatus. The spectral data for proton and carbon were measured by using Bruker 
AVANCE 700, 500, and 600 (College of Pharmacy, KSU and Department of Chemistry 
in TU Dortmund) (Bruker, Fallanden, Switzerland), resonating at either 700, 500, and 
600 MHz for proton or at 125 MHz for carbon. The chemical shift values were 
expressed in ppm with respect to the internal standard tetramethyl silane (TMS) or 
residual solvent peak, and the coupling constants (J) were recorded in Hertz (Hz). The 
two-dimensional NMR experiments (COSY, HSQC, and HMBC) were performed 
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using the standard Bruker program (Bruker, Fallanden, Switzerland). The silica gel 
60/230–400 mesh (Qingdao Oceanic Chemical Co., Qingdao, China), RP C18 silica gel 
40–63/230–400 mesh (Merck, Darmstade, Germany), and sephadex LH-20 with 
particle size 18–111 µm (GE Healthcare, USA) were used for column chromatography, 
while the silica gel and reversed phase 60 F254 (Merck, Germany) were used for thin-
layer chromatography (TLC). The detection was achieved by using 10% H2SO4 in 
ethanol or ceric sulfate followed by heating. Alkaloids were tested with Mayer’s 
reagent, Hager’s reagent, and Dragendorff’s reagent. All of the solvents for analytical 
purposes (HPLC and analytical grade) and the drugs for biological investigation 
(sodium nitroprusside, sulphanilamide, λ-carrageenan, acetic acid, ascorbic acid, and 
phenylbutazone) were procured from Sigma Chemical Company (Sigma-Aldrich, St 
Louis, MO, USA), and the solvents were distilled prior to use. The preparative and 
semipreparative Shimadzu HPLC were performed, characterized by Rp-18 (ODS-80 
TM, TSK, Tokyo, Japan), 10 μm PS, 30 cm L × 2.15 cm i.d. fitted with a guard column 
(10 μm PS, 7.5 cm L × 2.15 cm i.d.) (ODS-80 TM, TSK, Tokyo, Japan), and VP 250/10 
NUCLEODUR C18 HTec, 6 μm PS, 25 cm L × 2 cm i.d., respectively which both used 
a PDA detector. 
5.4.2. Plant Material 
The roots of J. pelargoniifolia were harvested from Wadi Mojasas, Jazan district 
(South of Saudi Arabia) in September, 2015. The plant was authenticated by Dr. Jacob 
Thomas, a botanist of the Science College Herbarium, KSU, where a voucher specimen 
(#23064) was deposited.  
5.4.3. Animals 
Male Wistar rats and white male Swiss albino mice with approximate body weights of 
200 g and 20–25 g, respectively, were divided into groups of six animals. The animals 
were obtained from the Experimental Animal Care Center, College of Pharmacy, KSU. 
After a 7-day period in animal accommodation, they were divided into groups and were 
maintained at 12 h:12 h light-dark conditions at 55% humidity. Purina chow rat diet 
(UAR-Panlab, Barcelona, Spain) and drinking water were supplied to the animals ad 
libitum. The protocols for the present study were based on the recommendations of the 
Ethical Committee of the Experimental Animal Care Center of KSU (approval number 
CPR-7569). 
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5.4.4. Extraction, Fractionation, and Purification  
The air-dried powder of the J. pelargoniifolia roots (2.5 kg) was divided into two 
parts—A and B. The 2.0 kg of part A was subjected to solvent extraction, while the 
remaining 500 g of the root powder (part B) was exposed to the acid-base treatment. 
Part A was extracted by maceration with 80% ethanol (3 L × 5) for three successive 
days. This process was repeated until complete exhaustion of the plant material [46]. 
The alcoholic extract was then concentrated to dryness under reduced pressure at 40°C 
using a rotary evaporator to give 270 g of the dried alcoholic extract. The dried alcoholic 
extract was suspended in H2O and was successively partitioned with petroleum ether, 
dichloromethane, ethyl acetate, and n-butanol (600–700 mL × 3) of each to obtain 13.3, 
10.3, 5.1, and 33.6 g, respectively.  
A part of the petroleum ether fraction (12.8 g) was chromatographed over silica gel 
CC (Column Chromatography) using a gradient of petroleum ether/EtOAc followed by 
methanol (MeOH). The 100 ml fractions of each were collected and screened by TLC, 
and similar fractions were combined together to give six fractions (A–F). Fraction A 
which was eluted by 15% EtOAc in petroleum ether (609.8 mg) was further subjected 
to CC and was eluted by petroleum ether/acetone gradient elution, sub fraction A1 
(188.9 mg) which was eluted by 6% acetone in petroleum ether was further purified by 
preparative HPLC gradient elution using acetonitrile: H2O: TFA to yield 25.0 mg of 
compound 1. Direct crystallization of fraction B, which was eluted by 20% EtOAc in 
petroleum ether, yielded 302.7 mg of compound 2. Fractions C and D which were eluted 
with 30 and 40% EtOAc in petroleum ether, respectively, were crystallized with 
acetone to yield compounds 3 and 4 (14.3 and 25.4 mg, respectively). Additionally, 
fraction E (287.3 mg) which was eluted by 50% EtOAc was also crystallized from 
acetone to give 20.2 mg of compound 5, while fraction F which was eluted with 40% 
MeOH in EtOAc yielded 330.4 mg of compound 6, which was purified by 
crystallization with acetone. 
The dichloromethane (DCM) fraction (9.8 g) was subjected to silica gel CC using 
a column that was packed by the wet method with petroleum ether. The polarity of the 
column was gradually increased by treating it with DCM, followed by MeOH to give 
142 fractions, and similar fractions were pooled together depending on their TLC 
similarity. Fraction 48–64 which was eluted by 10% MeOH in DCM was concentrated 
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(4.6 g) and was then subjected to repeated silica gel CC, followed by a preparative 
revered phase TLC using MeOH: H2O (3:1) as a solvent system, leading to the isolation 
of white crystals of compound 7 (7.5 mg). Moreover, subfractions that were obtained 
using 90% acetone in petroleum ether, 100% acetone, and 10% acetone in MeOH, 
followed by crystallization with MeOH, afforded compounds 8 (15.1 mg), 9 (15.9 mg), 
and 10 (16.4 mg), respectively.  
The EtOAC extract (4.6 g) was subjected to silica gel CC using a gradient of 
DCM/MeOH to give six fractions (I–VI). Fractions I which were eluted with 84% DCM 
afforded 17 mg of compound 11 after crystallization with MeOH. Fractions II which 
were eluted with 70% DCM afforded 8.6 mg of compound 12. The fractions that were 
eluted with 35 and 40% MeOH in DCM (II and IV) were further purified by repeated 
acetone crystallization to give 14.9 and 13.2 mg of compounds 13 and 14, respectively. 
Fractions V which were eluted with 45% MeOH were further subjected to CC using 
DCM/MeOH, followed by a semi-preparative HPLC (Rp-18) using MeOH: H2O: TFA 
as a solvent system afforded 8.6 mg white crystals of compound 15. Finally, fractions 
VI which were eluted with 50% MeOH in DCM were subjected to further purification 
over sephadex LH-20 (using water and methanol as an eluent in the gradient mode). 
The subfraction VI–A, which was eluted by 20% H2O/MeOH was further purified over 
a reversed-phase column to give 12 mg of compound 16.  
Furthermore, Part B was subjected to an acid-base treatment according to the Stas-
Otto method I which was described by Mandhumitha and Fowsiya [47]. The crude 
alkaloidal fraction was subjected to silica columns using gradient elution with solvent 
system DCM: MeOH: NH4OH, resulting in five fractions. The first fraction which was 
eluted using 17% MeOH in DCM with an addition of 1% NH4OH was followed by 
further purification by reversed-phase semipreparative HPLC using MeOH: H2O: TFA 
to give compound 17 (6.3 mg). The second fraction which was separated by 20% 
MeOH in DCM to afford a subfraction, which was further purified by a semipreparative 
HPLC gradient elution using MeOH: H2O: TFA as a solvent system, afforded white 
needle crystals of compound 18 (9.4 mg). The third and fourth fractions which were 
eluted by 23 and 26% MeOH in DCM, followed by an addition of a few drops of 
NH4OH, afforded 6.8 and 8.8 mg of compounds 19 and 20, respectively. The fifth 
fraction was eluted by 60% MeOH in DCM with an addition of a few NH4OH drops to 
yield 86.7 mg of a mixture of two compounds, which were subjected to further 
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purification using the reversed-phase semipreparative HPLC in gradient mode with 
MeOH: H2O: TFA as the mobile phase, resulting in the production of the white crystals 
of compounds 21 and 22 (20.3 and 21.5 mg), respectively. 
6-hydroxy-8-methoxycoumarin-7-O-β-D-glycopyranoside (compound 15): White 
crystals; m.p. 219–220 °C; UV (MeOH) λmax nm 325 and 250; IR (KBr) νmax (cm−1): 
3349, 1719, 1625, 1520, 1465, 829; 1H NMR, 13C NMR, and HMBC data, see Table 1 
and Figure 2; HRESIMS (positive) m/z 371.0900 [M + H]+ (calculated for C16H18O10, 
371.097825). 
3-(2-(methylamino)ethyl)-1H-indol-2-yl)methanol (compound 18): White needle 
crystals; m.p. 179–189 °C; UV (MeOH) λmax nm: 295, 287, 279, 230; IR (KBr) νmax 
(cm−1): 3309,1140, 1120, 1105, 1011, 855. 1H NMR, 13C NMR, and HMBC data, see 
Table 2 and Figure 3; HRESIMS (positive) m/z 205.1293 [M + H]+ (calculated for 
C12H16N2O, 205.134088). 
5.4.5. Biological tests:  
5.4.5.1. Antinociceptive Activity Test 
5.4.5.1.1. Hot-plate Method 
The hot-plate method that was described by Turner was used to determine the 
antinociceptive activity of the compounds that were isolated from the J. pelargoniifolia 
root [48]. 
5.4.5.1.2. Acetic Acid-induced Writhing in Mice Test 
The method of Koster et al. was used to evaluate the analgesic effect of the pure 
compounds that were isolated from the J. pelargoniifolia root [49]. 
5.4.5.1.3. Tail-Flick Method 
Acute nociception was induced using the tail-flick apparatus (Tail flick Apparatus 
Harvard), following the method that was recommended by D'amour and Smith [50]. 
5.4.5.2. Anti-Inflammatory Activity Test 
5.4.5.2.1. Carrageenan-Induced Edema in the Rat Paw Method 
The method that was described by Winter et al. was used to evaluate the anti-
inflammatory potency of the isolated compounds [51]. 
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5.4.5.3. Antipyretic Activity Screening 
5.4.5.3.1. Yeast-Induced Hyperthermia in Rats 
Hyperthermia was induced in the mice followed by the administration of the isolated 
compounds, and their hypothermic activity was determined by applying the method 
described by Loux [52]. 
5.4.5.4. Antioxidant Effect  
5.4.5.4.1. Nitric Oxide Radical-Scavenging Assay 
This assay was carried out according to the procedure that was described by Green et 
al. [53]. 
5.4.5.5. Statistical Analysis 
Data are expressed as mean ± standard error (SE). The results were first checked for 
normality by Kolmogorov and Smirnov test and homogeneity by Bartlett's test, and 
then analyzed using the Student’s t test and analysis of variance (ANOVA) test. Dunnett 
posttest was used to determine which groups significantly differed from the control 
group. The statistical analysis was performed using GraphPad Prism version 3. Results 
were considered significantly different if the p < 0.05 [54].  
5.5. Conclusions 
The wide traditional use of Jatropha species as anti-inflammatory and analgesics has 
prompted us to investigate the chemistry and bioactivity of J. pelargoniifolia growing 
in Saudi Arabia. The phytochemical study of the plant roots resulted in the isolation of 
six terpenoids, five flavonoids, three coumarinolignans, two tryptamines, and four 
tyramines (including their HCl salts), a coumarin, and a pyrimidine. The new 
compounds were identified as 6-hydroxy-8-methoxy coumarin-7-O-β-D-
glycopyranoside and 2-hydroxymethyl-N-methyltryptamine. To the best of our 
knowledge, the results indicate that hovetricoside C and N-methyltryptamine were 
isolated from the Euphorbiaceae family for the first time, while cleomiscosin B, 
hordenine, and N-methyltyramine with their salts, cynaroside, and linarin were 
characterized in the Jatropha species for the first time. 
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On the basis of the significant anti-inflammatory, analgesic, antipyretic, and 
antioxidant activities that were observed in the experimental animals for the alcoholic 
extract of J. pelargoniifolia, fifteen of the adequately isolated compounds were 
consequently biologically evaluated. Eleven of these compounds exhibited strong 
analgesic activity. Twelve out of the fifteen compounds succeeded to reduce the 
chemically-induced inflammatory marker in the animals in a dose-dependent manner. 
Moreover, five of the compounds showed an anti-pyretic effect by about a 1°C 
reduction in the temperature in an induced hyperthermia model. The isolated 
compounds also exhibited varying degrees of nitric oxide-scavenging activity. The 
significant antioxidant activity that was associated with the administration of J. 
pelargoniifolia roots was thus perhaps due to its phenolic content such as flavonoid, 
coumarins, and coumarinolignans. The synergistic effect between these bioactive 
constituents might explain the significant antinociceptive and anti-inflammatory effect 
of the alcoholic extract of J. pelargoniifolia roots and may scientifically justify the use 
of this plant in folk medicine for the treatment of pain and several inflammatory 
conditions. 
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6.1. Abstract 
The Arabian Peninsula is recognized as an arid area dominated by deserts and poor 
biodiversity. However, the Kingdom of Saudi Arabia (henceforth abbreviated into 
KSA) has a wide range of flora, consisting of different species of trees, herbs, and 
shrubs and containing numerous edible and medicinal plants. The KSA is characterized 
by its vast area of diverse geographical landscapes and climates. Consequently, there is 
enormous variation in the distribution of plants across the Kingdom. The traditional use 
of ethnomedical plants in the KSA represents a strong interconnection among familiar 
remedies, health, diet, and traditional healing practices characterized by specific 
cultures. 
The present paper reviews a collection of medicinal plants in KSA used in 
ethnomedicine. This review might be useful in developing strategies for the sustainable 
use of medicinal plants which are among the threatened important natural resources in 
folk medicine in the KSA.  The present study reports 309 genera which cover 471 
species from a total of 2,253 known species belonging to 89 families. The most 
dominating families are Asteraceae, Fabaceae, Lamiaceae, Euphorbiaceae, Solanaceae, 
Apiaceae, Brassicaceae, Chenopodiaceae, Poaceae, Amaranthaceae, Boraginaceae, 
Apocynaceae, Convolvoulaceae, Asclepiadaceae, Capparaceae, Polygonaceae, and 
Zygophyllaceae. 
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6.2. Introduction 
Plant diversity plays a vital role in serving the ecosystems and in maintaining and 
preserving ecological balance and stability not only in   KSA but in the whole world as 
well. Different plant species have been used in ethnomedicine since ancient times [1, 
2]. Medicines of the Egyptians (3,000 BC; Pharaohs), the Greeks (400 BC; 
Hippocrates), and the Romans (37 BC.; Dioscorides) have a longstanding history. The 
continus use of plants in therapy was conducted by Prophet Mohammad (Peace be upon 
him, 571-632 AD); a practice known as The Prophetic Medicine (Al-Ṭibb al-Nabawi) 
by Ibn Qayyim Al-jawziyyah [3]. This period is considered as the golden age for 
ethnomedicine genesis. The Muslims did not stop at that point, but developed different 
schools, including the Rhazes (865-925 AD) and Avicenna (980-1037 AD), and their 
encyclopedias on ethnomedicine: The Container Book in Medicine (Kitab Al-Hawi Fi 
Al-Tibb) and The Law in Medicine (Al-Qanun Fi Al-Tibb) respectively, all of which 
contributed to the development of herbal medicine [4, 5]. Several medications have 
been extracted from natural resources, including plants in the nineteenth-century. 
However, Prophetic Medicine is still a major reference for all Muslims in the Arabian 
Peninsula and the rest of the world. Many medicinal plants that have been reportedly 
used in Prophetic Medicine are currently used in folk medicine in the Arabian 
Peninsula. Scientific studies have proven that these plants, including garlic, 
pomegranate, black seeds, costus, miswak, henna, ginger, and fenugreek are effective 
for treating human diseases. Such plants have been widely used in the form of low cost 
and almost zero-side-effect products pharmaceutically manufactured and marketed 
under such trademarks as Black seed plus®, Fenugreek 610MG®, Ginkago Biloba Plus 
TM, Kyolic®, and Alvita®.  
The KSA, Kuwait, Bahrain, Yemen, Qatar, United Arab Emirates, and Oman 
formulate what is known as the Arabian Peninsula which is located in the Asian 
southwest. Its West and Southwest border is the Red Sea, its southern one is the Gulf 
of Aden, its southern and southeastern border is the Arabian Sea, and its eastern one is 
the Gulf of Oman and the Arabian Gulf [6]. Figure 1 highlights the geographical merge 
of the peninsula with the Syrian desert across the northern border, but the Northern 
boundaries of Saudi Arabia and of Kuwait are generally considered as marking the 
limit of Arabia there. 
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Figure 1: Geographical areas of Saudi Arabia 
The 2,250,000 km2 covered by KSA represent the largest part of the Arab 
Peninsula. Geographically, it is characterized by a variety of habitats including 
mountains, valleys, lava areas, meadows and rocky deserts. Therefore, KSA is made up 
of two areas: the rain fed zones of the western and southwestern highlands and the arid 
region of the interior area [6]. 
As for the first division, the Asir highlands constitute a flowing series of cliffs 
together with similar southwestern highlands, extending far unto the Yemeni borders. 
They rise up to 2000 m in some areas (Taif) and over 3000 m in others (Abha). The 
same continuity is to be found in the western continuous chain across the Tihama 
coastal plain. This continuity comes to an end on the northwestern sides where 
discontinuity dominates. On the other hand, the eastern part comprises a large amount 
of sand with much lower mountains and plains. These deserts extend to the northern 
Great Nafud and the southern Rub AlKhali (The Empty Quarter), with Dahna sands 
connecting both regions. As regards the Central Region, patchy, stone deserts, hillocks 
and valleys color the scene versus the complex of metamorphic rocks that characterize 
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the northern and northern central region. remarkable still is that the altitudes of the 
plains of the Central Region rise high up to 500-800 m as compared to such mountains 
and escarpments Jabal Shammar and Jabal Tuwayq which range from 300-600 m [6]. 
Forests cover 2.7 million hectares (about 1.35% of the total area) of KSA. Most of the 
forests are in the southwestern part of the Kingdom on the Sarawat mountain. 
With regard to the location of KSA, it is located in a climatic transitional zone 
of tropical and temperate climates. Moreover, the rains falling upon KSA are neither 
constant in amount and nor equal in distribution so much that the arid areas right in the 
interior of KSA the underscore no rain in some areas and over 200 mm in some others 
on an annual basis. Even in winter, there is rainfall, however irregular. 
It is noteworthy that winter in KSA ranges from cool to warm (2-20 oC) as 
opposed to the high summer temperature ranging from 35 to 50 oC, high humidity along 
the Red Sea coast and the Arabian Gulf coast; temperature becomes lower right in the 
interior.  
Geographical and climatic diversity in the kingdom lead to the diversity in the 
flora, examined for the first time in 1974 [7]. This was followed by two volumes of 
Medicinal Plants of Saudi Arabia that were published in 1987 and 2000 by Mossa et al. 
[8, 9]. 
Collenette (1998) asserts that KSA produces about 837 genera manifesting 
themselves in 2253 species distributed among 132 families. Nearly 20 % of these 
families stands for totally new and uncommon plants. The southwestern part of KSA 
embraces about 70% of the floristic elements grown across Taif to the Yemeni border. 
This is accounted for the regularity of rainfall upon the region [10]. 
Equally important is KSA flora provide a remarkably rich source for agriculture 
and medicinal plants. Although many items of the flora are grown locally and 
nationally, KSA still grows a curious amalgam of Africa, Asia, and the Mediterranean 
region.  
According to Al-Yahya (1984), employing and resorting to traditional medicine 
is still a fashionable practice nowadays in KSA [11]. It has become customary for KSA 
citizens to resort to natural herbs and traditional remedies in the hope that these will 
certainly heal their illness. Such practices are found in using such natural resources as 
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bee-honey, black seed, myrrh, fenugreek, kawajawa, among others. It has been to their 
good fortune that these practices have been handed from one generation to another. 
Mossa et al. (1987) spotlight the extensive range of flora that covers almost the whole 
KSA and offers sample opportunity for Saudis to make the best use of herbs and flora 
for their medications to local individuals for use in and therapeutic practices [8, 9]. 
The KSA is currently implementing an overall plan with a view to regulating 
and organizing the use of traditional medicine on a national basis. Thus, there is a 
tendency to legalize what is known as Complementary and Alternative Medicine 
(TM/CAM) via issuing organizing acts and issuing laws. This has been consolidated by 
the establishment of the National Office in 1995 on behalf of the Saudi Ministry of 
Health. Another important step came with the TM/CAM Committee in collaboration 
with the National Research Institute on herbal medicines studies established by King 
Saud University Medicinal, Aromatic and Poisonous Plant Research Center 
(MAPPRC), and the Department of Pharmacognosy, both of the College of Pharmacy.  
Historically, these practices in KSA date back to ancient times when using 
traditional medicine was the only way out for the treatment of many illnesses and 
diseases that were usually unknown and non-diagnosed. However, these medicines 
were too much respected as they were prescribed by those traditional healers known as 
Al-Hokama. It is worthy of notice, however, that such practices are beginning to vanish 
and pass away. That is why it has become a prerequisite to conduct folk and 
ethnobotanical surveys and studies in KSA on the vanishing of these practices before 
they become history. As result, this review can serve as a reference document on 
traditional uses of medicinal plants in Saudi Arabia and increase the possibility of 
discovering new drug resources. 
6.3. Materials and methods  
Journals, textbooks, proceedings, websites, periodicals, and databases dealing with 
medicinal plants used to treat human diseases in Saudi Arabia, Arabian Peninsula, and 
other parts of the world were checked for related information. Dictionaries of 
English/Arabic and Arabic/English were also consulted for accuracy. 
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6.4. Results and discussion 
Literature survey showed that a total of 309 genera containing 471 species in 89 
families are used in ethnomedicine (Table 1 and Fig. 2). Asteraceae and Fabaceae 
families have the highest number of ethnomedicinal species (54 and 49, respectively) 
in Saudi Arabia. Table 1S summarizes ethnobotanical data on all medicinal plants used 
in KSA [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 
32, 33, 34, 35, 36, 37, 38, 39, 40, 41]. 
Table 1 shows numerous plant species used for various illnesses associated with 
gastrointestinal problems, pains, rheumatism inflammations, ulcers, respiratory, 
circulatory, urological, and skin diseases, and some for toothache, diabetes, allergy, and 
gynecology. The most mentioned medicinal plant families were Asteraceae, Fabaceae, 
Lamiaceae, Euphorbiaceae, Solanaceae, Apiaceae, Brassicaceae, Chenopodiaceae, 
Poaceae, Amaranthaceae, Boraginaceae, Apocynaceae, Convolvoulaceae, 
Asclepiadaceae, Capparaceae, Polygonaceae, and Zygophyllaceae. All these families 
as well as other families mentioned in this review are already represented in Saudi 
Arabia flora [7, 42]. 
Resorting to traditional medicinal plants for treating some illnesses has resulted 
in many the production of many promising drugs and medications [43, 44]. The present 
paper reviews these practices from an ethnopharmacological perspective by targeting 
471 medicinal plants used on a regular basis by almost all Saudis (Table 1S). 
 
 
 
 
 
 
 
 
 
 
 
 
113 
 
Table 1: Number of traditionally used species per family in Saudi Arabia 
 
 
Family name 
Number of 
species in 
KSA 
 
Family name 
Number of 
species in 
KSA 
Acanthaceae 5 Lauraceae 1 
Adiantaceae 1 Linaceae 1 
Agavaceae 2 Lythraceae 2 
Aizoaceae 4 Malvaceae 5 
Amaranthaceae 13 Meliaceae 1 
Annonaceae 1 Menispermaceae 2 
Apiaceae (Umbelliferae) 18 Mimosaceae 1 
Apocynaceae 10 Moraceae 4 
Aracaceae 3 Moringaceae 1 
Aristolochiaceae 1 Myrtaceae 5 
Asclepiadaceae 9 Nyctaginaceae 2 
Asphodelaceae 4 Oleaceae 2 
Asteracea (Compositae) 54 Onagraceae 1 
Boraginaceae 13 Orobanchaceae 2 
Balanitaceae 1 Orchidaceae 1 
Brassicaceae (Cruciferaceae) 17 Oxalidaceae 1 
Burseraceae 5 Papavaraceae 3 
Cactaceae 1 Pedaliaceae 1 
Caesalpinaceae 1 Plantaginaceae 4 
Cannabaceae 1 Plumbaginaceae 2 
Capparaceae (Capparidaceae) 8 Polygonaceae 8 
Caryophyllaceae 2 Portulacaceae 2 
Celastraceae 2 Primulaceae 1 
Chenopodiaceae 15 Punicaceae 1 
Ceratophyllaceae 1 Ranunculaceae 3 
Cleomaceae 6 Resedaceae 3 
Clusiaceae 1 Rhamnaceae 2 
Commelinaceae 1 Rosaceae 4 
Convolvoulaceae 9 Rubiaceae 1 
Cucurbitaceae 6 Rutaceae 2 
Cupressaceae 2 Salvadoraceae 1 
Cuscutaceae 1 Sapindaceae 1 
Cynomoriaceae 1 Sapotaceae 2 
Cyperaceae 2 Scrophulariaceae 2 
Ephedraceae 1 Solanaceae 20 
Euphorbiaceae 26 Tamaricaceae 3 
Fabaceae (Leguminosae) 49 Thymelaceae 1 
Frankenaceae 1 Tiliaceae 2 
Fumariaceae 1 Typhaceae 1 
Geraniaceae 1 Urticaceae 2 
Graminae (Poaceae) 13 Verbenaceae 2 
Grossulariaceae 1 Vitaceae 2 
Iridaceae 1 Zingiberaceae 4 
Labiatae (Lamiaceae) 33 Zygophyllaceae 
 
7 
 Liliaceae 4 
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Figure 2: Number of traditionally used species per family in Saudi Arabia 
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According to Ali et al. (2017), these therapeutic practices and use of medicinal 
plants appear on the Use Index (UI), [UI = (na/NA ×100), where na is the number of 
questioners who refer to the species as valuable and NA is the total number of people 
met]. Three vital plants were at the core of Saudis' practices:  Juniperus procera, Rumex 
nervosus, and Ziziphus spina-chris [33]. Therefore, these three important and 
commonly used plants have been discussed here in detail. 
Juniperus procera Hochst. ex Endl is known as "Arar" in KSA. It is a long tree 
that reaches up to 8m tall with needle-shaped leaves, extending from the south reigon 
of the Arab Peninsula across the Red Sea into Africa [45]. Juniperus is one of the major 
genera of Cupressaceae family consisting of approximately 70 species [46]. 
Traditionally in Saudi Arabia, J. procera used for treating hepatic diseases, jaundice, 
gastrointestinal disturbances, pharyngitis, as antirheumatism, for gout and several 
inflammatory conditions [21, 47]. In ethnomedicine, the resinous material of J. procera 
was added to bee-honey and used as a remedy for curing hepatic and skin diseases [48].  
A previous phytochemical study of different parts of J. procera resulted in the 
isolation of different classes of sesquiterpenes and diterpenes. Where the stem bark of 
J. procera afforded two lignans identified as β-peltatin and deoxypodophyllotoxin [95]. 
In addition, the stem barks and leaves of same plant gave two diterpenes designated as 
totarol and sugiol with strong antimicrobial activity [49, 50]. Abietane, pimarane, and 
labdane types of diterpenes have been isolated from J. procera fruits which showed 
antiparasitic and nematicidal activities [51]. Moreover, totarol exhibited a synergistic 
effect with isoniazide (INH) towards four Mycobacterium species [52]. In addition, its 
essential oil possesses significant antioxidant/free radical scavenging activity [53].  
The less polar fraction of the aerial part of J. procera exhibited significant 
hepatoprotective effect against liver toxicity induced by CCl4. The hepatoprotective 
activity has been referred to the presence of terpenes in good yield; 4-epi-abietol, 
ferruginol, hinokiol, sugiol, Z-communic acid and hinokiol-1-one, 3-β-12-
dihydroxyabieta-8,11,13-triene-1-one, in addition to 8-α-acetoxyelemol sesquiterpene 
[54]. A toxicity study of J. procera extract revealed the safety of the extract even at 
high doses no acute or chronic toxicity appeared [48]. Figure 1S shows the structures 
of the major compounds isolated from J. procera.                       
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Rumex nervosus Vahl. is known locally as “Ithrib”. Some people in the Arabian 
Peninsula especially in Yemen and Saudi Arabia consume R. nervosus, which makes it 
an edible plant. However, if eaten in large quantities, it can produce toxic effects 
because of its high calcium oxalate content [55]. Rumex nervosus belongs to the family 
Polygonaceae and is a large annual herb that can grow up to 1.5 m tall, its leaves are 
usually sagittate, the inflorescence is considerably branched, and it has a leafless 
panicle. It has a light brown nut and its fruits are cordate-orbicular. It is widely 
distributed in Yemen, Saudi Arabia, Ethiopia, Somalia, Kenya, and Tanzania. Ithrib is 
a very common plant that is used by native people as a diuretic, antipyretic, 
antirheumatic and to treat gonorrhea, leprosy, lung tuberculosis, liver illness, as 
antihypertension, antihemorrhoids, antiscabies, antiemetic, aphrodisiac, antitussive, 
antirabies, for dermatitis, antiacne, hypoglycemic, antiinfective, and headache. 
Decoction of the leaf or root powder produces a substance that is used as a vermifuge. 
Moreover, the leaves of R. nervosus are utilized to treat skin rashes and young leaves 
are roasted to decrease the acid content before being eaten. The material formed after 
the burning of the stem is mixed with egg yolk or butter and applied to burns [55 – 59]. 
There are some reports on the anthelmintic [55], anti-inflammatory and antiviral 
[57], analgesic [58], diuretic and laxative [59], and antioxidant [60] effects of R. 
nervosus. 
It has been confirmed that R. nervosus extracts contain alkaloids, flavonoids, 
phenols, amino acids, furanocoumarins, and saponins by preliminary phytochemical 
screening [61]. 
Moreover, the genus Rumex is characterized by the presence of anthraquinones, 
naphthalene-1,8-diols, flavonoids, and stilbenoids [62]. Many phenolic compounds 
have been isolated from the R. nervosus ethyl acetate fraction, including kaempferol, 
quercetin, gallic acid, hyperoside, quercetin 3-O-(6″-acetyl)-galactoside, hesperidin, 
quercetin, p-hydroxy benzoic acid, catechol, and pyrogallol [63]. Figure 2S shows the 
structures of the major compounds isolated from R. nervosus. 
  Ziziphus spina-christi is commonly called Jujube" and is locally known as 
“Sidr” or “Nabuk”. It is a multiuse tree belonging to the family Rhamnaceae. Sidr is a 
native plant that grows in tropical and subtropical regions, and it is widely distributed 
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throughout the Mediterranean regions, Africa, Asia, and tropical America. In Saudi 
Arabia, Sidr is wildly distributed throughout the southern and southwestern area and 
has been used as an ornamental plant and for shade. It is a tall tree that can reach 20 m 
in height. Its leaves are glabrous on the upper surface, finely pubescent on the lower 
surface, and ellipsoid or ovate lanceolate in shape with an obtuse or acute apex [64]. 
Ziziphus spina-christi is greatly respected by Muslims since it is mentioned in 
the Sunnah and the Holy Quraan twice [65]. From ancient times, in Chinese traditional 
medicine, suan zao ren (Z. spinosa) has been used to increase blood flow to the heart 
and liver, and it is used to control irritability, insomnia, and palpitations [66]. In Saudi 
folk medicine, the leaves of Z. spina-christi (jujube) are used to heal wounds, treat some 
skin diseases and sores, cure ringworm, antipyretic, gonorrhea, sex diseases, some 
inflammatory conditions, and ulcers. Furthermore, it has been reported that Z. spina-
christi leaves are used in folk medicine as antidiabetic remedy [67]. In the Bedouin, the 
decoction of the stem bark and fresh fruits is used as a body rinse, to cure fresh wounds, 
and is also used for the management of dysentery, bronchitis, coughs, and tuberculosis 
[68].  
Previous phytochemical investigation revealed it contains biologically active 
secondary metabolites including, tannins, flavonoids, terpernoids, saponin glycosides, 
and alkaloids [68].  
Pharmacological studies have demonstrated that the total alcoholic extract of 
the current plant leaves and stem bark has showed significant antioxidant, antimicrobial 
and antidiarrheal activities [66, 69]. Additionally, the aqueous extract from the root 
bark has an antinociceptive activity [70] and central nervous system depressant effect 
in mice [71]. The butanol extract of Z. spina-christi leaves has shown potent 
hypoglycemic/antidiabetic activities [72]. The aqueous and ethanolic extracts of stem 
bark of Z. spina-christi have been studied and an anticholinergic effect was observed 
[73], which proved the traditional use of the plant as antispasmodic. A cytotoxic effect 
was observed for the aerial part of Z. spina-christi against cervical, breast and colon 
cancers [66].  
A phytochemical study of Z. spina-christi indicated the presence of betulic and 
ceanothic acids [74]. Cyclic peptide alkaloids, franaganine, mauritine C, and sativanine 
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A have been isolated and fully characterized from the stem bark of Z. spina-christi [75]. 
Triterpenoidal saponins were recently isolated from the leaves of the same plant and 
screened for their antidiabetic activity [76]. Additionally, four saponin glucosides 
identified as christinin A-D have been isolated from the leaves n. butanol extract leaves 
and their structures were fully characterized by using spectroscopic technique [77]. 
Furthermore, quercetin, hyperoside, ruin, and quercetin-3-O-[β-xylose-(1–2)-α-
rhamnose] 4′-O-α-rhamnose have also been isolated from the leaves and fruits of Z. 
spina-christi [78]. Figure 3S shows the structures of the major compounds isolated from 
Z. spina-christi. 
6.5. Conclusions 
Ethnomedicinal knowledge is not transferred from the older generations to the young 
age generations, meaning it will soon be erased especially as most younger individuals 
prefer to visit clinics and hospitals more regular than older people and the Bedouin. 
Moreover, folkloric healers (Hakeem) use wild herbs randomly and without any 
restriction, which increases the chance of extinction of certain medicinal plants. This 
requires greater consideration because more than 15,000 plant species might face 
extinction worldwide due to over-harvesting and misuse [2, 14]. Therefore, owing to 
the high diversity of medicinal plants in the KSA, the present review recommends the 
following: 
• Phytochemical and pharmacological studies on the different flora plants.  
• Creation of distribution maps for important medicinal plants using GPS 
coordinates. 
•  Data analysis of medicinal plants based on their phytochemical, 
chemotaxonomical, and pharmacognestical characteristics. 
• Monographs of some pharmacopoeial medicinal plants. 
• Continuing the surveying of plants and identification of their exact locations. 
• Plants provided with sequence bank and fingerprinting. 
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• Seed library for the plants or seed bank to preserve genetic diversity and to 
preserve rare plant species. 
A total of 471 plant species belonging to 89 families were recorded in the present 
review from the KSA, which means that this country has a large number of medicinal 
plants that need to be discovered and have their chemical and pharmacological 
properties studied.  
The findings from the present review paper lend support to the extensive traditional 
medicinal knowledge in the KSA, which provide the basis for further medicinal 
research on a scientific evidence basis. 
The current study has reviewed a total of 471 plant species belonging to 89 families 
grown in KSA. This highlights the vast wealth of medicinal plants in KSA. These plants 
have been used as medications for healing and treating many diseases on an 
ethnomedicinal, folk medicinal, and national basis. Practicing traditional medicine by 
resorting to these plants in KSA dates back to ancient times so that it has become 
fashionable among almost all Saudis. 
Therefore, it is suggested that further studies be conducted on unveiling the 
pharmaceutical, pharmacological, chemical, and laboratory properties of these 
medicinal plants that have never been targeted before via studies from this perspective. 
Thus, this tremendous treasure of medicinal plants in KSA needs a greater deal of 
attention so that researcher would direct future studies to dig out the undiscovered 
secrets of these plants from a scientific angle of vision. It is hoped these future studies, 
once scientifically conducted, will come up with new discoveries in the form of new 
drug leads extracted from natural resources that would utterly changes the medication 
shelves all over the world. 
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7.1. General discussion 
 
Skin wound ulceration represents a difficult clinical problem and a major source of 
morbidity in the Kingdom of Saudi Arabia (KSA) and world wide, especially in-patient 
suffering from chronic disease such as diabetes mellitus (DM). The patient's quality of 
life is also significantly affected by pain, swelling, and management of wound drainage. 
Wound ulcer, skin inflammation could be cause systemic symptoms lead to increase 
the risk of morbidity and mortality [1]. Wound care and therapy can be very 
challenging, and the major dream is discovering cheapest, safest and 100% effective 
wound ulcer and skin inflammation treatment.   
Since ancient times, nature has been an important source of medicinal agents. 
This fact is illustrated by the large number of natural products currently used medically. 
The flora of Saudi Arabia provides a rich resource of medicinal plants and endemic 
species for traditional medicine. Medicinal plants are essential in traditional health 
systems and are an important economic component of the biodiversity in Saudi Arabia 
[2]. An inventory of the medicinal plants of KSA is essential [3] to prioritize a scientific 
assessment of the native ethnomedicine, and to advance new derivative medicines and 
natural health products. The number of medicinal plants and trees among Saudi 
Arabia’s flora is more than 837 useful plants out of 2,253 species [2]. The majority of 
these flora species can be found in Asir and Hijaz in the western region of the KSA 
near the border of the Red Sea [2]. Based on some of the reported traditional uses of 
these herbal plants, it can be seen that many plants in the KSA (native or naturalized) 
are part of the natural healthcare system and should be scientifically studied [3] 
Identification and isolation of the bioactive compounds have possible promising 
pharmacological activities such as wound healing, skin ulcer curing and treatment for 
skin inflammation from native Saudi plants, can further the search for novel 
therapeutics for such medical conditions.  
Sap of the J. pelargoniifolia petioles was traditionally used as a healing agent 
for treatment of ulcers, wounds and skin inflammation, while the whole plant of J. 
glauca is taken to treat constipation and as ear drops [4].  
The toxicity study revealed that 24-hours LD50 was approximately more than 
1.2 ml/kg b.w. for the essential oils and 2 g/kg for the extracts, which encourage us to 
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do further biological investigation. The selected biological activities were an analgesic, 
anti-inflammatory and hepatoprotective activities as well hypoglycemic activity based 
on the above folkloric use. 
The root extracts from J. pelargoniifolia exhibited greater anti-inflammatory 
(50.63%) activity than J. glauca when compared with phenylbutazone (64.63%). While 
the roots of J. glauca showed higher hepatoprotective and antinociceptive (63.85%) 
activities in comparison to indomethacin (69.87%). 
Additionally, the oil of J. pelargoniifolia roots showed anti-inflammatory, 
antipyretic, and antinociceptive activities and showed significant (p < 0.01) effect as 
compared to a standard drug.  
 Phytochemical study of root fractions of J. pelargoniifolia resulted in the 
isolation and identification of 22 compounds. Compounds 6-Hydroxy-8-
methoxycoumarin-7-O-β-D-glycopyranoside (15) and 2-hydroxymethyl-N-
methyltryptamine (18) were isolated and identified as new compounds along with 
known diterpenoid, triterpenoid, flavonoid, coumarinolignan, coumarin, pyrimidine, 
indole, and tyramine-derived molecules. The anti-inflammatory, analgesic, and 
antipyretic activities were evaluated for fifteen of the adequately available isolated 
compounds, most of them showed significant biological activity. 
7.2. Summary 
The ethanolic extracts from J. glauca and J. pelargoniifolia (root and aerial parts) 
induced analgesic and anti-inflammatory effects; these results justify the traditional use 
of J. pelargoniifolia and J. glauca as analgesics for the treatment of inflammatory 
conditions (Chapter 2).  
The chemical composition of the essential oil obtained from J. pelargoniifolia 
roots was determined via GC-FID and evaluated for its potency as an anti-
inflammatory, antioxidant, antipyretic, and antinociceptive agent by in vivo and in vitro 
models. The findings demonstrated that the investigated essential oil of J. 
pelargoniifolia roots could be used as a natural source for their anti-inflammatory, 
antinociceptive, antipyretic, and antioxidant effects (Chapter 3). 
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The different chemical composition of the essential oils of the J. pelargoniifolia 
and J. glauca indicate that the chemical profile represents a valuable taxonomic 
character that can be useful in identification of different Jatropha species. The 
distribution of sesquiterpene, diterpene, and monoterpene hydrocarbons and their 
oxygenated derivatives could be used as differentiating parameters for the various 
species (Chapter 4).  
Moreover, the phytochemical study of the plant roots resulted in the isolation of 
six terpenoids, five flavonoids, three coumarinolignans, two tryptamines, and four 
tyramines, a coumarin, and a pyrimidine. The new compounds were identified as 6-
hydroxy-8-methoxy coumarin-7-O-β-D-glycopyranoside and 2-hydroxymethyl-N-
methyltryptamine. Hovetricoside C and N-methyltryptamine were isolated from the 
Euphorbiaceae family for the first time, while cleomiscosin B, hordenine and N-
methyltyramine with their salts, cynaroside, and linarin were characterized in the 
Jatropha species for the first time. The synergistic effect between these bioactive 
constituents might explain the significant antinociceptive and anti-inflammatory effect 
of the alcoholic extract of J. pelargoniifolia roots and scientifically justify the use of 
this plant in folk medicine for the treatment of pain and several inflammatory conditions 
(Chapter 5). 
The last part of the thesis is dealing with a review of the widely-distributed 
medicinal plants used in ethnomedicine in KSA.  This review might be useful in 
developing strategies for the sustainable use of medicinal plants which are among the 
threatened important natural resources in folk medicine in the KSA (Chapter 6). 
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7.3. Outlook 
Because J. pelargoniifolia Courb. produced many natural secondary metabolites with 
interesting pharmacological activities. More efforts should be done to prove their 
efficacies and their exact mechanism (in vitro and in vivo) before clinical 
recommendation. Not only their efficacies but their safeties should be observed. Beside 
doing toxicity tests by cell culture and brine shrimp test, in vivo studies in higher animal 
can be an option. The tests include acute toxicity test to know LD50 of each compound 
and subchronic test to know the safety of those compounds if they were given in 
repeated doses. Beside general toxicity test, we have done special test for mutagenicity. 
Further investigation is still needed for oil and extract safety because direct contact of 
J. pelargoniifolia latex and oil to the skin and eye cause severe irritation.  
Finally, the genus Jatropha comprises of 200 species, so far only a few species 
have been investigated chemically. There are still many species that have received no 
or little attention. So, phytochemical and biological studies should focus now on those 
plants to search for more potential bioactive components used as natural remedies for 
treatment of various diseases.  
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2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) ABTS 
Alkaline phosphatase ALP 
Alanine aminotransferase ALT 
Aspartate Aminotransferase AST    
Broad singlet brs 
Body weight b.w. 
Deuterated methanol CD3OD 
Centimeter cm 
Carbon Nuclear Magnetic Resonance 13C NMR 
Correlation Spectroscopy COSY 
Degree centigrade °C 
Doublet d 
Dichloromethane DCM 
Double doublet dd  
1,1-diphenyl-2-picrylhydrazyl DPPH     
Ethyl acetate EtOAc 
Ethyl alcohol EtOH 
Figure Fig. 
Ferric reducing antioxidant power FRAP 
Fraction Fr. 
Gram g 
Gas chromatography-flame ionization detector GC-FID 
Gas Chromatography- Mass Spectrometry GC-MS  
Gamma glutamyl transpeptidase GGT 
Heteronuclear Multiple Bond Correlation HMBC  
Proton Nuclear Magnetic Resonance 1H NMR 
High Pressure Liquid Chromatography HPLC 
Hour hr 
High Resolution Electron Spray Ionization -Mass Spectrometry HRESIMS 
Heateronuclear Single Quantum Correlation HSQC  
Hertz Hz 
Internal diameter i.d. 
Infrared spectrometry IR 
Intraperitoneal  i.p. 
Coupling constant J 
Mass over charge ratio m/z   
Molecular ion peak [M]+ 
Meter m 
Malonaldehyde MDA 
Melting point m.p.  
Milligram mg 
Milligram per kilogram mg/kg 
Milligram per milliliter mg/ml 
Mega Hertz MHz 
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Minute min 
Milliliter ml 
Milliliter per minute ml/min 
Non-protein sulfhydryl groups NP-SH 
Organization for Economic Co-operation and Development OECD 
Per os p.o. 
Part per million (10-6) ppm  
Reversed phase Rp 
Retention indices RI 
Retention time Rt 
Singlet s  
Subcutaneous s.c.   
Trichloroacetic acid TCA         
Thin layer chromatography TLC 
Total protein TP 
Ultra-violet spectroscopy UV  
Chemical shift value δ 
Maximum fluorescence emission wavelength λmax 
Micron μ 
Microliter μl 
Micrometer μm 
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Figure 1S: GC chromatogram of J. pelargoniifolia root oil 
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           Figures 2S a, b, c: Antioxidant activity of J. pelargoniifolia root essential oil  
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 Table 1S: Structures of major components of J. pelargoniifolia roots essential oil 
 
   Table 2S: Percentages of classes of compounds in the essential oil of J. pelargoniifolia roots 
Component names Concentration 
 
Structure 
 
γ-Eudesmol 
 
35.31 % 
 
 
5-Guaien-11-ol 
 
14.43 % 
 
 
Epi-Cedrol 
 
8.19 % 
 
 
Oleic acid 
 
5.23 % 
 
 
Bulnesol 
 
4.45 % 
 
 
trans-Isolongifolanone 
 
 
2.68 % 
H
O
 
 
Class 
 
Percentage 
Oxygenated monoterpenes  0.849 
Oxygenated sesquiterpenes  70.366 
Sesquiterpene hydrocarbons 6.941 
Fatty acids (saturated) 4.939 
Fatty acids (unsaturated) 9.690 
 Other 7.205 
Total 99.99 
HO
O H H
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    Table 3S: Effect of J. pelargoniifolia essential oil on cotton pellet granuloma in Wistar rats  
      All values represent mean ± SE.  **p < 0.01 (one-way ANOVA, followed by Dunnett's test) versus the control group, ###p < 0.001 (unpaired t-test) versus the control group, •••p < 0.001 (paired t-test) versus 
       initial   cotton weight. 
 
 
     Table 4S: Analgesic effect of J. pelargoniifolia essential oil on tail flick in mice 
     All values represent mean ± SE. *p < 0.05; **p < 0.01 (Repeated measures ANOVA, followed by Dunnett's test) versus pre-drug group, ###p < 0.001 (unpaired t-test) versus pre-drug group. 
     
 
 
 
 
Group (n=6) Dose 
(µl/kg) 
Initial weight of sterilized cotton pellet (mg) Mean increase in weight of pellet (mg±SE) 
 
Net % Inhibition 
Control - 30 81.900±1.912 ••• 51.900±1.912 - 
Essential Oil 120 30 69.667±1.787••• 39.667±1.787** 23.57 
Essential Oil 240 30 51.217±1.463••• 21.217±1.463** 59.12 
Phenylbutazone 100 mg/kg 30 41.700±1.065••• 11.700±1.065### 77.45 
                                                      Reaction time (seconds) post-drug administration Reaction time 
(seconds) pre -drug 
Dose 
(µl/kg) 
Treatment 
(n=6) %  
Inhibition 
120 min. %  
Inhibition 
60 min. % 
Inhibition 
30 min. 
39.28 6.500±0.428** 35.71 6.333±0.333** 17.85 5.500±0.224 4.667±0.333 120 Essential Oil 
64.51 8.500±0.428** 51.61 7.833±0.307** 29.00 6.667±0.422* 5.167±0.307 240 Essential Oil 
110.34 10.667±0.307### 79.31 8.667±0.333### 55.17 7.500±0.428### 4.833±0.307 4 mg/kg Indomethacin 
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 Table 5S: Analgesic effect of J. pelargoniifolia essential oil in mice via the hot plate method 
    All values represent mean ± SE. *p < 0.05; **p < 0.01 (Repeated measures ANOVA, followed by Dunnett's test) versus pre-drug group, ###p < 0.001 (unpaired t-test) versus pre-drug group. 
 
   Table 6S: Determination of LD5 
       LD50= Lethal dose-(Total Product/No. of animals), 4-(16.8/6)= 1.2 ml/kg.    
 
                                   Reaction time (seconds) post-drug administration Reaction time 
(seconds) pre -
drug 
Dose 
(µl/kg) 
Treatment 
(n=6) % Inhibition  120 min. % Inhibition 
Inhibition 
60 min. % Inhibition 30 min. 
36.84 8.667±0.333** 23.68 7.833±0.477* 10.52 7.000±0.365 6.333±0.211 120 Essential Oil 
75.00 11.667±0.333** 70.00 11.333±0.333** 42.50 9.500±0.224** 6.667±0.333 240 Essential Oil 
120.00 14.667±0.333### 97.50 13.167±0.307### 65.00 11.000±0.258### 6.667±0.333 4 mg/kg Indomethacin 
Group Dose ml/kg Dose difference (a) Dead Mean mortality (b) Product (a*b) 
1 0.2 - 0 - - 
2 0.4 0.2 1 0.5 0.1 
3 0.8 0.4 2 1.5 0.6 
4 1 0.2 4 3 0.6 
5 2 1 5 4.5 4.5 
6 4 2 6 5.5 11 
 
16.8 
50LD 1.2 
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Figure 1Sa: J. glauca aerial parts 
 
 
 
 
 
 
 
 
 143 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1Sb: J. pelargoniifolia aerial parts 
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Figure 2S: Contents (%) of classes of compounds in the essential oils of roots and aerial parts 
of J. pelargoniifolia and J. glauca 
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   Figure 1S: 1H NMR spectrum for compound 15 in CD3OD (600 MHz) 
 
 
 
 
 
  
 
 
 
 
  
 
  
   Figure 2S: 13C NMR spectrum for compound 15 in CD3OD (125 MHz) 
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   Figure 3S: COSY spectrum for compound 15 in CD3OD  
 
 
 
 
 
 
 
 
 
 
 
        
  Figure 4S: HMBC spectrum for compound 15 in CD3OD 
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Figure 5S: 1HNMR spectrum for compound 18 in CD3OD (700 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6S: 13CNMR spectrum for compound 18 in CD3OD (125 MHz) 
 149 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 7S: HMBC spectrum for compound 18 in CD3OD   
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 8S: HSQC spectrum for compound 18 in CD3OD 
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Table 9S: Analgesic effect of isolated compounds by using acetic acid-induced writhing in 
mice  
All values represent mean ± SE. *p < 0.05; **p < 0.01 versus control group (one-way ANOVA, followed by Dunnett's test), 
 ###p < 0.001 versus control group (unpaired t-test). 
•% inhibition is very low or no effect. 
 
 
 
 
 
 
 
 
 
Treatments (n=6) 
Dose 
(mg/kg) 
 
Number of writhing in 
20 min 
 
% Inhibition 
Control (20% acetic acid) 0.1 ml  36.000±1.155 - 
No-2 5 34.333±1.282 4.62 
No-2 10 34.500±1.310 4.16 
No-6 5 24.667±1.202** 31.48 
No-6 10 17.000±0.856** 52.77 
No-5 5 18.167±0.477** 49.53 
No-5 10 13.333±0.494** 62.96 
No-11 5 36.667±0.667 1.85 
No-11 10 32.500±0.922* 9.72 
No-14 5 30.833±1.138** 14.35 
No-14 10 27.500±0.764** 23.61 
No-13 5 21.167±0.980** 41.20 
No-13 10 15.000±0.577** 58.33 
No-16 5 26.833±1.046** 25.46 
No-16 10 25.333±0.667** 29.62 
No-3 5 35.667±1.706 • 
No-3 10 32.333±1.430 10.18 
No-4 5 23.167±1.014** 35.64 
No-4 10 18.333±0.882** 49.07 
No-1 5 24.333±1.308** 32.40 
No-1 10 18.167±0.946** 49.53 
No-8 5 37.833±1.014 • 
No-8 10 37.167±1.327 • 
No-9 5 34.000±1.366 5.55 
No-9 10 30.000±1.065** 16.16 
No-10 5 26.500±0.885** 26.38 
No-10 10 24.167±0.946** 32.87 
No-21 5 38.000±0.966 • 
No-21 10 37.000±0.966 • 
No-22 5 24.000±1.483** 33.33 
No-22 10 12.333±0.558** 65.74 
Indomethacin 4 9.833±0.601### 72.68 
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All values represent mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001 versus the corresponding pre-drug trated group (Repeated measures ANOVA, followed by Dunnett's test). 
•% inhibition is very low or no effect 
Table 10S: Analgesic effect of isolated compounds by using hot plate method in mice 
Treatments Dose mg/kg Reaction time (sec.) pre-drug 
Reaction time (sec.) post-drug 
30 min. % Change 60 min. % Change 120 min. %Change 
No-2 5 7.167±0.307 6.830±0.307 4.65 7.667±0.333 6.97 7.667±0.333 6.97 
No-2 10 7.007±0.365 7.833±0.307 11.90 7.667±0.333 9.52 8.333±0.422* 19.04 
No-6 5 8.000±0.365 8.667±0.337 8.33 10.167±0.307** 27.08 11.667±0.422** 45.83 
No-6 10 7.833±0.307 11.000±0.365** 40.25 12.667±0.333** 61.70 13.667±0.422** 74.46 
No-5 5 7.833±0.307 9.333±0.494* 19.14 10.500±0.428** 34.04 11.333±0.333** 44.68 
No-5 10 7.667±0.494 11.000±0.365** 43.47 12.667±0.333** 65.21 13.000±0.516** 69.56 
No-11 5 7.833±0.307 7.333±0.422 • 7.667±0.333 • 8.333±0.333 6.38 
No-11 10 7.333±0.333 8.000±0.365 • 7.833±0.307 • 8.833±0.303* 20.45 
No-14 5 7.500±0.428 7.833±0.307 4.44 8.167±0.307 8.88 9.167±0.477* 22.22 
No-14 10 7.167±0.307 7.833±0.307 9.30 8.333±0.333 16.27 9.667±0.422** 34.88 
No-13 5 8.000±0.364 9.333±0.333 16.66 10.667±0.422** 33.33 11.000±0.365** 37.50 
No-13 10 7.833±0.307 11.000±0.365** 40.42 11.667±0.426** 48.93 12.500±0.619** 59.57 
No-16 5 7.167±0.307 8.000±0.365 11.62 9.000±0.365** 25.58 10.167±0.307** 41.86 
No-16 10 7.167±0.307 8.667±0.422 20.93 10.833±0.401** 51.16 11.000±0.365** 53.48 
No-3 5 7.000±0.365 7.333±0.333 4.76 7.167±0.307 2.38 8.333±0.422 19.04 
No-3 10 7.000±0.365 7.333±0.333 4.76 7.833±0.307 11.90 9.000±0.365** 28.57 
No-4 5 7.167±0.307 7.667±0.333 6.97 8.500±0.428 18.60 9.833±0.477** 37.20 
No-4 10 7.500±0.428 10.000±0.577** 33.33 10.500±0.428** 40.00 13.000±0.365** 73.33 
No-1 5 7.667±0.333 7.500±0.428 • 7.667±0.333 • 8.000±0.447 4.34 
No-1 10 7.500±0.428 7.667±0.494 2.22 7.833±0.401 4.44 8.333±0.494 11.11 
No-8 5 7.000±0.365 7.333±0.333 4.76 7.500±0.428 7.14 8.167±0.401 16.16 
No-8 10 7.167±0.307 7.667±0.494 6.97 8.167±0.307 13.95 9.000±0.365* 25.58 
No-9 5 6.833±0.307 7.000±0.365 2.43 7.833±0.307 14.63 8.167±0.401 19.51 
No-9 10 7.667±0.333 7.833±0.307 2.17 8.667±0.422 13.04 9.833±0.477** 28.26 
No-10 5 7.167±0.307 8.000±0.258 11.62 8.667±0.422* 20.93 10.167±0.307** 41.86 
No-10 10 7.000±0.365 9.000±0.258** 28.57 10.500±0.342** 50.00 12.333±0.494** 76.19 
No-21 5 6.833±0.307 7.000±0.365 2.43 7.167±0.307 4.87 8.000±0.365 17.07 
No-21 10 7.000±0.365 7.667±0.333 8.52 7.500±0.428 7.14 7.833±0.401 11.90 
No-22 5 7.000±0.365 7.833±0.307 11.90 8.667±0.422* 23.89 10.333±0.422** 47.61 
No-22 10 7.000±0.365 8.500±0.342* 21.42 9.167±0.401** 30.95 12.500±0.428** 78.57 
Indomethacin 4 7.167±0.307 10.167±0.307*** 41.86 12.833±0.401*** 79.06 14.667±0.333*** 104.65 
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All values represent mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001 versus the corresponding pre-drug trated group (Repeated measure ANOVA, followed by Dunnett's test). 
 •% inhibition is very low or no effect. 
Table 11S: Analgesic effect of isolated Compounds by using tail flick method in mice 
Treatments Dose mg/kg Reaction time (s) pre-drug 
Reaction time (s) post-drug 
30 min. % Change 60 min. % Change 120 min. % Change 
No-2 5 5.200±0.195 5.117±0.189 • 5.300±0.235 • 5.167±0.126 • 
No-2 10 5.100±0.277 5.133±0.123 • 5.283±0.206 3.59 5.083±0.087 • 
No-6 5 5.150±0.134 5.450±0.136 5.82 5.883±0.138** 14.23 5.967±0.156** 15.85 
No-6 10 5.417±0.160 5.983±0.108 10.45 6.700±0.106** 23.69 7.600±0.372** 40.30 
No-5 5 4.933±0.133 6.067±0.076** 22.97 6.483±0.160** 31.41 7.000±0.097** 41.89 
No-5 10 5.283±0.125 6.783±0.119** 28.39 7.333±0.152** 38.80 7.850±0.173** 48.58 
No-11 5 5.200±0.153 5.017±0.130 • 5.117±0.108 • 5.250±0.099 • 
No-11 10 5.250±0.100 5.117±0.130 • 5.050±0.115 • 5.267±0.112 • 
No-14 5 4.933±0.126 4.867±0.084 • 4.983±0.087 • 5.183±0.114 • 
No-14 10 5.050±0.134 5.133±0.141 • 5.383±0.119 6.60 5.767±0.189** 14.19 
No-13 5 4.967±0.112 5.300±0.110 6.71 6.150±0.112** 23.82 6.533±0.180** 31.54 
No-13 10 5.150±0.106 6.017±0.162** 16.82 6.950±0.195** 34.95 7.933±0.145** 54.04 
No-16 5 5.217±0.135 5.967±0.120 14.37 7.260±0.568** 39.55 7.000±0.124** 34.18 
No-16 10 5.100±0.113 6.800±0.141** 33.33 7.250±0.134** 42.15 7.833±0.171** 53.59 
No-3 5 5.100±0.129 5.133±0.105 • 5.350±0.152 4.90 5.767±0.148* 13.07 
No-3 10 5.067±0.145 5.467±0.214 7.89 5.417±0.183 6.90 6.100±0.129** 20.39 
No-4 5 5.117±0.095 6.017±0.209** 17.58 6.633±0.174** 29.64 7.183±0.149** 40.39 
No-4 10 5.267±0.198 6.700±0.265** 27.21 7.683±0.158** 45.88 8.300±0.232** 57.59 
No-1 5 4.833±0.253 6.033±0.133** 28.82 6.317±0.158** 30.68 7.000±0.097** 44.82 
No-1 10 5.083±0.122 7.217±0.147** 41.96 7.867±0.176** 54.75 8.500±0.270** 67.21 
No-8 5 4.867±0.123 5.083±0.119 4.45 5.367±0.136 10.27 5.500±0.169* 13.01 
No-8 10 5.150±0.195 5.167±0.095 • 5.417±0.125 5.17 5.750±0.099* 11.65 
No-9 5 4.983±0.145 5.167±0.143 3.67 5.300±0.106 6.35 5.850±0.128** 17.39 
No-9 10 5.517±0.170 5.867±0.112 6.34 6.050±0.123* 9.66 6.117±0.095* 10.87 
No-10 5 5.050±0.134 5.883±0.151** 16.50 6.683±0.117** 32.34 7.100±0.086** 40.59 
No-10 10 5.100±0.146 6.733 ±0.161** 32.02 7.150±0.250** 40.19 8.183±0.119** 60.45 
No-21 5 5.033±0.251 5.183±0.182 2.98 5.267±0.143 4.63 5.157±0.182 9.60 
No-21 10 5.133±0.131 5.233±0.128 • 5.967±0.080** 16.23 6.250±0.089** 21.75 
No-22 5 5.467±0.199 6.633±0.282** 21.34 7.000±0.250** 28.04 7.550±0.128** 38.10 
No-22 10 5.050±0.143 7.067±0.246** 39.93 7.983±0.108** 58.08 8.450±0.165** 67.32 
Indomethacin 4 5.317±0.154 7.650±0.246*** 43.48 8.050±0.251*** 51.41 10.400±0.427*** 95.61 
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  All values represent mean ± SE. *p < 0.05; **p < 0.01 versus only carrageenan group (one-way ANOVA, followed by Dunnett's test), •••p < 0.001 versus the corresponding before carrageenan group (paired t-test), 
   ###p < 0.001 versus only carrageenan group (unpaired t-test). 
   •% inhibition is very low or no effect. 
Table 12S: Effect of isolated compounds on carrageenan-induced paw edema in albino rats 
Treatments Dose mg/kg Before carrageenan 3 h after carrageenan Net % Inhibition 
Only carrageenan 0.2 ml 1.063±0.023 1.667±0.017••• 0.603±0.007 - 
No-2 5 1.067±0.021 1.673±0.020••• 0.607±0.008 • 
No-2 10 1.053±0.027 1.645±0.020••• 0.592±0.046 • 
No-6 5 1.083±0.027 1.482±0.021••• 0.398±0.009** 33.97 
No-6 10 1.072±0.024 1.367±0.025••• 0.295±0.017** 51.10 
No-5 5 1.087±0.030 1.383±0.019••• 0.327±0.021** 45.85 
No-5 10 1.093±0.011 1.387±0.017••• 0.293±0.014** 51.38 
No-11 5 1.047±0.027 1.652±0.011••• 0.605±0.022 • 
No-11 10 1.075±0.021 1.675±0.015••• 0.600±0.009 • 
No-14 5 1.103±0.011 1.668±0.025••• 0.565±0.021 6.35 
No-14 10 1.098±0.007 1.640±0.019••• 0.542±0.025 10.22 
No-13 5 1.063±0.026 1.507±0.027••• 0.443±0.022** 26.51 
No-13 10 1.027±0.036 1.337±0.036••• 0.310±0.010** 48.61 
No-16 5 1.063±0.025 1.507±0.027••• 0.443±0.022** 47.23 
No-16 10 1.027±0.036 1.337±0.036••• 0.310±0.010** 55.24 
No-3 5 1.090±0.009 1.650±0.020••• 0.560±0.018 7.18 
No-3 10 1.047±0.033 1.568±0.027••• 0.522±0.021** 13.53 
No-4 5 1.078±0.023 1.600±0.021••• 0.522±0.018** 13.53 
No-4 10 1.088±0.013 1.412±0.012••• 0.323±0.014** 49.17 
No-1 5 1.052±0.032 1.547±0.025••• 0.495±0.043* 17.95 
No-1 10 1.095±0.014 1.367±0.014••• 0.272±0.009** 54.94 
No-8 5 1.097±0.010 1.687±0.011••• 0.590±0.016 2.20 
No-8 10 1.132±0.013 1.657±0.023••• 0.525±0.031* 12.98 
No-9 5 1.047±0.025 1.617±0.013••• 0.570±0.019 5.52 
No-9 10 1.085±0.025 1.627±0.017••• 0.542±0.012* 10.22 
No-10 5 1.002±0.033 1.482±0.018••• 0.480±0.036** 20.44 
No-10 10 1.103±0.007 1.315±0.013••• 0.212±0.012** 64.91 
No-21 5 1.097±0.010 1.661±0.009••• 0.565±0.013 6.35 
No-21 10 1.065±0.026 1.622±0.022••• 0.555±0.018* 8.01 
No-22 5 1.100±0.008 1.435±0.012••• 0.335±0.007** 44.47 
No-22 10 1.087±0.015 1.387±0.009••• 0.30±0.010** 50.27 
Phenylbutazone 100 1.038±0.027 1.225±0.024••• 0.187±0.007### 69.06 
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All values represent mean ± SE. *p < 0.05; **p < 0.01; ***p < 0.001 versus the corresponding yeast administration group (Repeated measure ANOVA, followed by Dunnett's test), •••p < 0.001 versus the corresponding 
normal group (paired t-test).
    Table 13S: Effect of isolated compounds on yeast-induced hyperthermia in mice 
Treatments Dose mg/kg Normal temperature 
Rectal temperature after yeast administration 
  
Rectal temperature after drug administration 
30 min 60 min 120 min 
No-2 5 35.067±0.099 38.833±0.109••• 38.800±0.121 38.733±0.143 38.200±0.121* 
No-2 10 35.167±0.123 38.650±0.126••• 38.517±0.154 38.450±0.138 38.083±0.125* 
No-6 5 35.20±0.11 38.767±0.143••• 38.250±0.118* 38.267±0.126* 37.783±0.119** 
No-6 10 35.167±0.105 38.817±0.127••• 37.917±0.111** 37.567±0.174** 36.98±0.15** 
No-5 5 35.533±0.117 38.883±0.105••• 38.333±0.056** 37.933±0.076** 37.817±0.162** 
No-5 10 35.333±0.112 38.783±0.192••• 37.917±0.168** 37.400±0.179** 37.000±0.097** 
No-11 5 35.383±0.087 38.850±0.161••• 38.717±0.185 38.683±0.119 38.567±0.169 
No-11 10 35.283±0.087 38.700±0.115••• 38.600±0.129 38.533±0.133 38.250±0.092 
No-14 5 35.400±0.163 38.817±0.125••• 38.683±0.158 38.617±0.158 38.433±0.139 
No-14 10 35.933±0.582 38.967±0.120••• 38.817±0.114 38.567±0.112 38.433±0.123* 
No-13 5 35.533±0.141 38.700±0.165••• 38.417±0.158 37.967±0.120** 37.367±0.126** 
No-13 10 35.567±0.120 38.850±0.118••• 37.900±0.093** 37.283±0.101** 37.033±0.099** 
No-16 5 35.350±0.118 38.750±0.214••• 38.217±0.079 37.900±0.093** 37.583±0.0162** 
No-16 10 35.383±0.185 38.800±0.200••• 37.833±0.123** 37.117±0.095** 36.833±0.109** 
No-3 5 35.650±0.112 38.933±0.133••• 38.933±0.154 38.800±0.132 38.667±0.112 
No-3 10 35.717±0.114 38.883±0.135••• 38.733±0.136 38.517±0.079 38.600±0.148 
No-4 5 35.833±0.120 38.900±0.086••• 38.917±0.128 38.600±0.115 38.483±0.145* 
No-4 10 35.767±0.133 38.917±0.079••• 38.883±0.149 38.367±0.112* 38.317±0.117** 
No-1 5 35.667±0.088 38.883±0.133••• 38.283±0.095** 37.983±0.154** 37.883±0.158** 
No-1 10 35.550±0.169 38.883±0.117••• 38.133±0.131** 37.583±0.176** 37.067±0.173** 
No-8 5 35.567±0.230 38.883±0.119••• 38.800±0.132 38.783±0.135 38.650±0.111 
No-8 10 35.617±0.187 38.750±0.152••• 38.533±0.150 38.617±0.114 38.333±0.184 
No-9 5 35.667±0.126 38.767±0.169••• 38.750±0.118 38.617±0.130 38.300±0.106 
No-9 10 35.600±0.129 38.817±0.125••• 38.767±0.112 38.633±0.133 38.000±0.097** 
No-10 5 35.833±0.095 38.867±0.141••• 38.317±0.098* 37.817±0.130** 37.267±0.092** 
No-10 10 35.783±0.125 38.850±0.154••• 37.833±0.112** 37.400±0.171** 37.133±0.284** 
No-21 5 35.633±0.163 38.850±0.138••• 38.850±0.123 38.717±0.114 38.533±0.123 
No-21 10 35.683±0.128 38.867±0.171••• 38.667±0.123 38.450±0.145 38.200±0.124** 
No-22 5 35.700±0.115 38.817±0.114••• 38.100±0.103**  37.800±0.159** 37.200±0.115** 
No-22 10 35.750±0.099 38.867±0.123••• 38.233±0.102** 37.117±0.101** 36.733±0.136** 
Indomethacin 4 35.717±0.189 38.950±0.106••• 37.100±0.093*** 36.850±0.180*** 36.333±0.112** 
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Table 14S: % Inhibition of nitric oxide scavenging activity for isolated compounds at 
different concentrations 
All parameters are expressed as mean ± SD of three independent measurements. 
 
 
 
 
 
 
 
 
 
 
 
Treatments 
(% Inhibition ± SD) 
 
Concentration 
20 
µg/ml 
 
40 
µg/ml 
 
60 
µg/ml 
 
80 
µg/ml 
 
100 
µg/ml 
 
Compound-2 30.150±14.360 54.430±3.140 63.960±10.700 71.600±10.480 76.830±5.010 
Compound-6 10.560±5.340 23.090±3.040 33.500±8.520 50.030±4.000 56.540±6.030 
Compound-5 5.160±2.480 10.430±3.250 19.360±8.720 21.630±10.280 27.000±7.850 
Compound-11 7.400±4.560 20.060±8.580 36.710±16.530 50.500±10.210 57.000±10.210 
Compound-14 17.860±15.850 28.100±22.280 42.400±23.650 59.160±14.840 70.360±14.730 
Compound-13 10.400±6.320 14.160±4.350 25.610±5.180 30.040±3.350 33.060±1.860 
Compound-16 6.660±2.100 11.260±0.280 19.200±6.400 21.860±5.350 25.610±5.180 
Compound-3 7.400±4.560 12.630±5.430 19.430±6.210 28.460±12.000 38.300±5.630 
Compound-4 23.860±8.910 41.430±7.770 48.160±7.160 66.030±8.240 77.360±4.220 
Compound-1 11.460±5.000 27.900±0.450 44.300±6.760 61.530±2.560 71.660±0.700 
Compound-8 7.500±1.550 15.750±0.440 42.610±10.720 50.170±9.220 63.670±12.850 
Compound-9 15.060±7.500 29.300±2.980 38.270±2.980 50.430±7.230 63.670±12.850 
Compound-10 33.310±19.720 45.380±20.110 56.550±9.420 64.730±4.350 75.260±5.540 
Compound-21 39.970±7.660 54.970±6.680 61.700±2.950 63.180±1.660 67.760±5.750 
Compound-22 23.860±8.910 41.430±7.770 48.160±7.160 66.030±8.240 77.600±4.220 
Ascorbic Acid 64.380±15.470 66.640±15.420 78.130±3.220 85.680±1.690 87.230±0.980 
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Table 1S: Ethnobotanical information on some medicinal herbs used in different regions of Saudi Arabia 
Scientific name Local name Family Part used Traditional uses Region  Reference 
Blepharons ciliaris L. Shook 
aldabb 
Acanthaceae Leaves & 
whole plant 
Toothache & skin wound. M, W, S 12, 13, 14, 15, 
16 
Blepharis maderaspatensis Athrarh Leaves Used as treatment for scorpion sting. - 17 
Ecbolium viride (Forssk) Khoseer Leaves 
powder 
Treat pimples & when applied around 
genital area it improves urination. 
S 15, 16 
Ecbolium gymnostachyum (Nees) Syhan Leaves Wound healing & bone fracture. M 13 
Hypoestes forsskalii (Vahl) Nadqah Leaves Anti-inflammatory & wound healing in 
cattle. 
M 13 
Adiantum capillus-veneris Kizbratal 
Baer 
Adiantaceae Whole plant Antipyretic, antitussive, diuretic, 
emmenagogue, expectorant & 
pulmonary catarrh. 
M, W 12, 13 
Dracaena ombet Kotschy & Peyr. Azef Agavaceae Resin Used as antihemorrhagic & for skin 
infections. 
S 15, 18 
Sansevieria ehrenbergii Schweinf. ex 
Baker 
Salaf Leaves Used for treating blisters. S 15, 18 
Aizoon canariense L. Hodaq Aizoaceae Whole plant Used to treat indigestion flatulence & 
hypertension. 
M 13 
Mesembryanthemum crystallinum  Nabat Al-
thalg 
Whole plant Antimicrobial. S 19 
Mesembryanthemum forsskalei  Samh Seeds Making bread. S 19 
Trianthema portulacastrum Laani leaves Used as treatment for scorpion sting. - 17 
Achyranthes aspera L. Mahwat Amaranthaceae 
 
 
 
 
 
 
 
 
Leaves, roots, 
seeds & barks 
Stomachache, bowel complaints piles, 
boils, scorpion sting & skin eruptions. 
S, W 
 
15, 17 
Aerva javanica (Bunn.f.) Tuwain Whole plant Toothache, hemorrhage, snake & insect 
bites. 
M, W, S 12, 13, 15 
Roots (juice) Treat eye diseases in cattle. 
Aerva lanata L. 
 
Al-Athlab Whole plant Diuretic, scorpion sting & demulcent. M, S 13, 15, 8, 17 
Alternanthera pungens Kunth.  - Whole plant Used as treatment for scorpion sting. M 17 
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Scientific name Local name Family Part used Traditional uses Region  Reference 
Alternanthera sessilis L. R.Br. ex DC. 
 
- Amaranthaceae 
 
Leaves Used as treatment for scorpion sting. M 17 
Amaranthus caudatus L. Kaf-
Almehana 
Whole plant Diuretic, strangury, blood purifier & for 
the treatment of piles. 
S 15 
Leaves Used as an abortifacient. 
Amaranthus graecizans L. Thaflah Leaves Chewed & the liquid swallowed to treat 
tonsillitis, scorpion sting & used as 
anthelmintic. 
M 13, 17 
Amaranthus hybridus Spinach Sabanih Whole plant Treat jaundice, inflammation, blood 
tonic, laxative & as digestive. 
- 20 
Amaranthus retrofexus Oshba 
alqanzeer 
Leaves Astringent & anthemorrhagic. M 13 
Amaranthus spinosus L. Da,ad Whole plant Antipyretic, diuretic, laxative, scorpion 
sting & stomachic. 
S 15, 17 
Roots  Treat gonorrhea & constipation & 
jaundice. 
 
Amaranthus viridis L. Shae Whole plant Antipyretic, diuretic, emollient in 
scorpion sting, expectorant, laxative & 
leprosy. 
M, S 13, 15, 17 
Bassia muricata L. Hassaniya Whole plant Antimicrobial. 
 
S 15, 19 
Celosia trigyna L. Trgana Leaves & 
flowers 
Treatment of diarrhoea & for excessive 
menstruation 
S 13, 19 
Annona squamosa L. - 
 
 
Annonaceae 
 
Leaves, roots 
& barks 
Used as treatment for scorpion sting. - 17 
Ammi majus - Apiaceae 
(Umbelliferae) 
Whole plant Skin diseases, leukoderma, 
contraceptive, diuretic, tonic, angina, 
carminative, antiasthmatic & toothache. 
 
M 12 
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Table 1S: Cont. 
Scientific name Local name Family Part used Traditional uses Region  Reference 
Anethum graveolens L.  Dill, Shibt Apiaceae 
(Umbelliferae) 
Whole plant, 
roots, leaves, 
seeds, fruits 
Antimycobactetial, Antifungal, 
insecticides, psychoactive, 
hallucinogenic, appetizer, colic gripes, 
mouth wash, carminative, aphrodisiac, 
diuretic, astringent, cordial, laxative, 
stimulant, emmenagogue, anthelmintic, 
abortifacient, antispasmodic, treating 
bronchitis, liver and spleen disorder, 
lumbago & galactagogue. 
 
S, M, W 12, 15, 13 
 
Apium graveolens 
 
Karfas Flowers 
roots & seeds 
Digestive, antacid, body tonic, laxative, 
chest ailments, arthritis, jaundice, 
appetizer, colic gripes, tonic, purgative, 
vermifuge, antiasthma, liver and spleen 
disorder, antirheumatic, anasarca, 
homeopathic, antispasmodic, sedative, 
high blood pressure, kidney problems, 
anticonvulsant & calming. 
 
M 12, 20 
 
Bepleurum semicompositum - Fruits Stomach troubles, carminative & 
mentalis disorders. 
M 12 
Carum carvi L. 
 
- Roots Used as treatment for scorpion sting. - 17 
Conium maculatum L. Shawkaran 
 
 
Flowers & 
leaves 
Used as treatment for scorpion sting. - 17 
Coriandrum sativum L. Kosbarah Whole plant Antiflatulence, antidiarrhea, anticolic & 
as general tonic. 
S 15 
Cuminum cyminum 
 
 
 
Kamun Seeds & 
leaves 
Diuretic, carminative, anticolic, 
antioxidant, uterine discharge, hiccup, 
appetizer, deafness, spasm & digestive. 
 
S 21, 20 
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Scientific name Local name Family Part used Traditional uses Region  Reference 
Daucus carota Linn. Jizr Apiaceae 
(Umbelliferae) 
Leaves & 
roots 
Mucolytic, chest pain, cough, hepatic 
and gastric problems, diuretic, brain 
stimulant, coarseness of voice, digestive, 
fatigue, hypertension, nervousness & 
skin diseases. 
- 20 
Ducrosia ismaelis L. - Whole plant Antimicrobial. S 15, 19 
Echinosciadium arabicum L. - Whole plant Central nervous system stimulation & 
antimicrobial. 
S 15, 19 
Eryngium foetidum L. Cilantro Whole plant Used as antipyretic, antiemetic & 
antidiarrheal. 
S 15, 18 
Foeniculum vulgare Mill. 
 
Shawmar,  
Sheeh 
Whole plant  
seeds, leaves 
& stems 
Used to relieves digestive problems, 
increases lactation, antiflatulence, 
reduces inflammation, antimicrobial, 
used for skin disorders, antitussive, 
stomach problems, as toothbrush, used 
for conjunctivitis & used for blepharitis 
of the eye. 
W 13, 22 
S 
 
15, 16, 23 
Petroselinum crispum L. - 
 
Whole plant Used against kidney stones. S 15 
Petroselinum sativum L. Maqdunes Whole plant & 
root 
Used against kidney stones, diuretic & 
liver disease. 
S 15, 23, 20 
Pimpinella anisum Lnn. Yanisun Leaves & 
seeds 
Purgative, cough, mucolytic, headache, 
dejection & earache. 
- 20 
Pituranthus triradiatus L. - Whole plant Treat hypertension &as antimicrobial. S 15, 19 
Trachyspermum ammi L. Kemyon, 
Nahwa 
Seeds & stem Used against kidney stones & used as 
treatment for scorpion sting.  
S 15, 23 
Adenium arabicum Balf. Adnah Apocynaceae Barks & 
whole plant 
Used in bones dislocations, painful 
joints, wounds & skin infections. 
S 15, 21 
Adenium obesum L. Aden Whole plant & 
barks 
Applied on wounds as antimicrobial & 
used as treatment for scorpion sting. 
S 15, 16, 19, 17 
Blyttia reticuloses L. - Whole plant Antimicrobial. S 15, 19 
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Table 1S: Cont. 
Scientific name Local name Family Part used Traditional uses Region  Reference 
Canthranthus roseus Biftah Apocynaceae Leaves & 
roots 
Digestive, astringent, emetic, purgative, 
hemorrhagic, emmenagogue, diabetes, 
used as treatment for scorpion sting & 
cancer. 
M 12, 17 
Carlumab penicillata (Defl.) Ghaltha Whole plant & 
leaves 
Central nervous system stimulation, 
used in diabetes, stomach ulcer & 
smallpox. 
S 15 
Carissa edulis Vahl Symb. Bot. A'rm, 
Airoon 
Whole plant Anthelmintic, antiscorbutic, astringent, 
stomachic & toothache. 
S 15 
Holarrhena pubescens (Buch.-Ham.)  Kurchi Seeds & barks Treating painful joints & in diarrhea. S 21 
Nerium oleander L. Dafla Leaves & 
roots 
Treat skin disease & steam of boiled 
leaves inhaled in sinusitis. 
W, S 15, 16 
Rhazya stricata Decne. Harmal Whole plant Antirheumatic, pain relief, antibacterial 
& treatment for allergy. 
M, S 12, 14, 15, 17 
Torularia torulosa L. - Whole plant Lower blood pressure & cardiac 
stimulation. 
S 15, 19 
Arisaema flavum Dakaf Aracaceae Rhizome Used as treatment for scorpion sting. - 17 
Hyphaene thebaica L. Mart., Hist. Doom Whole plant Cardiac stimulation & antimicrobial. S 15, 19 
Phoenix dactylifera L. Nakhl Flower & 
pollen 
Used as an aphrodisiac & as a general 
tonic. 
S, W, M 21 
Aristolochia bracteolata Lam. Loiya Aristolochiaceae Leaves Used to treat snake bite & scorpion 
sting. 
S 16, 17 
 Calotropis procera Ait.  Oshar Asclepiadaceae Whole plant 
& latex 
Respiratory system, antiasthmatic, 
anticancer, joint inflammation, 
antibacterial, purgative, expectorant, 
dysentery, emetic & for leshmaniasis. 
M, W, S 12, 13, 14, 16 
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Scientific name Local name Family Part used Traditional uses Region  Reference 
Caralluma sinaica (Decne.)  Ded-Elkalba Asclepiadaceae Whole plant & 
leaves 
Hypoglycemic & antiprotozoal. S 15, 24 
Caralluma tuberculata N. E. Br. Pawany Whole plant Used in the case of diabetes, peptic 
ulcers, inflammation & its juice as 
drops for ear inflammation. 
S, W 16 
Cynanchum acutum L. Al-Modeed Leaves & 
stems 
Insecticide & parasiticide. S 15 
Gomphocarpus fruticosus L. Ait.f. Alqaraa 
Kabeer 
Leaves Tumors, skin disease, scabies & itching. S 25 
Gomphocarpus sinaicus  Arjal Whole plant Used for hemorrhagic disorders, 
rhinorrhagia & metrorrhagia. 
M 12  
Leptadenia pyrotechnica (Forssk.) Markh Whole plant & 
seeds 
Used for flu, tussive, lactagogue & 
antimicrobial. 
M, S 12, 15 
Pergularia tomentosa L. Gholfa Whole plant Skin diseases. M, W, S 13, 14, 15 
Periploca aphylla L.  Sawas 
 
Whole plant Antiprotozoal, stomachic & purgative. S 18, 24 
Aloe tomentosa Defl. Sabbar Asphodelaceae Leaves & sap Applied on skin for rashes & sunburn. 
Sap is applied for inflammation of eyes. 
S 16, 21 
Aloe vera (L.) Burm. f. Saqal, Sabar Whole plant, 
Juice of 
leaves, bulbs 
& roots 
As laxative, in asthma, peptic ulcers, 
burns & diabetes. 
S 15, 26 
Asphodelus centifolias L. Broque Seeds Used in colds, haemorrhoids & as 
antirheumatic. 
 
S 15 
Asphodelus fistulosus Towaim,  
 
Whole plant & 
seeds 
Diuretic, ulcers, toothache & 
antiinflammatory. 
W, M, S 12, 14, 15 
Achillea biebersteinii Afan. Thafraa Asteraceae 
(Compositae) 
Leaves Strong antimicrobial activity, relieve 
itching, remove readiness & swelling in 
eyes.  
 
S 15, 19, 21 
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Scientific name Local name Family Part used Traditional uses Region  Reference 
Achillea fragrantissima L. Qusom Asteraceae 
(Compositae) 
Whole plant Central nervous system stimulation & 
antimicrobial. 
S, M 15, 19 
Ambrosia maritima L. Ambrosia Whole plant Antiflatulence & diuretic. S 15, 21 
Anthemis melampodina L. Aqhwan Whole plant Antimicrobial. S 15, 19 
Anthemis pseudocotula L. Aqhwan Whole plant Antimicrobial. S 15, 19 
Anvillea gracinii (Burm.f) DC. Nougd Whole plant Used treatment for colds, diabetes. W, S 13 
Artemisia abyssinica L. Boatheran Whole plant Antimicrobial. S 15, 19 
Artemisia herbaalba L. Chih Flowery tips Digestive disorders, abdominal pain, 
colic & liver failure. 
S 15 
Artemisia judaica Boaithran Whole plant Antipyretic, menstruation regulator, for 
nerve system, carminative & 
emmenagogue. 
M 12 
Artemisia monosperma Adar Leaves & 
flowers 
Constipation, antirheumatic & flu. 
 
 
M 12 
Artemisia scoparia Slikah Whole plant Purgative, earache, antibacterial, 
hypercholesteremia, antipyretic, 
antiseptic, cholagogue, diuretic, 
vasodilator, jaundice, hepatitis, 
inflammation of the gall bladder & 
treatment of scorpion sting. 
M 12, 17 
Artemisia sieberi Besser. Chih Leaves Used as an anthelmintic. S, M 12, 15, 27 
Atractylis carduus  Korshoof Whole plant Cardiac depression. W, S 13, 19 
Calandula micrantha L. - Whole plant Central nervous system stimulation. S 15 
Carthamus tinctorius L. Zafaran Leaves Treating red, swollen eye & 
conjunctivitis. 
 
S 21 
Centaurea iberica - Leaves Treatment of scorpion sting. - 17 
Centaurea sinaica DC. Marar Whole plant Central nervous system stimulation. 
 
W, S 13, 19 
Centaurothamnus maximus 
 
 
Byad 
 
Leaves Wound healing. - 25 
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Scientific name Local name Family Part used Traditional uses Region  Reference 
Chrysanthenum coronarium - Asteraceae 
(Compositae) 
Whole plant Blennorrhagia, purgative, inflammation, 
syphilis, expectorant, stomachic & 
gonorrhea. 
M 12 
Cichorium intybus L. Hendiban Leaves, seeds 
& roots 
Antipyretic, dyspepsia, headache, 
jaundice & as demulcent. 
- 21 
Cnicus benedictus L. - Whole plant Treatment of scorpion sting. - 17 
Conyza bonariensis L. Khoa Whole plant Antimicrobial. S 15, 19 
Conyza dioscoridis L. (Desf.) 
 
Ain alkatkot Leaves Epilepsy in children. S 15 
Conyza incana L. Arfaj Whole plant Central nervous system depression, 
cardiac stimulation & antimicrobial. 
S 15, 19 
Echinops galalensis L. Karshoof Whole plant Antimicrobial. S 15, 19 
Echinops hussoni L. - Whole plant Antimicrobial. 
 
S 6, 8 
Echinops spinosissimus Tuna. Shook Al-
gamal 
 
Whole plant Splenic disease & sore throat. W, M, S 13, 14, 28 
Eclipta prostrata L. - Whole plant & 
leaves 
Treatment of scorpion sting. - 17 
Euryops arabicus Steud. Kaboor Whole plant Cardiac stimulation & for wound 
healing. 
W, S 13, 19, 21 
Francoeuria crispa (Forssk) Githgath Whole plant Used for swellings & as anti-
inflammatory. 
M, S 14, 28 
Gnophalium luteo-album - Leaves & 
stems 
Expectorant, astringent, cholagogue, 
diuretic, haemostatic & breast cancer. 
M 12 
Jasonia candicans L. - Whole plant Cardiac stimulation & antimicrobial. S 13, 19 
Kleinia pendula (Forssk.) DC. Laban Roots Otitis. S 25 
Lactuca saligna  Odad Whole plant & 
seeds 
Tonic, carminative, diuretic, colic, 
catarrh, bronchitis, typhoid, fever & for 
digestive problem.  
 
M 12 
Lactuca serriola L. - Latex 
 
Treatment of scorpion sting. - 17 
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Launea nudicaulis L. Hwwa Asteraceae 
(Compositae) 
Leaves Antipyretic & antihemorrhagic after 
childbirth. 
S 21 
Matricaria aurea (Loel.) Sch.Bip. Babunaj Flowers Used for making a tea for all stomach 
ailments & used to treat skin diseases. 
S 14, 15, 18 
Picris abyssinica L. - Whole plant Antimicrobial. S 15, 19 
Picris cyanocarpa Hozan Whole plant Central nervous system stimulation, used 
for hypertension & cardiac stimulant. 
S 15, 19 
Pluchea arabica (Boiss.) Qaiser & 
Lack 
Godot Whole plant Treating boils, skin sores & ear 
infection. 
S 15, 18 
Psiadia arabica Jaub. Tubbak Heated 
branches 
Antirheumatic & heal broken bones. S 16 
Psiadia punctulata DC. Fotaa Branches & 
stems 
Relieve muscle pain. W, S 13, 18 
Pulicaria arabica L. Garaez Whole plant For hypertension & antimicrobial. S 15, 19 
Pulicaria crispa  Arararabi Whole plant Antimalarial & stomach disorders. S 15 
Pulicaria guestii Rawi - Whole plant Strong antimicrobial. S 15, 19 
Pulicaria jaubertii Gamal-Eldin Ansif Leaves & 
flowers 
Used for digestion problem & as tonic. S 21 
Pulicaria undulata (Forssk.) Oliver. Gathgath Wole plant Central nervous system depression & 
antimicrobial. 
W, S 13, 15, 19 
Rhanterium epapposum L. Arfaj Whole plant Antimicrobial. S 15, 19 
Senecio asirensis Boulos & J. R. I. 
Wood 
Pedaa, 
Henna 
Leaves Antipyretic. S 15, 18 
Sonchus oleraceus L. Uddaid Leaves & 
flowers 
Promotes menstruation & treatment of 
scorpion sting. 
 
W, M 13, 14, 17 
Tagetes minuta L. Bard-
agoosh 
Leaves & 
flowers 
Treatment for cold & constipation. S 16 
Verbesina encelioides (Cav.) Safeara Leaves Wound & skin disease. S 15 
Vernonia schimperii L. Neeka Leaves  Treat scorpion bites, antipyretic & bites. S 15, 21 
Roots & seeds Anthelmintic. 
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Xanthium spinosum L. Shobet Asteraceae 
(Compositae) 
Wole plant Antimicrobial. S 15 
Alkanna orientalis (L.) Boiss. Lebbed Boraginaceae Whole plant Central nervous system stimulation, 
antimicrobial & throat pain. 
S 19, 21 
Anchusa milleri L. - Whole plant Central nervous system stimulant. S 19 
Arnebia hispidissima (Lehm.) DC. Kohaeel Whole plant Antipyretic. W, S 13 
Cordia myxa L. Bambar 
 
 
 
 
Leaves & 
seeds 
Used for stomach ailments, wounds 
healer, tonic, expectorant, refreshing, 
heart and brain diseases & respiratory 
system. 
M 12, 21 
Cordia sinensis Lam.  Tanab Leaves & 
stems 
Antirheumatic, painful menstruation, 
bladder diseases, gastric ulcers & 
malaria. 
- 24 
Echium horridum L. - Whole plant For hypertension. S 19 
Heliotropium aegyptiacum Lehm. Ramram Root Treatment of scorpion sting. - 17 
Heliotropium arbainense Fresen. Ramram Whole plant  For hypertension & antimicrobial. W, S 13, 19 
Heliotropium digynum (Forssk) - Leaves Skin diseases, demonomania & 
antimicrobial. 
M, W, S  12, 13, 19 
Heliotropium europaeum L. - Whole plant Antimicrobial. W, S 13, 19 
Heliotropium ramosissimum DC. Rmram Whole plant Used for snake bites. 
 
W 13 
Heliotropium strigosum Willd. Ramram Whole plant Used for snake bites. - 17 
Trichodesma africanum L. 
 
Hamham Whole plant Treatment for cough & cold. M, S 14 
Balanites aegyptiaca (L.) Del - Balanitaceae Whole plant Treatment of different ailments such as 
syphilis, jaundice, liver and spleen 
problems, epilepsy, as treatment for 
scorpion sting & yellow fever. 
S 15, 17 
Anastatica hierochuntica L. Khaf-
Maryam 
Brassicaceae 
(Cruciferaceae) 
Whole plant Facilitate labor & antidiabetic activity. M, S 14, 29 
Brassica rapa L. - Whole plant As aphrodisiac. 
 
S 15 
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Diplotaxis acris (Forssk) Boiss Fegl 
Algabal 
Brassicaceae 
(Cruciferaceae) 
Leaves Antidiabetic & wound healing. S 15 
Diplotaxis harra L. Harra Whole plant Antimicrobial. S 15 
Eruca sativa L. Rocka Seeds Used in ringworm. M, S 14 
Farsetia aegyptiaca Turra. Jarbaa Whole plant Antirheumatic. W, S 13, 14 
Farsetia longisiliqua Decne - Whole plant Central nervous system depression. S 19 
Lepidium aucherii L. - Whole plant For hypertension & cardiac stimulant. S 19 
Lepidium draba L. - Whole plant Central nervous system stimulation & 
antimicrobial. 
S 19 
Lepidium sativum L. Thuffa, 
Rashad 
Leaves & 
seeds 
Used for aches and pains, emollient, 
antifungal & for measles. 
S 30, 21 
Morettia parviflora L. - 
 
Whole plant Antimicrobial. S 15 
Nasturtium officinale R.Br. Jarjir Whole plant, 
leaves & roots 
Diuretic, digestive, herpetic eruptions, 
jaundice & renal disease. 
- 20 
Notoceras bicorne L.  - Whole plant Antimicrobial. S 19 
Savignya parviflora L. - Whole plant Central nervous & cardiac systems 
stimulant. 
S 15 
Schimpera arabica L. - Whole plant Cardiac stimulant. S 19 
Sisymbrium irio L. - Seeds Antipyretic. S 18 
Zilla spinosa Prant L. Shibrim Leaves  Purgative but toxic at high dose. S 14 
Commiphora Africana L. - Burseraceae Whole plant Anticancer & anti-inflammatory. S 21 
Commiphora habessinica  Mrr Resins Used for chest pain & as antiinfective. - 21 
Commiphora molmol (Engl.) - Barks Treatment of snake bites. 
 
- 17 
Commiphora myrrha (Nees) Engl. Myrrha Resins Antimicrobial, antiseptic, astringent, 
carminative, disinfectant, antileishmania 
& expectorant. 
 
S 15, 27 
Commiphora opobalsamum L. 
 
- Whole plant Antimicrobial. S 19, 15 
Opuntia ficus-indica Mill. Barshoom Cactaceae Succulent Treatment for pimples & skin problems. 
 
S 15, 16 
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Tamarindus indica L. 
 
Tamr-Hindi Caesalpinaceae Fruits Headache, jaundice, relieve stomach 
problem, antihypertensive, wound 
healing & antiemetic. 
S 115 
Celtis Africana N.L.Burm, - Cannabaceae Leaves & 
stems 
Antirheumatic, toothache & anticancer. - 24 
Cadaba farinose Forssk. Asaf Capparaceae 
(Capparidaceae) 
Whole herb Purgative, anthelmintic, emmenagogue 
& aperient. 
S 8, 24 
Leaves A remedy for dysentery, fever, cough & 
lungs problem. 
Cadaba glandulosa Forssk. Qormot Leaves & 
stems 
As anthelmintic. - 24 
Capparis cartilaginea Shafallah Whole plant  Disinfectant, anti-inflammatory, wound 
wash, antitumor, tonic & purgative. 
 
M, S 12, 15 
Capparis decidua Tandhab Whole plant Antirheumatic, astringent, cough, 
tremor, wound, sedative, vermifugal, 
antidiabetic & gout. 
M, W, S 12, 13, 15, 31 
Capparis spinosa Kabar Roots, barks 
& leaves 
Aperient, tonic, diuretic, antidiabetic & 
expectorant. 
 
M, W, S 12, 13, 15, 31 
Dipterygium glaucum Alqa Leaves Expectorant, analeptic & stimulant. M, S 12, 15 
Maerua crassifolia Sarh Leaves Used in toothache & intestinal disease. W, S 8, 13 
Maerua oblongifolia Maru Whole plant Hypocholesterolemic. S 8 
Dianthus deserti Alhilba Caryophyllaceae Roots Used for sprains. 
 
W 13 
Polycarpaea repens Rokeka Whole plant Used as antidote against snake bites. W, S 13, 15 
Catha edulis Forsk. Khat Celastraceae Leaves Central nervous system stimulant & 
treatment for diabetic. 
S 16 
Moytenus ovatus 
 
Hurgran Leaves Used for stomach problems. W, S 13, 20 
Anabasis articulate L. - Chenopodiaceae Whole plant Cardiac stimulation & antihypertension. 
 
 
S 19 
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Anabasis setifera Moq. Himd Chenopodiaceae Leaves   Antidepressant.  M, S 14, 15 
Atriplex halimus L. Rughl Seeds Emetic. W 13, 20 
Beta vulgaris - Roots Headache, toothache, liver pain, burns, 
constipation, emmenagogue, purgative, 
eye inflammation, itch, scurf & dandruff, 
tumor, leukemia, anemia, snake bite, 
vermifugal & antirheumatic. 
M 12 
Brassia eriophora - Whole plant & 
seeds oil 
Antirheumatic, snake bite & vermifugal. M 12 
Brassia muricata - Whole plant & 
seeds oil 
Kidney diseases, antirheumatic & ulcer 
gargle. 
M 12 
Chenopodium album L. Atrah Leaves & 
fruits 
Postnatal problems. W, M, S 13, 14, 15 
Chenopodium ambrosioides L. - Leaves Used as treatment for scorpion sting. - 17 
Chenopodium murale L.  AlZorbiah, 
Jkheara 
Whole plant & 
Flowers 
Stomachache, leishmaniasis, antitumor 
& antihypertension. 
M, W, S 12, 13, 15, 32 
Cornulaca monacantha Delile Had Leaves Used for liver problems, jaundice & 
purgative. 
W, S 13, 15 
Haloxylon salicornicum Ramath Whole plant Antidiabetic & used for cold. W, M, S 13, 14, 15 
Kochia indica - Whole plant Heart tonic. M 12 
Salsola imbricate Kha,reet Whole plant Anthelmintic. M, S 14, 15 
Seidletzia rosmarinus Bunge ex Boiss Ushnan. Leaves Antimicrobial. S 19 
Suaeda vera L. - Whole plant Cardiac stimulant. 
 
S 15 
Ceratophyllum demersum L. - Ceratophyllaceae Whole plant Treatment for scorpion sting. - 17 
Cleome amblyocarpa  Khunayzah Cleomaceae Whole plant Antimicrobial. W, S 13, 15 
Cleome arabica Zafrah-
Amal 
Leaves Tonic, stimulant, appetizer, purgative & 
for panicula. 
M, S 12, 15 
Cleome brachycarpa Birbran Whole plant Itching, antirheumatic, inflammation, 
leukoderma & skin disease. 
 
M, S 12, 15 
Cleome chrysantha Safaira,a Whole plant Anthelmintic & antiseptic. 
 
S 8 
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Cleome gynandra L. - Cleomaceae Whole plant Treatment for scorpion sting. - 17 
Cleome viscosa L. Om-Hanif Whole plant Carminative, anthelmintic & 
rubefacient. 
S 8 
Hypericum chrysostrictum L. - Clusiaceae Whole plant Central nervous system depression & 
antimicrobial. 
S 19 
Commelina benghalensis L. - Commelinaceae Whole plant Treatment for scorpion sting. - 17 
Convolvulus arvensis L. Olaique Convolvoulaceae Leaves & 
fruits 
Foot cracking. W, M, S 13, 14, 15 
Convolvulus fatmensis Al-oleeq Leaves Anti-inflammatory. S 15 
Convolvulus hystrix - Whole plant Antimicrobial. S 15 
Convolvulus oxyphyllus - Whole plant Cardiac depression. S 15 
Convolvulus pilosellifolius - Whole plant Antimicrobial. S 15 
Cressa cretica Naduoh Whole plant Digestive, tonic, vermifugal, 
antiasthmatic, tuberculous, hematonic, 
CNS depressant & appetizer. 
M, S 12, 19 
Evolvulus alsinoides L. - Whole plant Treatment of scorpion sting. - 17 
Ipomoea aquatic Forssk. - Leaves Treatment of scorpion sting. - 17 
Ipomoea eriocarpa R.Br. - Leaves Treatment of scorpion sting. 
 
- 17 
Citrullus colocynthis L. Hunzal Cucurbitaceae Roots, seeds 
& fruits 
Used as diuretic, emetic, expectorant, 
purgative, jaundice, ascites, analgesic, 
anesthetic, anti-HIV, antiaging, allergy, 
antiasthmatic, antibacterial, antidiabetic, 
sedative, antihemolyteic, antimalaria, 
antimitotic, antioxidant, antiscorbutic, 
antiseptic, antitumor, carminative, 
fungicide, herbicide, insecticide, 
laxative & lubricant. 
 
M, W, S 12, 15 
Coccinia grandis L. 
 
Bakhra,a Leaves Treat earache & for scorpion sting.  
 
 
 
S 16, 17 
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Cucumis melo Shamam Cucurbitaceae Leaves & 
fruits 
Astringent, demulcent, laxative, 
antipyretic, jaundice & renal calculi. 
- 20 
Cucumis prophetarum Shree- 
Elzeeb 
Roots, seeds 
& fruits 
Sexual diseases, liver diseases, 
stomachache, demonomania, emetic, 
antimicrobial & purgative. 
M, S 12, 15 
Kedrostis foetidissima Jacq. Cong. - Leaves  Used for warts. S 25 
Momordica balsamina L. Madoda Whole plant Antimicrobial. S 19 
Juniperus polycarpos L. - Cupressaceae Whole plant CNS stimulant & antimicrobial. S 15 
Juniperus procera Arar Leaves Gout, jaundice & cure wounds.  
 
S, W 33 
Fruits The smoke of fruiting branches used as 
antirheumatic, headaches & skin 
diseases. 
Twigs & buds 
& small 
branches 
Intestinal worms and a decoction of dry 
young branches is used as medicine 
against itch of camels. 
Resin Stimulant and for treatment of ulcers and 
liver diseases. 
Cuscuta campestris - Cuscutaceae Whole plant Purgative & constipation. M 12 
Cynomorium coccineum L. Tartooth Cynomoriaceae Whole plant Astringent, aphrodisiac, laxative & 
tonic. 
M 12, 15 
Cyperus longus L. - Cyperaceae Whole plant Treatment of scorpion sting. - 17 
Cyperus rotundus L. Alsaad Whole plant Treatment of scorpion sting. W 13, 17 
Ephedra alata L. (female) - Ephedraceae Whole plant Central nervous system stimulant & 
antimicrobial. 
S 19 
Acalypha ciliata Forssk - Euphorbiaceae Leaves Antimalaria, anti-scabies & 
anthelmintic. 
S 25 
Acalypha fruticosa Forssk Zohar Leaves Used for treating bee stings. S 15 
Acalypha indica L. Thfelan Whole plant Used for cure from bronchitis, 
pneumonia & asthma. 
S 15 
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Andrachne aspera Spreng. var. 
glandulosa A.Rich 
Kamas Euphorbiaceae Whole plant Used in eye problems & for eye wash. S 9 
Chrozophora oblique L. - Whole plant Antimicrobial. S 15 
Chrozophora oblongifolia (DC.) A. 
Juss. ex Spreng 
Tannoum Whole plant Antimicrobial, cathartic & emetic. S 15 
Chrozophora plicata (Vahl) A. Juss Tanoom Whole plant Depurative & purgative. S 8, 18 
Leaves Used for the cure of leprosy. 
Clutia lanceolata Forssk. Laukh Whole plant Hypoglycemic. S 9 
Croton lobatus L. - Leaves Used as treatment of scorpion sting. - 17 
Euphorbia arabica Hochst. - Whole plant Used in skin infection. S 34 
Euphorbia cuneate Vahl. AL-baky Whole plant Sedative & antimicrobial. W, S 13, 9 
Euphorbia cyparissioides L. - Whole plant Antimicrobial. S 19 
Euphorbia dracunculoides Lam. Yaktin Leaves & 
fruits 
Purgative, intestinal disorders, antitumor 
& wart remover. 
M, S  12, 8 
Euphorbia granulate Forssk.  
 
 
Lebbein Whole plant Blood purifier, diuretic, purgative & 
vermifugal. 
M, W, S 12, 13, 53 
Latex 
 
Used as purgative. 
Euphorbia helioscopia L. Emaiah Whole plant Purgative, ulcer, antirheumatic, 
vermifugal, cholera, cancer, 
anthelmintic, catarrh & eruptions, 
neuralgia. 
 
M, S 8, 12 
Euphorbia hirta L. - Whole plant Antiasthmatic, antiasthmatic & 
bronchitis. 
 
S 15 
Euphorbia peplus L. 
 
 
 
Khaneez 
 
Whole plant Antihypertension. W, S 13, 15 
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Euphorbia retusa Forssk. Ghazalah Euphorbiaceae Whole plant  Antitussive, antiasthmatic & mentalia 
disorders. 
M, S 12, 14, 15 
Latex Eczema, wound healing & for 
leishmaniasis. 
Euphorbia schimperiana Scheele. Saibarisodis Whole plant Antitussive, antiasthmatic, earache, skin 
infections & snake bites. 
S 35 
Euphorbia scordifolia Jacq. Rummid Whole plant Antipyretic & constipation. 
 
S 34 
Euphorbia terracina L. Harmal Whole plant Used as a remedy for fever & paralysis. S 34 
Jatropha curcas L. Kharat Leaves Used in wounds, eczema & scabies. 
 
S 9 
Jatropha glauca Obeeb Whole plant Treatment of chronic skin diseases. S 9 
Jatropha pelargoniifolia Obab Whole plant & 
petioles 
The sap of the petiole is applied to ulcers. S 15 
Phyllanthus maderaspatensis L. Tamarhindi Leaves Used for headache. S 8 
Ricinus communis L. Kharwah Whole plant Treatment of scrofulous sores, boils & 
rheumatic swellings 
W, S 13 
Acacia arabica L. - Fabaceae 
(Leguminosae) 
Bark, gum, 
leaves, seeds 
& fruits 
 
Nutritive, expectorant, antihemorrhagic, 
diarrhea, cough, blennorrhagia, 
mouthwash, astringent, dysentery, 
gargle, tonic, inflammation of urinary 
tract, hemorrhagic, transudation, 
aphrodisiac & diabetes. 
S, M 18, 12 
Acacia ehrenbergianan Salam Wood Used to treating paralysis. - 20 
Acacia farnesiana 
 
 
 
 
 
- 
 
Whole plant Vermifugal, dysentery, mouth wash, 
blood diseases, antipruritic, ulcers, 
leukoderma, catarrh, vulvovaginitis, 
astringent, demulcent, aphrodisiac, 
antispasmodic & insecticidal. 
M 12 
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Acacia gerardi Benth. Karat 
 
Fabaceae 
(Leguminosae) 
Resin & pods Used for burns, toothache & antipyretic. - 20 
Acacia seyal Talh Barks, gums 
& seeds 
Astringent, cold, ophthalmia, diarrhea, 
haemorrhage & leprosy. 
M 12 
Acacia negrii Pichi. Salam Leaves Treat eye diseases. S 16 
Acacia oerfota Forssk. - Whole plant Treatment of scorpion sting. - 17 
Abrus precatorius L. Habb 
shoush 
 
 
Root Used to treatment of scorpion sting, 
emetic, eye disease & purgative. 
- 17, 20 
Albizia lebbeck - Fruits & stems Used for snake bites, mouthwash, 
antiparalysis, night blindness, astringent, 
diarrhea, dysentery, gonorrhea & 
swelling of cervical glands. 
M 12 
Alhagi graecorum Boiss Aqool Whole plant Analgesic, antitussive, antihemorrhoids, 
anti- rheumatic, aphrodisiac, diuretic & 
laxative. 
S 15 
Alhagi maurorum Medic. Al-Agool Leaves Antioxidant & analgesic. S 15 
Alhagi melorum - Whole plant Antipyretic, digestive, tonic, purgative, 
diuretic & catarrh. 
M 12 
Astragalus atropilosus - Leaves For backache. S 15 
Astragalus mareoticus - Leaves Treatment of scorpion sting. - 17 
Astragalus sieberi - Whole plant Antihypertension. S 19 
Astragalus spinosus (Forssk.) Muschl. Katad Whole plant Treat leukemia & promote wound 
healing. 
W, S 13, 15 
Astragalus tribuloides - Seeds Anti-esophagitis, anti-enteritis & peri 
colitis. 
M 12 
Cassia holosericea - Leaves & 
fruits 
Tonic for digestive system, flatulence & 
purgative. 
M 12 
Cassia senaa L. Senna Whole plant Antimicrobial, laxative & purgative. 
 
S 19, 16 
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Cassia italic Mill.  Ishriq Fabaceae 
(Leguminosae) 
Leaves Laxative, treating influenza and other 
respiratory disease & urinary tract 
purifier. 
M, S 15, 16 
Cicer arietinum L. Himas Seeds Used in abortion, cure ulcer, antitumor, 
anti-scabies, for pimples, toothache, 
oedemas, renal calculi, aphrodisiac & 
diuretic. 
- 20 
Clitoria ternatea L. - Leaves, roots 
& stems 
Treatment of scorpion sting. - 17 
Crotalaria retusa L. - Stem Treatment of scorpion sting. - 17 
Delonix elata L. Ranf Leaves & 
seeds. 
Mosquito control agent. S 15 
Desmodium gangeticum 
 
- Roots Treatment of scorpion sting. - 17 
Dichrostachys cinereal L. - Roots & 
leaves 
Treatment of scorpion sting. - 17 
Glycyrrhiza glabra L. Irk al hiel Rhizomes Treating muscle pain & treatment of 
scorpion sting. 
S 17, 18 
Indigofera articulate Gouan. Khedaish 
 
 
 
 
 
Roots Relieve toothache. M, S 12, 18 
Whole plant Purgative, diuretic, lithotomy, 
antitoxicant, swelling of spleen, 
antitumor, antirheumatic, teeth 
protection & snake bite. 
Indigofera oblongifolia  Hasar Roots & 
Leaves 
Analgesic, remove hair dandruff & anti-
inflammatory. 
S 20 
Indigofera tinctorial L. - Whole plant Treatment of scorpion sting. - 17 
Lablab purpureus L. Lablab Roots Laxative, diuretic & regulate 
menstruation. 
S 20 
 176 
 
 
 
 
 
Table 1S: Cont. 
Scientific name Local name Family Part used Traditional uses Region  Reference 
Medicago sativa L. Jat Fabaceae 
(Leguminosae) 
Leaves Used for bone fracture, bruises reliever 
& used as an aphrodisiac. 
S 20 
Melilotus albus Medik. Otrah Whole plant Astringent & as antirheumatic. W, S 20 
Melilotus indicus L. Handaquq Whole plant Emollient. 
 
- 20 
Melilotus officinalis Iklilulmalik Flowers, stems 
& roots 
Diuretic, scabies, boils, wounds, for 
edema, insomnia & colic. 
S 20 
Ononis serrate L. - Whole plant Antimicrobial. S 19 
Prosopis cineraria L. Ghaf Whole plant Treatment of scorpion sting. 
 
- 17 
Prosopis juliflora L. - Whole plant Antiprotozoal. 
 
S 18 
Psoralea plicata L. - Whole plant Antimicrobial. 
 
S 19 
Raetam ratam L. - Whole plant Anticancer & anti-inflammatory. S 27 
Senna alexandrina Mill. Sana Leaves & 
fruits 
Stimulant laxative & cathartic. S 15 
Senna italic Mill. Sana-mekki Leaves & 
fruits 
For elephantiasis & ophthalmic diseases. M, W, S 12, 13, 15 
Taverniera lappacea L. - Whole plant Central nervous system stimulation & 
antimicrobial. 
S 15, 19 
Tephrosia apollinea Del. Dhafran Whole plant Antihypertension & cardiac stimulant. S 15, 19 
Tephrosia nubica ssp. Arabica (Boiss.) 
Gillet. 
- Whole plant Antihypertension & cardiac stimulant. S 15 
Tephrosia purpurea Sakhal Seeds Relieve urinary tract problems. S 16 
Trigonella anguina L. Nafel Whole plant Antimicrobial. S 19 
Trigonella foenum-graecum L. Helba Seeds Relieve upset stomach. S 16 
Trigonella stellate Forssk. Girgas Whole plant Hair diseases. N 14 
Frankenia pulverulenta - Frankenaceae 
 
 
Whole plant Carminative & analgesic. 
 
 
M 12 
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Fumaria parviflora Humaida Fumariaceae Whole plant Digestive, increase biliary secretion, 
antipyretic, antitoxic, hematonic, 
diuretic, appetizer, blood purifier, skin 
diseases, spleen disorder, purgative & 
antiemetic. 
 
M 12 
Geranium trilophum Boiss. Zahra,a Geraniaceae Whole plant Relieve backache. 
 
S 16 
Avena sativa L. Shofan Gramineae 
(Poaceae) 
Colloidal oat 
extract. 
Skin diseases. S 8 
Chloris virgata - Whole plant Tonic. 
 
M 12 
Cutandia memphitica L.  - Whole plant Central nervous system stimulant & 
antimicrobial. 
S 15 
Cymbopogon schoenanthus L. El-lemad Whole plant Antipyretic, colic, antispasmodic, 
hypotension, carminative, colic gripes, 
flatulence, polyarthritis, hysteritis, 
analgesic, sedative & expectorant. 
 
M, S 12, 15 
Cynodon dactylon Thail Whole plant, 
roots & juice 
Diuretic, astringent, ophthalmic 
disorders, hemorrhage, rhinorrhagia, 
dysentery, urinary tract inflammation & 
dysuria. 
M, W, S 12, 13, 14, 15 
Dactylotenium aegyptium Bahma Whole plant & 
seeds 
Analgesic & wound sepsis. M, S 12, 14, 19 
Echinochloa colona - Whole plant Digestive, constipation, treatment of 
scorpion sting & increase bile secretion. 
M, W 12, 17 
Eleusine indica - Whole plant Antispasmodic, antipyretic &liver 
diseases. 
 
M 12 
Heteropogon contortus L. 
 
  
- Whole plant Treatment of scorpion sting. - 17 
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Imperata cylindrica   Halfa Gramineae 
(Poaceae) 
Roots, 
flowers, 
branches, 
young buds 
Antipyretic, diuretic, hemorrhagic, 
hemolysis, rhinorrhagia, carminative, 
astringent, tonic, emollient, hematuria, 
hematemesis, edema, jaundice, 
antibacterial, cancer & tonic. 
M, W 12, 13 
Panicum turgidum Forssk. Tammam Whole plant Eye infection. W, M, S 13, 14, 15 
Phragmites australis Cav. Hajna Whole plant Used as antiemetic & antipyretic. - 20 
Setaria viridis (L.) P. Beauv. - Leaves Treatment of scorpion sting. - 17 
Ribes nigrum L. - Grossulariaceae Fruits For throat inflammation & respiratory 
tract ailment. 
- 24 
Iris germanica L. - Iridaceae Roots For treatment of cancer, inflammation, 
bacterial & viral infections. 
- 24 
Lanata camara L. 
 
- Labiatae 
(Lamiaceae) 
Whole plant Antipyretic, antimicrobial & 
antimutagenic. 
S 15 
Lavandula coronopifolia  Dikta Whole plant Antibacterial. S 9 
Lavandula dentata L. Dhurum Leaves & 
flowers 
Used in headache, relieve rheumatic pain 
& cold.  
 
W, S 13, 16 
Lavandula pubescens Decne. Attan Leaves & 
flowers 
For cold & headache. W, S 16 
Lavandula stoechas subsp. Stoechas 
 
 
 
Lavender 
 
 
Whole plant antiseptic, antispasmodic, digestive, 
expectorant & antiasthmatic. 
S 9 
Marrubium vulgare L. Frasyoon Whole plant Used for the treatment of coughs, and 
chronic bronchitis, dyspepsia, jaundice 
amenorrhea, rheumatism & hepatitis. 
W, S 13, 19 
Mentha lavendulaceae Willd. Niena,a Whole plant Analeptic & carminative. 
 
S 15 
Mentha longifolia L. Haback Leaves Used for headache, antipyretic, 
menstrual cramps & anti-infective. 
 
 
W, S 13, 16 
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Mentha microphylla C. Koch Niena,a,  
bariniena,a 
Labiatae 
(Lamiaceae) 
Whole plant Analeptic, appetizer & carminative. W, S 13, 34 
Meriandra benghalensis Benth. Dharah Leaves Used for headache, joint ache & muscle 
pain & skin problems. 
S 16 
Nepeta deflersiana Shya,a Leaves Relieve stomach ache, antimicrobial & 
in burns. 
S 16, 19 
Ocimum americanum L.  Sims Leaves Used in parasitic skin disease. S 15 
Ocimum basilicum L. Rayhan Leaves  Allay upset stomach ache, cold & in 
fever. 
W, S 13, 16 
Ocimum tenuiflorum L. Shajrat-
azzir 
Whole plant Snake bites & scorpion sting. S 15 
Leaves Used in cough & bronchitis. 
Origanum majorana L. Bardakush Whole plant Used in asthma, cough, indigestion, 
rheumatism & headache. 
S 9 
Origanum syriacum L. Al-barda 
 
Leaves Antitussive & anti-inflammatory. S 15 
Oriranum syriacum var. bevanii L Oregano Whole plant Treating tooth decay, gum infections & 
cough. 
S 15 
Otostegia fruticose Forssk. Shakab Leaves & 
flowers 
Irritation of eye, as remedy for sun stroke 
& for gout. 
 
W, S 15, 16 
Plectranthus asirensis Shar 
Elkrood 
Leaves Used to treat diaper rash & itching. S 16 
Plectranthus barbatus Andres. Shar 
Elkarood 
Leaves As deodorant. S 15 
Plectranthus cylindraceus Khurub Whole plant A remedy for sore throat. 
 
S 15 
Plectranthus tenuiflorus  Shar 
 
Leaves Used for earache. S 16 
Rosmarinus officinalis L. Eklel 
Aljabal 
Whole plant Antifungal. S 15 
Salvia aegyptiaca Ghashba Whole plant Eye diseases, diarrahoea & 
blennorrhagia. 
W, M, S 8, 12 
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Salvia lanigera L. Jurayba Labiatae 
(Lamiaceae) 
Whole plant Carminative & used in indigestion. S 34 
Salvia spinose L. Harsha Seeds Used for the cure of toothache, 
gonorrhea & urethritis. 
S 8 
Stachys Sp. Aff. Schimperi Vatke - Whole plant Strong antimicrobial activity. S 19 
Teucrium oliverianum Ging.  Qassapa Whole plant Diabetes. M, S 14, 15 
Teucrium polium L. Jaada Whole plant Treat liver disease, jaundice, diabetes, 
fertility problems & cancer. 
W, S 36 
Teucrium yemense Defl. Rechal 
Fatimah 
Whole plant Used as anti-diabetic & in kidney 
problems. 
 
S 15 
Thymbra spicata subsp. Spicata L. Za,atar Whole plant Antimicrobial. S 15 
Thymus decussates Benth. Za,atar Whole plant Antiemetic. 
 
S 15 
Thymus vulgaris L. 
 
 
 
 
Za,atar Whole plant Antiseptic, anthelmintic, expectorant, 
carminative, diuretic, sedative, used in 
veterinary medicine. 
S 15 
Allium ampeloprasum 
 
- Liliaceae Leaves Antimicrobial. S 15 
Allium cepa Basl Bulb Diabetes, colic gripes, flu, catarrh, 
bronchitis, ulcers, dysentery, 
antiepileptic, rhinorrhagia, jaundice, 
diuretic, ophthalmia & demonomania. 
M 12 
Allium sativum 
 
 
 
Thom Bulb Antiasthmtic, increase blood circulation, 
muscle relaxation, diabetes, catarrh, 
bronchitis, flu, dysentery, hypertensive, 
urinary tract inflammation, liver 
diseases, antirheumatic, diuretic, 
emmenagogue, diarrhea & antiemetic. 
 
M 12 
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Asparagus africanus Lam. Khurus Liliaceae Leaves Relieve breathing problems. W, S 16, 15 
Cinnamon zellanicum L. 
 
Qerphah Lauraceae Whole plant Antimicrobial. S 15 
Linum usitatissimum L. Hab kattan Linaceae Seeds Constipation, painful joint, urinary 
disorder & venereal diseases. 
- 20 
Lawsonia inermis L. Henna Lythraceae Branches, 
leaves, flowers 
& young buds 
Gargle, spleen tumor, skin diseases, hair 
tonic, headache & jaundice. 
M, S 12, 16 
Syzygium aromaticum L. Mesmar Whole plant Treat toothache, respiratory disorders, 
inflammation & gastrointestinal 
disorders. 
S 18 
Abutilon pannosum G. Forst. - Malvaceae Whole plant Antimicrobial. S 19 
Gossypium barbadense L. Khutin Seeds Treatment for earache. S 16 
Hibiscus europaeum L. Raein 
 
 
Whole plant Antimicrobial S 15 
Hibiscus sabdariffa L. Karkeda Whole plant Antihypertension, reduce the testicular 
damage & ameliorate the drop-in sperm 
quality. 
S 15 
Malva parviflora L. Khobaiza Whole plant Laxative & promotes hair growth. M, S, W 13, 14, 15 
Azadirachta indica A. - Meliaceae Whole plant  Antifungal. W, S 15, 30 
Cocculus hirsutus L. Hamr 
almajun 
Menispermaceae Leaves & 
roots 
Used as febrifuge, emetic, demulcent, 
for digestive problem & purgative. 
S 20 
Cocculus pendulus - Whole plant Antipyretic. M 12 
Albizzia lebbeck L. 
 
Lebbeck Mimosaceae Phloem Anthelmintic. M 12 
Dorstenia foetida Forsskal. Kartib Moraceae Seeds Stomach disorders. - 20 
Ficus carica L. Teen Leaves, fruits 
& latex 
Used for burns, leprosy, tonic & as 
diuretic. 
 
W 20 
Ficus palmata  Forssk. Hamat Latex Yogurt production. W, S 12, 16 
Ficus salicifolia Lithab Whole plant Leukoderma & eye wash. 
 
M, S 12, 19 
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Moringa peregrine Forssk. Habb 
Elyasar 
Moringaceae Seeds Analgesic, abdominal pain, burns, 
constipation, laxative & for headache. 
S 37 
Eucalyptus camaldulensis Dehnh. Khafour Myrtaceae Whole plant Abortion & perfume. M, S 14, 15 
Eucalyptus dives L. Eucalyptus Whole plant Strong antiseptic & antiviral activity. S 15 
Eucalyptus globules L. - Whole plant Antifungal. S 15 
Myrtus communis L. Hadas Leaves Used for abdominal colic, antipyretic, 
cough & as insecticidal. 
- 20 
Pimenta dioica L. - Whole plant Anti-inflammatory, analgesic & 
antipyretic. 
S 15, 38 
Boerhavia coccinea - Nyctaginaceae Roots Diuretic & urinary tract disorders. M 12 
Commicarpus grandifloras - Whole plant Strong antimicrobial activity. S 19 
Jasminum grandiflorum L. Anbar, 
Yasmin 
 
Oleaceae Leaves & 
flowers 
Treatment for dysentery, abdominal pain 
& colic. 
S 20 
Olea european L. Athm Twigs & 
branches 
Used as tooth brush & keeping gums 
healthy, liver diseases, ulcer, for edema 
& diabetes. 
W, S 13, 16, 20 
Epilobium hirsutum L. Saqalqurab Onagraceae Whole plant Central nervous system depression & 
antimicrobial. 
S 19 
Cistanche tubulosa Dhanun Orobanchaceae Leaves, stems 
& flowers 
Used for jaundice & diarrahoea. S, M 12, 21 
Lindenbergia sinaica L. - Whole plant Antimicrobial. S 19 
Eulophia petersii Reichb.f.  Iseb Orchidaceae Basal stem 
bulbs 
Used to treat skin problems. S 20 
Oxalis corniculate L. - Oxalidaceae Leaves & 
flowers 
Antiparasitic, antivertigo & mouth 
inflammation. 
S 25 
Argemone Mexicana L. Argemonia Papavaraceae Whole plant Antimicrobial. W, S 19 
Agemone ochroleuca Sweet 
 
- Whole plant Strong antimicrobial activity. W, S 19 
Papaver somniferum Schl. Hashish Capsules & 
seeds 
Antitussive & insomnia. S 15, 20 
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Sesamum indicum L. Gilgilan Pedaliaceae Seed oils Used as treatment for dysentery, colic & 
urinary problems. 
S 20 
Plantago ammplexiculis Cav. Rabal Plantaginaceae Whole plant & 
leaves 
Renal disease & urinary tract purifier. M, S 14 
Plantago coronopus L. Rebla Whole plant Used as laxative & wound healing. - 20 
Plantago major L. Lisan 
Alkalb 
Leaves & 
seeds 
Used for diarrhea, dysentery, ulcer & 
abscesses. 
- 20 
Plantago ovata Forssk. Geneima Seeds Used as a laxative, an emollient, 
demulcent and astringent & particularly 
in chronic colitis. 
S 15 
Limonium axillare Forssk. Kattaf Plumbaginaceae Whole plant Central nervous system depression & 
antimicrobial. 
 
S 15 
Plumbago zeylanica L. Ensain Whole plant Antirhumatic, dysmenorrhea, 
carbuncles, contusion of the extremities, 
ulcers & elimination of intestinal 
parasites. 
S 15 
Calligonum comosum L. Arta,a Polygonaceae Whole plant  Anti-inflammatory & antiulcer activity. S 15 
Emex spinous L. Hambazz Whole plant Purgative, diuretic, digestive, appetizer, 
stomach troubles & anthelmintic.  
M, S 12, 15, 18 
Polygonum argyrocoleum Steud. Abuzalaf Whole plant Used in stomach troubles. S 34 
Rheum palmatum L. - Roots & 
Rhizomes 
Antimicrobial. S 15 
Rumex nervosus Vahl. Ithrib Leaves & 
roots 
Edible plant, diabetes, skin burns, 
inflammatory diseases, diarrhea, 
wounds, typhus, rabies, skin disorders. 
diuretic, gonorrhoea, lung tuberculosis, 
leprosy, antipyretic, liver disease, 
hypertension, haemorrhoids, scabies, 
antiemetic, aphrodisiac, cough, for 
rabies, antirheumatic & antimigraine. 
 
S, M 16, 12 
Rumex pictus Forssk. Hamsees 
 
 
Whole plant Sedative, relieve spasm & antimicrobial. S 9, 15 
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Rumex steudelii Tabal Polygonaceae Whole plant Remedy for abdominal pains due to 
intestinal worms. 
S 15 
Rumex vesicarius L. Hammaad Whole plant Used for toothache. W, M, S 13, 14, 15 
Seeds For the cure of dysentery. 
Portulaca oleracea L. Regla Portulacaceae Whole plant Anti-inflammatory, antidiabetic and for 
cold. 
W, M, S 13, 14 
Portulaca quadifida L. - Stems Treatment of scorpion sting. - 17 
Anagallis arvensis L. Ayn Algat Primulaceae Whole plant Used for skin rash & ulcers. 
 
- 20 
Punica granatum L. Ruman Punicaceae Fruits Dysentery, microbial infection, diarrhea, 
haemorrhage & respiratory 
pathogenesis. 
- 24 
Clematis simensis Fresen. Haya,a Ranunculaceae Leaves Relieve rheumatic pain. 
 
S 19 
Clematis wightiana L. - Whole plant Cardiac depression & antimicrobial.  
 
S 19 
Nigella sativa L. Habbatus 
sauda 
Whole plant Carminative, mucolytic, anti-ulcers, 
anti-diabetes, antidote, antiasthmatic, 
hypertension, hepatoprotective, 
antiobesity, migraine, haemorrhoid & 
expel rodents. 
 
S 20 
Reseda muricate Presl. Danban Resedaceae Fruit Menstruation tonic. 
 
M, S 14 
Ochradenus arabicus L. Kardey Whole plant Hypoglycemic activity. 
 
W, S 13 
Ochradenus baccatus Del.  
 
Ghorzaa Whole plant Backache, fistula & antimicrobial. W, M 13, 14 
Zizyphus nummularia L.  Zyzafun Rhamnaceae Whole plant Antispasmodic, emollient, antitussive, 
anti-poison, laxative & skin eruption. 
 
 
 
S 20 
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Ziziphus spina-christi L. Sidr, Nubak Rhamnaceae Whole plant & 
bark 
Duodenum and stomach ache, remover 
dandruff, weaknesses, diabetes, 
pharyngitis, bronchitis, anemia, diarrhea, 
skin infections, antipyretic, sleep 
irritability, liver problems, digestive 
disorders, antimicrobial, anti-
inflammatory, antiulcer, antitumor & 
cardiovascular disorders 
W, M, S 13, 14 
Amygdalus arabica L.  - Rosaceae Whole plant Antimicrobial. S 19 
Cotoneaster nunnularia - Whole plant Purgative, antiflatulence, expectorant, 
appetizer, digestive, antitussive, aperient 
& stomachic. 
M 12 
Prunus amygdalus L. - Whole plant As aphrodisiac. S 15 
Rosa abyssinica Lindley. Aball Whole plant Antimicrobial. S 19 
Coffea arabica L.  Bun Rubiaceae Seeds Relieve stomachache, colds, cough, 
antipyretic & toothache. 
S 16 
Haplophylum tuberculatum Forssk. - Rutaceae Whole plant Used in liver disease S 34, 39 
Leaves Used as sedative, treatment of scorpion 
sting & strengthen week muscle. 
Ruta chalepensis Shathab Leaves & 
stems 
Relieve snake bite, headache, sore ears, 
rheumatism & wound healing. 
S 16 
Salvadora persica L. Miswak Salvadoraceae Whole plant Used as toothbrush & treatment of 
scorpion sting. 
S 15, 17 
Dodonaea viscosa Jacq, Shath Sapindaceae Leaves Used for treating chronic ulcers, burns & 
leishmaniasis. 
 
S 15, 40 
Monotheca buxifolia Falc. But Sapotaceae Ripe barriers General tonic. 
 
S 15, 21 
Schweinfurthia pterosperma  
 
 
- Whole plant Antimicrobial. 
 
 
 
S 15 
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Striga hermonthica Del.  Doosh, 
Odaar 
Scrophulariaceae 
 
Flowers Used for irritating & infected eyes. 
 
 
S 16 
Verbascum bottae Deflers. - Leaves & 
flowers 
Antitussive, skin disease & 
antirheumatic.  
 
S 15, 25 
Datura fastuosa Benj, Mang Solanaceae Roots, leaves, 
seeds & 
flowers 
Antispasmodic, antiepileptic, headache, 
eye and ear diseases, epilepsy, madness, 
astringent, anthelmintic, parasiticide, 
narcotic, emetic, tuberculosis & 
antiasthmatic, antirheumatic. 
 
M 12 
Datura innoxia Binj Leaves & 
seeds 
Colic gripes, carminative, antiasthmatic, 
antitussive, antitumor, hysteria, 
antirheumatiod, emmenagogue, flu, 
headache & anesthetic. 
 
M, S, W 12, 13, 15 
Datura metel L. Binj Leaves, 
flowers & 
seeds 
Antiasthmatic, inflammation, 
antirheumatoid, earache & eye diseases. 
S, M 12, 15 
Datura stramonium L. Binj-daturah Leaves, roots, 
stems & seeds 
Antirheumatic, antiasthma, antitussive, 
bronchitis, earache, hair fall & treatment 
of scorpion sting. 
 
S, W 15, 13, 17 
Hyoscyamus albus L. - Whole plant Used as treatment for scorpion sting. 
 
- 17 
Hyoscyamus muticus L. Asakran Leaves, 
flowers & 
buds 
Antitussive, expectorant, antiasthmatic, 
carminative, sedative, antispasmodic, 
sea sickness & toothache. 
M 12 
Hyoscyamus pusillus L. Babekh 
Safaree 
 
Seeds Toothache. 
 
 
 
S, M 12, 15 
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Lycium shawii Roem. Awsag Solanaceae Fruits Mouth ulcers. S, W, M 13, 14, 15 
Nicotiana rustica L. Al-tabag Tobacco snuff Useful in nasal polyp, nasal catarrh, 
headache, chronic giddiness, fainting, 
rheumatic swellings & skin diseases. 
S 15 
Nicotiana tabacum L. - Leaves Used as treatment for scorpion sting. - 17 
Physalis minima L. - Whole plant Used in gonorrhea & earache. S 15 
Solanum anguivi Lam. - Stems Used as treatment for scorpion sting. - 17 
Solanum careens L. - Whole plant Antimicrobial. S 15 
Solanum forskalii Dunal. Nashbah Whole plant Used for treating ulcers. W, S 13, 15 
Solanum glabratum Dunal. - Leaves & 
fruits 
Diuretic, for scabies, cough & 
hemorrhoids. 
 
S 15 
Solanum incanum L. Aeen 
Elbagar 
Fruits Antimicrobial. W, S 13, 41 
Solanum nigrum L. Enab-
Alzeeb 
 
 
Whole plant Used in jaundice, antipyretic, gonorrhea, 
diarrhea, heart diseases, inflammation, 
edema, mastitis & hepatic cancer. 
S 15 
Solanum surattense Burm.  f. Bankum-
Bakini 
Whole plant Antipyretic, antiasthmas, antitussive, in 
sexual diseases & to promote female 
fertility. 
S 34 
Solenostemma argel (Del.) Hayne. 
 
Al-Argal Leaves Antirheumatic & antitussive. S 15 
Withania somnifera L. 
 
 
 
 
Sem-alfaar 
 
 
 
 
 
 
Leaves Used in ulcers. 
 
W, M, S 13, 14, 17 
 
 
 
 
Whole plant 
 
 
Antirheumatic, dyspepsia, appetizer & 
for edem. 
Roots Used as tonic for uterus of women after 
habitual miscarriage. 
 
Stems 
 
Used as treatment for scorpion sting. 
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Tamarix amplexicaulis L. - Tamaricaceae Whole plant & 
roots 
For central nervous system depression, 
cardiac stimulation & antimicrobial. 
S 19 
Tamarix aphylla L. 
 
 
Athel Leaves & 
roots 
Wound infection & stomachache. W, M, S 13, 14 
Tamarix nilotica Ehrenb. 
 
 
Tarfaa Leaves & 
seed,s oil 
Used for leg varices. M, S 14 
Gnidia somalensis Franch. 
 
Barha Thymelaceae Leaves As emetics & purgatives. S 21 
Grewia tenax Forssk. Khadar Tiliaceae Wood & barks Antitussive, analgesic, central nervous 
system depression & antimicrobial. 
M, S 12, 15 
Triumfetta flavescens L. - Whole plant Central nervous system stimulant & 
cardia stimulation. 
S 19 
Typha domingensis (Pers.) Poir. Pardey Typhaceae Whole plant Cardiac depression. 
 
S 19 
Forsskalea tenacissima L. Lussaique Urticaceae Whole plant Used for ulcers M, W 14, 13 
Urtica urens L. Hurraikha Leaves Used for muscle pain & antirheumatic. S 16 
Lantana petitiana Saaf Verbenaceae Leaves & 
roots 
Used for abdominal colic. - 21 
Phyla odiflora L. - Leaves Used as treatment for scorpion sting. - 17 
Cissus rotundifolia L. Ghalaf Vitaceae Whole plant Heated plant used to relieve backache. S 16 
Cyphostemma ternatum Kum Leaves & 
stems 
Used to treating infections. - 21 
Alpinia galangal L. - Zingeberaceae 
 
Rhizomes Used against kidney stones. S 23 
Alpinia officinalis L. - Roots & 
rhizomes 
Antirheumatic & children whooping 
cough. 
 
S 15 
Curcuma longa L. Kurkum 
 
 
Rhizomes Skin disorders, bronchitis, antitussive & 
eye infections. 
S 15 
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Zingiber officinalis L.  Zingibil Zingeberaceae 
 
Rhizomes Hepatoprotective, clears vision, 
digestive, aphrodisiac, gout, 
antirheumatic, voice clearness, 
antipyretic, antiscorbutic & food 
condiment. 
  
S 20 
Fagonia bruguieri Prod. 
 
Shika,a Zygophyllaceae 
 
Whole plant Antipyretic, antiasthmatic, anti-emetic, 
dysentery, typhoid, anti-toxic, anti-
tumor, blood and heart tonic & for 
ulcers. 
W, M, S 12, 13, 14 
Fagonia indica Burm. Showaika Whole plant Used for smallpox & gout. M, W, S 12, 13, 14 
Peganum harmala L. Harmal Seeds Sexual stimulation. W, S 13, 16 
Tribulus terrestris L. Shirshir Leaves Renal colic. W, M, S 12, 13, 14 
Zygophyllum album L. Retret Whole plant Antidiabetic & cardiovascular disease. S 15 
Zygophyllum coccineum L. Harm Whole plant Anthelmintic. M, S 13, 14 
Zygophyllum simplex L. AL-damran Whole plant Used in ophthalmic disease. W, M, S 12, 13, 14 
W= west region of KSA, S= south region of KSA, M=middle region of KSA 
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         Figure 1S: Structures of the major compounds isolated from J. procer 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Figure 2S: Structures of the major compounds isolated from R. nervosus 
 
 191 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Figure 3S: Structures of the major compounds isolated from Z. spina-christi 
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